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Abstract

EXTRACELLULAR MATRIX-BASED SUBSTRATES FOR PROPAGATION OF
HUMAN PLURIPOTENT STEM CELLS
By Sheena Abraham, M.S.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: Raj R. Rao
Assistant Professor, Chemical and Life Science Engineering

In human pluripotent stem cell (hPSC) research and applications, the need for a culture
system devoid of non-human components is crucial. Such a system should exhibit
characteristics observed in conventional culture systems that have used mouse embryonic
fibroblast feeders for hPSC self renewal without the requirement of excessive
supplementation with growth factors. To achieve this, we focused on the identification and
characterization of extracellular matrix (ECM) substrates for hPSC propagation. ECM
substrates derived from mouse and human fibroblasts were assessed for their ability to
support self-renewal of hPSCs. Characterization of hPSCs on ECM-based substrates
1
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demonstrated maintenance of pluripotent characteristics based on a) high nuclearcytoplasmic ratio b) immunocytochemical analyses for pluripotent markers (Alkaline
phosphatase, AP, Octamer Binding Transcription Factor-4, OCT4 and Specific surface
embryonic antigen-4, SSEA4) c) in vitro differentiation potential by embryoid body
formation d) Real time RT-PCR analysis for pluripotent and germ-layer specific markers
and e) karyotype analysis for chromosome number. Compositional characterization of the
ECM substrates using proteomic analysis identified some of the major constituents of the
matrix that might contribute to hPSC self-renewal. Based on results from the proteomic
analysis, combinatorial ECM substrates were formulated using commercially available
proteins and evaluated for applicability in hPSC propagation. Extensive characterization of
hPSC propagated on the ECM substrates suggest that a combination of heparan sulfate
proteoglycan and fibronectin was sufficient for the promoting hPSC sef-renewal. Finally,
an in-direct co-culture system utilizing microporous membranes coated with acellular
substrates and a physically separated feeder layer was developed as a microenvironment
for hPSC propagation. Real time conditioning of the growth medium and an ECM-based
substrate for hPSC adhesion provides a synergy of the biochemical and biophysical cues
necessary for hPSC self-renewal. hPSCs cultured in this system demonstrated equivalent
pluripotent characteristics as those propagated in conventional culture systems, and
provided opportunities for scale up without cell mixing. Overall, these studies could prove
to be useful in the development of humanized propagation systems for the production of
stable hPSCs and its derivatives for research and therapeutic applications.

CHAPTER 1: Background and literature review

Summary
Human pluripotent stem cells that include embryonic and induced pluripotent stem cells
hold enormous potential for the treatment of many diseases, due of their ability to generate
cell types useful for therapeutic applications. Currently, many stem cell culture
propagation and differentiation systems incorporate animal-derived components for
promoting self-renewal and differentiation. However, use of these components are labor
intensive, carry the risk of xenogenic contamination and yield compromised experimental
results that are difficult to duplicate. From a biomaterials perspective, the generation of an
animal-free and cell-free bio-mimetic microenvironment that provides the appropriate
physical and chemical cues for stem cell self-renewal or differentiation into specialized cell
types would be ideal. This chapter presents the use of natural and synthetic polymers that
support propagation and differentiation of stem cells, in an attempt to obtain a clear
understanding of the factors responsible for the determination of stem cell fate.
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Introduction
Over the last decade, human pluripotent stem cells (hPSCs) that include human
embryonic stem cells (hESCs) [1, 2] and more recently, induced pluripotent stem cells
(iPSCs) [3-5] have garnered a lot of attention due to their inherent self renewal and
pluripotent capabilities. The pluripotent nature of these cells i.e., the ability to differentiate
into all somatic cell types, have opened avenues for potential stem cell based regenerative
therapies, development of drug discovery platforms and as unique in vitro models for the
study of early human development. To meet specific needs for cell-based therapies, some
of the key research questions that need to be addressed include a) the elucidation of
molecular mechanisms that determine the stem cell fates of self-renewal, differentiation,
apoptosis and quiescence; and (b) bioprocessing strategies to generate bankable and
uniform populations of undifferentiated cells. The key variables in the development of
bioprocessing strategies for propagation of pluripotent stem cells involve medium
formulations and biomaterials as substrates. In this chapter, we present an overview of the
potential for different biomaterials in determining pluripotent stem cell fate (mouse and
human) relating to self-renewal and differentiation.
Mouse embryonic stem cells (mESCs) were one of the first ES cell types derived
from the inner cell mass (ICM) of pre-implantation blastocysts, and cultured in direct
contact with mitotically inactivated mouse embryonic fibroblasts (MEF) feeder layers [6].
This culture methodology was primarily adopted to provide the cells with the appropriate
conditions conducive for self-renewal rather than differentiation and has since been
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employed by many laboratories for the isolation and maintenance of pluripotent stem cells
of different species. In primates, ES cells were first isolated from rhesus monkeys and
subsequently from humans, and maintained for extended periods without undergoing
differentiation in direct co-culture with MEFs. The removal of MEF feeders in the culture
system triggered spontaneous differentiation into many somatic cell types [2, 7].
From a cell-based regenerative therapy perspective, the use of MEFs for the
propagation of hPSCs is recognized as a potential hurdle by many researchers. It is widely
acknowledged that mice carry pathogenic parasites, bacteria, and viruses as well as
endogenous retroviruses in their genome. Some endogenous retroviruses have the
capability to infect foreign species and have been shown to cause diseases like leukemia in
immuno-suppressed primates [8]. Researchers in the stem cell community are thus
presented with the challenge of developing of hPSC propagation systems that do not
involve the use of other species-derived feeders.
Biomaterials have been investigated extensively as substrates for cell propagation,
scaffolds for tissue engineering and as delivery vehicles in many regenerative biomedical
paradigms. One of the key benefits of using biomaterials for pluripotent stem cell
propagation is the elimination of direct co-culture with a feeder layer. This removes the
risk of contamination with xenogenic pathogens and reduces variability in experimental
outcomes due to feeder layer contribution. Additionally, specialized biomaterials that
include appropriate chemical (incorporation of growth factors) and physical (topographic
features) modifications, have contributed to successful differentiation of ES cells to
multiple cell types.

4
Biomaterials such as hydrogels have been used in mammalian cell culture for over
30 years, because of its high water absorbability and tissue-like texture. Poly
methylmethacrylate (PMMA) and Poly lactic glycolic acid (PLGA) are examples of a few
biocompatible materials used in various tissue culture based applications [9, 10]. In ES cell
research, polymeric substrates have largely been used as carrier systems for lineage
specific differentiated cells. Instances of the use of polymeric-based biomaterials employed
in hPSC self renewal maintenance are few in number. The use of a polymer-based
substrate that can be synthesized with "off-the shelf" constituents for hPSC culture has
several advantages, as a) economic feasibility b) reduction in the labor involved to
maintain an additional cell line as feeders and c) elimination of the source of potential
xenogenic contamination. It is expected that advances in biomaterial-based approaches will
immensely contribute to standardization of culture methodologies, leading to development
of bioprocesses for hPSC propagation and differentiation. Here, we attempt to present the
knowledge acquired from the integration of biomaterial engineering and pluripotent stem
cell biology to chalk out standardized routes for stem cell self-renewal and/or directed
differentiation.
Substrates for pluripotent stem cell self-renewal
The need for an unlimited supply of starting hPSC populations for current research
and future therapeutic applications fuels this area of research. In this section, we address
the application of different substrates that are both feeder-dependent and feeder-
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independent systems and have contributed to successful long term propagation of
pluripotent stem cells in their undifferentiated state.
Feeder-layer dependent propagation systems
Mitotically inactivated mouse embryonic fibroblasts (MEFs) have been the
traditional ‘feeder-layer’ of choice since the isolation and propagation of mESCs [6]. They
have served as ideal substrates as they provide appropriate physical and chemical cues
conducive for the maintenance of self-renewal in pluripotent stem cell populations. In a
few cases, such as those involving rat ES cells and American mink ES cell propagation, it
was demonstrated that the best feeder-layer were fibroblasts derived from the host animal
[11, 12]. However, the isolation and propagation of several rodent, non-rodent ES [13-15]
and non-human primate ES cells [7, 16] required MEFs as feeders for long term
propagation. MEFs have also been used as the feeder of choice for culture systems that
were initially developed for propagating hESCs and were shown to be capable of
maintaining hESCs in their undifferentiated state for > 250 population doublings [1, 2].
The successful long term maintenance of ESCs on MEFs has been attributed to
unidentified physical cues provided by the cellular layer or chemical cues based on
nutrients released into the growth medium that create an environment suitable for
proliferation and self-renewal. However, the use of animal cells as a substrate poses risks
of xenogenic contamination by animal pathogens, which in turn could be transmitted to
patients. Recent findings have revealed the presence of a non-human carbohydrate moiety
on the surface of hESCs with the potential of eliciting an immune reaction from humans
[17] Figure 1.
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Figure 1
Schematic of the transfer of non-human carbohydrate moiety from mouse feeder layers
onto the cell surface of human pluripotent stem cells. Contamination of hESCs with a nonhuman sialic acid, N-glycolylnueraminic (Neu5Gc) due to its metabolic uptake acid from
MEFs, animal-based serum and other products in the growth medium. In humans, a
precursor to Neu5Gc; N-acetylneuraminic acid (Neu5Ac) and circulating antibodies for
this foreign sugar are present, which might lead to the rejection of specialized cells derived
from such hESCs

7
Extensive research to propagate hPSCs in culture conditions with reduced or zero
animal-derived products is being actively pursued. One of the earliest advances towards a
xeno-free environment was the elimination of serum, specifically fetal bovine serum in
hESC cultures. Fetal bovine serum has been extensively used in mammalian cell cultures;
however, the composition of serum is not entirely known and different batches vary in
their capabilities to support undifferentiated proliferation. A serum replacement, Knockout
Serum Replacement (KSR) [18] optimized for mESC cultures, was successfully introduced
in hPSC cultures [19], and is now routinely used as a serum–substitute in many
laboratories to propagate hPSCs [20, 21]. In attempts to make the hPSC culture conditions
animal-free, several human fibroblast cell lines have been tested and proven to be suitable
feeders. Propagation conditions involving human foreskin fibroblasts as feeders in KSRsupplemented growth medium have been used to maintain hESCs for 70 passages [22], and
in the derivation of new hESC lines [21]. An advantage to using human foreskin
fibroblasts as a feeder layer lies is in its ability to be continuously cultured for about 42
passages unlike MEFs which senesce in 5-7 passages. There was no significant difference
found in the hESCs propagated on different lines of foreskin fibroblasts obtained from
several newborns leading to the conclusion that the source of the foreskin fibroblasts does
not affect the undifferentiated propagation of hESCs [23, 24].
Other human fibroblast feeders tested include fetal skin and muscle cells, adult
fallopian tubal epithelial cells, adult skin, muscle, glandular and stromal endometrial cells,
and commercially available fetal skin, lung and neonatal foreskin cell lines. One general
observation made by the investigators was that fetal lines were more supportive of long
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term hESC propagation compared to adult lines [25, 26]. Other examples of human feeders
tested were human marrow stromal cells[27], human adult uterine endometrial cells,
human adult breast parenchymal cells, embryonic fibroblasts[28], and human placental
fibroblasts[29, 30]. To test the efficiency of hESC derived fibroblasts (hES-dF) as possible
feeders, two different hESC lines (NCLI and H1) were grown on their autogenic as well as
allogeneic fibroblast derivatives. These studies demonstrated that hESC derived feeders
were capable of maintaining self renewal in both the parent as well as a foreign hESC line
[31]. Cynomolgus monkey ES cells grown on human placental feeder layers; amniotic
epithelial plate cells or chorionic plate cells, remained pluripotent for at least 18
passages[32]. These studies demonstrated that regardless of the source of the feeder layer,
certain cell types are more capable of maintaining self-renewal capabilities of pluripotent
stem cells. Detailed analyses of the similarities and differences between such feeders will
provide valuable insights on key factors that maintain self-renewal capabilities and prevent
differentiation of pluripotent stem cells.
Feeder-layer independent propagation systems
A few groups have demonstrated that hESCs can be maintained without feeders or
feeder-conditioned medium, relying on growth medium supplementation with high
concentrations of basic-fibroblast growth factor (bFGF). Many of these studies helped
ascertain the molecular mechanisms involved in hESC self-renewal, such as the central
role played by inhibition of components of the BMP signaling pathway[33, 34]. In this
section we have focused on the role of natural biopolymers such as Gelatin, Matrigel™,
naturally derived polymers such as alginate, agarose, and hyaluronic acid and several
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synthetic polymers that allow controlled modifications and incorporation of physical,
chemical and mechanical cues for the maintenance of pluripotent stem cells.
Natural biopolymers for pluripotent stem cell self renewal
Gelatin is thermally denatured collagen derived from animal skin and bones, and
has long been used as a promoter of cell adhesion and proliferation in various cell lines
[35-37]. mESCs, in the absence of a feeder layer have been maintained on gelatin coated
dishes and growth medium supplemented with interleukin-6 family member cytokine
Leukemia Inhibitory Factor (LIF) for extended periods [38-40]. The binding of LIF
receptor β/gp130 heterodimer and the activation of the JAK/STAT3 signaling pathway has
been implicated in mESC self-renewal [41]. As a cost-effective alternative to periodic LIF
supplementation; LIF immobilized photoreactive gelatin demonstrated that mESCs
maintained pluripotent characteristics after six days of culture [42]. The cells grown on
gelatin-coated polyamide nanofibers electrospun onto glass coverslips demonstrate
enhanced proliferation and self-renewal capabilities when compared to cells directly grown
on gelatin-coated glass coverslips. These effects were correlated to an increase in the
expression of NANOG, activation of the small GTPase Rac, and the activation of the
phosphoinositide 3-kinase (PI3K) pathway. The relationship between the PI3K pathway
and regulation of STAT3 and ERK make it likely that microenvironmental cues are a
major factor in control of mESC self-renewal [43, 44].
In an attempt to move away from MEF-based feeder layers in human pluripotent
stem cell cultures, an extracellular (ECM) -based substrate, Matrigel™ has been used to
support hESC cultures. Matrigel™ is an ECM protein based gel derived from the basement

10
membrane of Engelberth-Holm-Swarm (EHS) mouse sarcoma. Matrigel ™ has been found
to be rich in collagen, laminin, heparin sulfate proteoglycans and growth factors such as
transforming growth factor β (TGFβ), epidermal growth factor (EGF), fibroblast growth
factor (FGF) [45-47]. Extensive studies on the efficacy of Matrigel™ and the individual
components of Matrigel™; such as laminin, collagen IV and fibronectin have been
investigated for hESC propagation. Collagen IV and fibronectin individually did not
support hESC propagation whereas laminin was successful in maintaining long-term
undifferentiated hESC cultures. However, all of these hESCs were propagated in mouse
embryonic fibroblast conditioned medium (MEF-CM), with the absence of MEF-CM
leading to extensive spontaneous differentiation of the hESCs [48]. Another study
demonstrated the successful maintenance of hESC cultures in growth medium containing
KSR supplemented with high concentrations of bFGF, TGFβ1and LIF, on a fibronectin
matrix [20]. The premise for the use of these factors was that (a) bFGF is routinely used to
maintain hESC cultures [19]; (b) TGFβ1 was found in Matrigel™ [48]; (c) fibronectin
promotes cell adhesion [49] and (d) leukemia inhibitory factor (LIF) activates the
JAK/Stat3 pathway and is sufficient for the self-renewal of mESCs [38-40, 50] and might
elicit the same response in hESCs. However, it was found that neither the addition of LIF
nor the activation of Stat3 pathway contributed to self-renewal in hESCs [2, 51].
Apart from the use of Matrigel™, very few studies have demonstrated the use of
ECM based substrates for hESC maintenance, with one study reporting the use of human
serum as a substrate to maintain hESCs for over 27 passages [52]. A recent study that is
extremely promising has focused on the usefulness of hyaluronic acid (HA) based
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hydrogels for propagation of hESCs [53]. HA is a nonsulfated linear polysaccharide of (1β-4) D-glucuronic acid and (1-β-3) N-acetyl-D-glucosamine found largely in the ECM of
undifferentiated cells during early embryogenesis and shows reduced expression on
differentiation [54]. Hyaluronic acid (HA) is also present in the body as a major constituent
in ECM in connective, neural and epithelial tissue. Large scale microbial production of HA
has allowed for the use of this polymer in different therapeutic applications. Such naturally
derived polysaccharides also considered as synthetic ECM hydrogels can substitute natural
ECM. The premise for the use of ECM based protein hydrogels is to create a
microenvironment that mimics the physiological milieu of the inner cell mass (ICM), by
acting as a host that provides the resident cells with 3-dimensional architecture and
mechanical support for structured organization and easy diffusibility for nutrients and
metabolites [55-57]. HESCs that were encapsulated within the HA construct in MEF
conditioned medium maintained their undifferentiated state for 20 days. The cells were
released from the hydrogel by treating the constructs with hyalurodinase to digest the HA
hydrogel, cells showed no adverse effects to extended exposure (24 hours) to the enzyme.
Although natural biopolymers such as polysaccharides, ECM-based substrates and other
hydrogels hold great promise as biomaterials for pluripotent stem cell propagation and
presenting cells with familiar microenvironments, new strategies are required for greater
control to promote uniform proliferation of stem cells in their undifferentiated state.
Synthetic Biomaterials for pluripotent stem cell self-renewal
Replacing natural materials with synthetic polymers allows for controlled modifications;
such as addition of embryologically relevant growth factors. It is useful to note that
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mammalian cell culture propagation have traditionally been conducted on flat, rigid
substrates. However, the three-dimensional microenvironments that the cells encounter in
the body have a combination of physical, chemical and mechanical cues [58, 59] (Figure
2). Consequently, the ease with which polymers can be engineered into complex 3D
structures is a key benefit of using polymers instead of feeder cells in pluripotent
propagation systems. Poly (α-hydroxy esters), and polyurethane are few examples of
synthetic polymers that have been used as part of pluripotent stem cell propagation
systems. Poly(α-hydroxy esters) with enhanced surface hydrophilicity and roughness
properties [60], and fluorinated hydroxyapatites have been identified as substrates that can
maintain mESCs as colonies[61]. Poly (hydroxyethyl methacrylate) p(HEMA), a widely
used non-degradable biomaterial is another synthetic polymer that supports mESC
proliferation[62, 63]. mESCs were maintained in their undifferentiated state for a limited
time period of 4 days, which was confirmed by replating the cells extracted from the
hydrogel slabs onto gelatin-coated dishes. Cells that were allowed to proliferate for longer
periods in the p(HEMA) slabs, formed large clusters (6-8 days) and showed reduced
expression of pluripotent markers when replated on gelatin-coated dishes compared to the
4-day cultures. mESCs grown on non-woven polyester fabrics from polyethylene
teraphthalate (PET) initially exhibited high expression of pluripotent markers alkaline
phosphatase (AP) and Stage-specific embryonic antigen (SSEA-1)[64]. However, reduced
expression of SSEA-1 was seen in mESCs after 72-96 hours, indicating that PET
substrates did not facilitate long-term undifferentiated propagation and would be best
suited for differentiation studies rather than for maintaining self renewal.
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Figure 2:
Components of the cellular microenvironment in vitro need to mimic in vivo conditions:
Synergy of biochemical cues such as signaling molecules and growth factors; biophysical
cues such as substrates; mechanical cues such as hemodynamic forces, shear forces and
periodic strains; and cell-cell interactions are required for determination of fate of
pluripotent stem cells
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However, another study involving fibrous PET matrices was shown to sustain long-term
growth of mESCs [65], where matrices with pores 30-60 μm wide caused more rapid cell
growth than in pores of 60-130 μm in width. This was attributed to greater contact between
the cells and PET fibers within smaller pores leading to increased attachment and better
support. Large pores allowed cells to aggregate more easily, which induced mESC
differentiation. Gelatin coating of the polymers did not improve mESC proliferation and
self-renewal, though such effects could be due to blocking and partial destruction of the
pore structure of the PET matrices. One drawback of such a 3D fibrous matrix construct
for ESC culture is poor oxygen supply at high cell densities. The effects of poor oxygen
transfer could be seen when cell proliferation slowed and cellular death was seen at or near
day 14. Thus comparative studies of superporous polymers with varying pore sizes, surface
charges and hydrophobicity characteristics show that substrates with smaller pores sizes in
the range of 30μm wide supported proliferation of mESC better than pores of larger
dimensions(100μm). Neutral or cationic substrates as compared to a negatively charged
substrate and hydrophobic surfaces compared to a hydrophilic allowed for greater mESCs
adhesion and aggregation for colony formation [62, 63] The effect of surface roughness on
mESC culture on poly(α-hydroxy esters) substrates demonstrated that within a certain
range increase in roughness with a corresponding reduction in hydrophilicity enhanced
mESC attachment and proliferation[60]. These informative studies demonstrate that
surface texture modifications can play a role in influencing the self-renewal properties of
stem cells
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Studies have demonstrated that presentation of various cell adhesion ligands,
introduction of roughness and patterned features can influence stem cell fate by stimulating
cell attachment, proliferation and differentiation [66, 67]. Patterned surfaces of hylauronan
and poly-L-Lysine (PLL) were shown to maintain mESC in their undifferentiated state
within a spatially controlled culture system with fibroblasts. In these studies, Hyaluronan
was lithographically patterned on glass surfaces to create parallel strips alternating with
glass; fibronectin was selectively deposited on the glass, with poly-L-Lysine on
hyaluronan permitting differential cell adhesion on the two surfaces. Fibroblasts were
grown on glass surfaces treated with fibronectin and mESC on PLL surfaces. Such systems
have a potential advantage over random co-culture where mixing of feeder cells with ESC
is unavoidable [68].
A three-dimensional porous polymer scaffold of elastomer, poly-(glycerolcosebacate)acrylate (PGSA) support undifferentiated hESC culture for one week [69]. PGSA is an
elastic hydrogel that is known to elicit low inflammation in response to in vivo
transplantation [70, 71] and allows for future applications as a biocompatible and
biodegradable scaffold. Polyurethane microwells coated with MatrigelTM demonstrated the
ability to maintain hESCs in for three weeks without the need for routine passaging. The
cells grown in these conditions maintained their pluripotency and differentiated into the
three germ layers when cultured in suspension. The use of mouse-derived MatrigelTM as a
substrate indicated that an ECM modification of the synthetic polymer was essential for
propagating hESCs [72]. A synthetic 3-D ECM based semi-interpenetrating polymer
network of poly(N-isopropyl acrylamide-co-acrylic acid) was reported to support short
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term hESC self-renewal. Modification of the hydrogel polymer with the incorporation of
synthetic RGD peptides to present the cells with adhesion sites improved cell attachment,
allowed the formation of colonies and maintained pluripotency for a limited period of five
days [73]. Recent studies have also investigated the feasibility of culturing hESCs on
microcarriers in feeder-free, 3-dimensional suspension culture[74, 75]. These studies
suggest that suspension-based propagation of hESCs on microcarriers may provide unique
opportunities for bulk hESC production and storage.
Combinatorial and microarray approaches have been adopted recently in highthroughput screening of materials to control ESC fate on polymer surfaces. Such highthroughput approaches also hold much promise in 3-D screening of libraries of
biofunctional groups such as morphogenetic proteins incorporated within synthetic 3-D
materials. A vast number of possible combinations of polymers, surface treatments,
surface-bound ligands, and other substrate modifications need to be investigated in ES cell
propagation systems. A recent study has demonstrated the potential of high-throughput
arrays in studying biomaterial- ES cell interactions and provided insights on the role of
specific polymers in promoting cell attachment, proliferation and differentiation [76].
Another combinatorial approach focused on the effects of eighteen different lamininderived peptides on proliferation and self-renewal of hESCs. Self assembled monolayers
(SAMs) were designed which allowed the formation of array elements of well-defined
shapes and sizes. Five out of the eighteen peptides tested were effective in maintaining the
undifferentiated state of hESCs for 5-7 days. Further characterization of the five peptides
with a nanofibers based peptide (RNIAEIIKDI)- amphiphile containing 3D- hydrogel
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demonstrated their potential in promoting proliferation and maintaining undifferentiated
hESCs [77].
Recent developments involving transductions of somatic cells to induce
pluripotency has been heralded as one of the major breakthroughs in stem cell research;
primarily due to its potential to advance customized cell-based therapies and the evasion of
embryo-related ethical debates [3-5]. Although the use of synthetic materials for promoting
iPSC fate from somatic cells has not been explored, the use of synthetic polymers as gene
or protein delivery vehicles for inducing pluripotency is a definite possibility. Recent
studies have demonstrated the potential of poly (amino esters) based biodegradable
nanoparticulate vectors for gene delivery to efficiently transfect ESCs with low
cytotoxicity [78, 79]. These methodologies have significant implications in the generation
of iPSC lines that are free of exogenous viral additions to the genome. Ultimately, the
development of a completely synthetic substrate to maintain hESC cultures or in the
induction of pluripotency from somatic cells would present the ideal feeder-free and
animal-free culture environments for long term undifferentiated and stable hESC
propagation.
The culture of pluripotent stem cells on polymeric surfaces with or without
immobilized proteins opens up avenues for identification of synthetic microenvironments
that can be easily synthesized and modified to form scaffolds that support the
differentiation of ES cells into highly ordered 3D structures.In ES-cell studies, biomaterials
have been frequently used to direct differentiation to specific lineages, in the presence of
appropriate growth factors. However, maintenance of its undifferentiated state has proven
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to be a challenge. The use of native and synthetic polymers in promoting ES cell selfrenewal is still in its nascent phase and has great potential as demonstrated by the various
studies conducted to date (summarized in Table 1).
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Table 1
Summary of substrates used for propagation of human and mouse pluripotent stem cells
Substrate Type

Cell Source

Substrate

Time line of study

References

Feeder layer
based

hESCs

Human foreskin fibroblasts

> 70 passages

[80] [23, 81]

Fetal skin cells
Fetal muscle cells
Adult skin fibroblasts
Adult muscle fibroblasts
Commercially available fetal skin
fibroblasts Adult Fallopian tubal
epithelial fibroblasts
Adult marrow cells
human adult uterine endometrial
cells (hUECs),
Human adult breast parenchymal
cells (hBPCs),
Human embryonic fibroblasts
(hEFs)

20 passages
> 50 passages
> 30 passages
> 30 passages
> 25 passages
> 20 passages

[82, 83]

13 passages
90 passages
50 passages
80 passages

[84]
[85]

Human placental fibroblasts
HESC derived fibroblasts

> 25 passages
44 passages
30-52 passages

[86, 87]
[88],[89]

6 days
3 days

[90]
[43]

hESCs

LIF immobilized on gelatin
Gelatin-coated polyamide
nanofibers
Matrigel
Human Serum
Mouse embryonic fibroblasts ECM
Hyaluronic Acid

~130 passages
> 27 passages
> 30 passages
20 days

[91]
[52]
[92]
[93]

mESCs

Hydroxyapatites polymers

48 hours (time
required for
colonization)
4 days
72-96 hours
15 days

[94], [95]

1 Week

[97]

> 21 days
5 days

[98]
[73]

Natural substrates

Synthetic
substrates

mESCs

Poly(hydroxyethyl Methacrylate)
LIF immobilized PET fibers
Gelatin immobilized PET fibers
hESCs

Poly - (glycerolcosebacate)acrylate (PGSA)
Polyurethane micro-wells
Poly(N-isopropyl acrylamide-coacrylic acid) sIPN

[62]
[64]
[96]
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Substrates for pluripotent stem cell differentiation
The excitement in the biomedical community with regard to pluripotent stem cells
centers on their ability to differentiate into any somatic cell type. This unique property
makes it possible to derive rare tissue types in unlimited quantities, which would be of
immense use in areas such as in vitro drug screening and regenerative medicine.
Differentiation of ESCs occurs spontaneously either in prolonged cultures or in the
absence of feeder layers, leading to populations consisting of multiple cell types from
many different lineages. Directed differentiation involves either a) exposure of ES cells to
growth factors that mimic natural pathways in embryonic development b) co-culture with
suitable cytokines secreting feeders or c) replating enriched populations derived from EBs.
A more commonly used method to induce differentiation is the formation of embryoid
bodies (EB), which are three-dimensional ES cell aggregates grown in suspension or in an
environment that does not support cell adhesion [99]. Heterogeneous subpopulations are
enriched for a cell type of interest, isolated and replated [100-105], with induction of
differentiation by the addition of growth factors to the medium [106, 107]. Cell types that
have been derived through use of EB include those of chondrogenic, adipogenic,
neurogenic, cardiogenic, hematopoietic and myogenic lineages. However, thus far, the
resulting populations have been largely random in their phenotype and organization.
Consequently, there exists a need for protocols that can differentiate ES cells to highly
specific derivatives with increased reproducibility and capacity for scale-up. The
challenges in directed differentiation protocols are a direct result of the basic lack of
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understanding of the mechanisms involved in lineage specification. In this section we
briefly describe feeder-dependent and feeder-free (natural and synthetic polymers)
approaches to differentiation of ES cells into multiple cell types from the three different
germ layers (ectoderm, endoderm and mesoderm).
Endodermal Differentiation
Of the several cell types that originate from the endoderm, differentiation strategies
for hepatic and pancreatic cell types have been extensively studied. Induction of hepatic
and pancreatic differentiation from ESCs has garnered a lot of attention due to possible
therapeutic applications for diseases such as liver damage and diabetes. Studies of the
differentiation of ESCs into the pancreatic lineage largely involve formation of EBs
followed by a sequential and elaborate exposure to endodermal lineage promoting growth
factors and extracellular matrix proteins [108, 109]. Currently, there are no reports that
points of the use of polymeric substrates for induction of pancreatic differentiation in
mouse or human ES cells. However, there have been published reports on the use of both
feeder layers and polymers in the differentiation towards the hepatic lineage. Co-culture of
mESCs with primary adult rat hepatocytes has been shown to induce hepatocyte
differentiation, with enhancement upon addition of hepatotrophic growth factors [110].
Additional studies for hepatic differentiation have focused on the use of natural polymers
such as collagen and alginate [111]. Alginate is a biocompatible hydrophilic viscous gum
derived from algae and has been used in various biomedical applications due to its
hydrogel and ECM gel-like properties[112, 113]. The use of alginate beads for EB
formation allows for scale up of hepatocyte derivation and act as a source of cells for a
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bioartifical liver system [114]. Naturally derived alginate beads were used to form EBs
from mESCs followed by replating of the dissociated cells in medium supplemented with
appropriate growth factors to induce hepatocyte differentiation.
Synthetic polymers such as polyurethane have also been used to promote
hepatogenesis. For example, a polyurethane foam (PUF) as part of a hepatocyte culture
system was presented as a hybrid artificial liver [115], with subsequent replacement of
hepatocytes with ES cells as a cell source within this module. When mESCs were placed in
the porous PUF, they aggregated into spherical multicellular structures, on further
exposure to a cocktail of growth factors, differentiated into mature hepatocytes [116]. An
improvement to this culture system was later introduced by the same group of researchers
that included a bioreactor consisting of a PUF block with capillaries to aid growth medium
flow to effect hepatic lineage induction in mouse and cynomolgus monkey ES cells [117,
118].
Hepatocytes have commonly been derived from hESCs by either replating cells
from EBs or by sequential exposure to different growth factors [119-121]. Similar to
mESCs, natural ECM-based polymers have been used in hepatic differentiation of hESCs.
A comparative study between 2D and 3D culture systems that utilized collagen
demonstrated that 3-D collagen scaffolds induced specification in 5 day old EBs. Further,
addition of exogenous growth factors to 3-D collagen scaffold allowed for better
hepatocyte differentiation than collagen coated 2-D dishes [122]. Unlike mESCs, no
reported studies of synthetic polymers as substrates in hESC hepatogenesis have been
identified.
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Mesodermal Differentiation
Derivatives of the mesoderm that have been successfully differentiated from ESC
cultures include cardiomyocytes, cells of hematopoietic lineage, endothelial cells, and
germ line cells [123-129]. The utilization of biomaterials as part of differentiation
strategies for specialized cells from the mesodermal lineages: hematopoietic, osteogenic,
chondrogenic and adipogenic, have been extensively studied.
Feeder dependent and feeder free systems have been extensively used in
hematopoietic differentiation of mESCs. Cells of the hematopoietic lineage were the first
reported cell types derived by direct differentiation of mESCs using a bone marrow
stromal cell based feeder layers, OP9 cells [130] and RP010 [131], in growth medium
conditioned by fetal liver stromal cells and supplemented with interleukin 6 (IL-6).
Natural polymers such as MatrigelTM, fibrin, dextran and collagen have been used
as substrates for differentiation of mESCs to both the hematopoietic and endothelial
lineage. Researchers achieved hematopoietic differentiation of mESCs by culture on
collagen type IV, through a chain of intermediate differentiation steps, with mESCs first
forming cells from the proximal lateral mesoderm, followed by formation of
hemangiogenic progenitors, differentiation into hematopoietic precursors and ultimately
mature blood cells. This study also identified the progression of lineage commitment for
hematopoietic precursor cells and its was noted that hemangiogenic progenitor constituted
a critical stage for the divergence of the endothelial and hematopoietic lineage [132, 133].
Differentiation of mESCs on Collagen IV substrate was later adapted to generate a pure
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endothelial progenitor population [134, 135]. However, collagen-based substrates were
found to be inefficient in differentiating rhesus monkey ES cells to endothelial cells [136].
Endothelial and hematopoietic differentiation of ES cells have also been
demonstrated within three-dimensional fibrin constructs [137]. Researchers demonstrated
that fibrin polymers reinforced with poly(ethylene glycol) (PEG), promoted a high
expression of VE(vascular endothelial)-cadherin in encapsulated mESC-derived EBs
formed within the construct. It has been postulated that PEGylation of fibrin blocks
antigens, resulting in a reduction of cell-matrix interactions as fibrin gels have the capacity
to engage cell-adhesion molecules [138], this reduced cell-matrix interaction might be
involved in promoting differentiation of the ES cells [139]. 3D dextran constructs modified
with bioactive ECM molecules have also been used to generate EBs from mESCs.
Addition of vascular endothelial growth factor (VEGF) within the dextran constructs
yielded cells with increased expression of endothelial markers KDR/Flk-1 and decreased
expression of ectodermal and endodermal markers. These cells also showed lower
ectodermal (Nestin) and endodermal (α-fetoprotein) marker expression, indicating a
preference for mesodermal differentiation of ESCs within the VEGF - dextran culture
environment. Further specification was achieved by removing the cells from the hydrogels
and propagating on gelatin-coated dishes in endothelial differentiation medium [140].
Another study which further highlighted the importance of ECM components in the
differentiation of mESC-derived EBs involved the used of 3D constructs that consisted of a
collagen-based semi-interpenetrating polymer networks (SIPNs) with varying
concentrations of fibronectin (FN) and laminin (LM) [141]. EBs differentiating within the
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FN-loaded SIPNs formed cord-like structures indicative of endothelial differentiation,
while LM-loaded SIPNs produced beating cells that provided evidence of increased
differentiation towards cardiomyocytes.
Synthetic polymers have also been used to direct differentiation of ES cells to
hematopoietic cells based on use of Cytomatrix®, a porous tantalum-based scaffold
synthesized using chemical vapor deposition of metals onto an open pore carbon scaffold,
creating a mechanically strong and highly porous scaffold. EBs generated in this scaffold
produced hematopoietic progenitor cells with a greater efficiency than EBs generated from
traditional 2D culture dishes, and exhibited a greater propensity to produce dendritic celllike myeloid cells. Dynamic culture conditions using spinner flask technology increased
the efficiency of hematopoietic differentiation within the scaffolds, EBs within the
scaffolds were less likely to aggregate when covered with an ECM coating.
These studies demonstrated that differentiation within 3-D microenvironment enhanced
ECM production, which in turn increased cell-cell and cell-substrate interactions and
contributed to more efficient hematopoietic differentiation [137, 142].
Recent studies that have focused on differentiation of hESCs to hematopoietic cells have
utilized human feeders and other natural polymers. Direct co-culture of hESCs with
stromal cells from mouse hematopoietic tissue, bone marrow cells line S17, or a yolk sac
endothelial line C166 induced differentiation into the hematopoietic lineage [143]. An
example of the application of natural polymers in mesodermal differentiation involved a
study that compared three models for differentiation: 2D culture conditions, EBs formed
within a polymeric (alginate) scaffold and a slow turning lateral vessel bioreactor.
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Undifferentiated hESCs seeded into the porous scaffolds formed EBs similar to those
produced by a slow-turning lateral vessel bioreactor, in that they were well-rounded and
did not form aggregates. However, alginate scaffolds induced vascular differentiation to a
greater extent than the 2D culture plates and the bioreactor [144]. Unlike mESCs, no
reported studies of synthetic polymers as substrates in hESC differentiation to
hematopoietic and endothelial cells have been identified.
Feeder layers of similar lineage have been shown to support and induce osteogenic
differentiation in mESCs and hESCs. For example, fetal murine osteoblasts with mESCs
[101] and human periodontal ligament fibroblasts (hPLFs) with hESCs have been used in
co-culture systems to enhance osteogenic differentiation [145].
Alginate was initially postulated to support chondrogenic proliferation [146, 147] but
studies showed that EBs formed from mESCs encapsulated within an alginate construct
with dexamethasone supplementation showed no enhanced chondrogenic potential when
compared to intact EBs [148]. Additionally, there was no stimulatory effect of
dexamethasone on chondrogenic differentiation. However, this report was one of the first
to demonstrate chondrogenic potential of EBs within a 3-D construct. Successful examples
of the application of a scaffold for osteogenic differentiation from mESCs include; the use
of a 3-dimensional self assembling peptide substrate [149] and alginate beads loaded into a
bioreactor fed with osteogenic inducing growth medium [150].
Synthetic polymers such as PEG have been successfully used in a recent study that
reported the induction of chondrogenic differentiation in mESCs within a poly-(ethylene
glycol) based polymeric 3-D environment. In these studies, 5 -day old EBs prepared in
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suspension cultures were encapsulated in a photopolymerizable PEG polymer, with
addition of TGFβ1 and glucosamine to the growth medium, enhancing the chondrogenic
differentiation capabilities of EBs [151, 152]. Such 3D systems exhibit potential for ES
cell delivery to the site of injury circumventing issues that arise with low proliferative
capacity of differentiated chondrocytes as well as loss of phenotype during ex-vivo
expansion [153]. An inorganic substrate derived from bioactive sol-gel glass initially used
for the differentiation and proliferation of human and murine osteoblasts was also used to
promote osteogenic differentiation from mESCs. Temporal and dose dependent
manipulations of growth factors supplementation further enhanced the positive effect of
this sol-gel [154, 155].
For osteogenic and chondrogenic induction of hESCs, researchers have
demonstrated that pre-differentiated hESCs (5-day old EBs) replated in the presence of
osteogenic supplements induced differentiation. In vivo implantation of these predifferentiated cells within poly-D, L-lactide (PDLLA) scaffolds in severely combined
immunodeficient (SCID) mice allowed for further differentiation to specialized
mineralizing tissue [156].
Substrate based adipogenic differentiation of mESCs have only been demonstrated
on polycaprolactone (PCL) synthetic polymer. The study reported the use of nanoscale
fibers from electrospun PCL scaffolds to mimic ECM architecture and induce mESC
differentiation. mESCs were directly seeded onto the scaffolds and treated with insulin,
triiodothyronine (T3) and retinoic acid (RA) to induce adipogenesis. On comparing cells
derived from this 3D culture system to those derived from a 2D system which involved
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pre-specification with EB formation, it was noted that optimal results were achieved when
the cellular micro-environments closely resembled in-vivo conditions [157].
A high-throughput screening approach utilized microprinting technology to present
pluripotent cells with combinations of ECM proteins in a microarray [158] and in a
multiwell format [159]. A commercial arrayer was used to deposit mixtures of varying
concentrations of collagen I, collagen III, collagen IV, fibronectin, and laminin onto a thin
custom-made acrylamide gel pad. The ECM was deposited in a highly controlled manner,
and there were no detected instances of cross-contamination between spots. A multiwell
format was generated using a slide carrier and gaskets, followed by seeding of mESCs
within these wells and presentation of twelve different combinations of four growth factors
known to induce cardiac differentiation. A total of 240 ECM and growth factor signaling
environments were studied and the results acquired during this expansive run, were
consistent with published data on cardiogenesis. The nature of the microenvironment that
comprises of specific physical, chemical and mechanical cues need to be taken into
account, prior to determining the biomaterial to be used in specific directed differentiation
strategies.
Ectodermal differentiation
Ectodermal derivatives are often seen in spontaneously differentiating cultures and
are considered as the “default pathway” for differentiation of pluripotent stem cells [160].
Several ectodermal derivatives such as oligodendrocytes, dopaminergic neurons and motor
neurons have been produced using a cocktail of growth factors including FGF2, retinoic
acid (RA), epidermal growth factor, brain and glial derived neurotrophic factor and sonic
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hedgehog (SHH) [52, 161-164]. Direct co-culture of mouse and primate ES cells with PA6
stromal cells induced differentiation into dopaminergic neurons and circumvented the
formation of multicellular aggregates (EBs) in the differentiation process. These studies
determined that stromal cell- derived inducing activity (SDIA) was responsible for the
differentiation, but little was ascertained of its molecular nature or induction mechanism
[165, 166]. Naturally derived ECMs and synthetic polymers have both been used to
differentiate mESCs into ectodermal derivatives. A comparative study was conducted to
determine the effects of 2-D and 3-D fibrin based constructs on neural differentiation of
EBs from mESCs. These studies showed that intact EBs encapsulated within the 3D fibrin
gel differentiated more readily that those grown on 2D-fibrin gel into mature neurons and
astrocytes under specific culture conditions [167]. mESCs cultured in hollow fibers made
of cellulose triacetate polymer and ethylene vinyl alcohol copolymer in the presence of
stromal cell conditioned medium differentiated into dopaminergic neurons [168]. This
study presents a model system for in-vivo delivery of mESCs within scaffolds that promote
differentiation. Such transplantation strategies might avoid obstacles that arise with
rejection of implanted cells by the host with the added advantage of the semi-permeable
membrane permitting the influx of nutrients for the survival of the implanted cells and the
efflux of dopamine.
Few studies have reported the application of synthetic biomaterials for neural
differentiation of hESCs. When pre-differentiated hESCs as 8-day old EBs were
dissociated and seeded in a 50/50 blend of poly L-lactic acid) and poly(lactic co-glycolic
acid) based biomaterial, multilayered rosette like bodies with epithelial cell-lined narrow
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lumen was induced by supplementing the growth medium with retinoic acid. However, in
the same construct, mesodermal differentiation was induced by addition of TGFβ and
endodermal differentiation was induced by addition of Activin A and IGF [169]. Enhanced
neural differentiation of hESCs was achieved in the construct by addition of RA, nerve
growth factor (NGF) and neurotrophins [170].
As part of a teratoma formation protocol used to investigate pluripotent potential of
hESCs, researchers investigated the differentiation potential of hESCs seeded in laminincoated poly-(lactic-co-glycolic acid) (PLGA) scaffolds [171]. Further analysis of the
teratomas provided evidence of different cell types that originated from the three germ
layers. However, close to 38% of the cells, exhibited increased expression of the neuronal
marker, Nestin, thereby indicating that the nature of pre-transplantation treatment, the site
of transplantation, and the ECM components in the scaffold could selectively enhance
neural phenotypes within the teratoma [172].
The differentiation of mouse and human ES cells into the different lineages and specialized
cells using different feeder dependent and independent substrates is summarized in Table
2.
Based on the different self renewal maintenance and differentiation strategies described in
this chapter, it is evident that numerous physical, chemical and mechanical factors are at
play in determining stem cell fate. Taking this into consideration, we attempt to generate
and study in detail a substrate that will allow for undifferentiatied propagation of hPSCs.
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Table 2
Substrates used to induce differentiation in mouse and human pluripotent stem cells.
Substrate Type

Cell
Source

Substrate

Differentiation
Lineage

References

Feeder layer
based

mESCs

Primary rat hepatocyte

Hepatic

[173]

Mouse stromal cells OP9 and RP010
Fetal murine osteoblasts
Stromal cells PA6

Hematopoietic
Osteogenic
Neuronal

[130], [131]
[174]
[175]

Mouse bone marrow cells line S17,
yolk sac endothelial line C166
Human periodontal ligament
fibroblasts

Hematopoietic

[143]

Osteogenic

[145]

Collagen coated plates
Alginate Beads
Collagen type IV
Fibrin polymers reinforced with
poly(ethylene glycol)
Dextran constructs
Semi-interpenetrating polymer
networks (SIPNs) with fibronectin
(FN) and laminin (LM).
Alginate construct
Self assembling peptide construct
Fibrin polymer construct

Hepatic
Hepatic
Hematopoietic
Endothelial and
Hematopoietic
Endothelial
Endothelial and
Cardiac

[111]
[114]
[176]
[177]

Chondrogenic
Osteogenic
Neuronal

[148], [180]
[181]
[167]

hESCs

Collagen scaffolds
Alginate scaffolds

Hepatic
Hematopoietic

[122]
[144]

mESCs

Polyurethane foam

Hepatic

[117, 118]

Cytomatrix
Poly-(ethylene glycol)
Nanoscale fibers based electrospun
polycaprolactone (PCL) scaffolds
Copolymer of cellulose triacetate
polymer and ethylene vinyl alcohol

Hematopoeitic
Osteogenic
Adipogenic

[177, 182]
[183], [184]
[185]

Neuronal

[186]

Poly-D, L-lactide (PDLLA) scaffolds
Poly (L-lactic acid) and Poly(lactic coglycolic acid)
+ Retinoic Acid
+ TGFb
+ Activin A and IGF

Osteogenic

[187]
[188]

hESC

Natural substrates

Synthetic
Substrates

mESCs

hESCs

Neuronal
Chondrogenic
Pancreatic

[178]
[179]
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Rationale for study
Human pluripotent stem cells (hPSCs) that include human embryonic stem cells (hESCs)
and more recently, induced pluripotent stem cells have conventionally been cultured on
mouse embryonic fibroblasts (MEFs) as feeder layers [1-5] The use of an additional cellline as feeders and complex expansion techniques make hPSC culture a labor intensive
process. In an attempt to engineer hPSC culture conditions devoid of non-human
components, alternative feeders, mostly involving the use of MEF conditioned medium
[22-26] or a mouse derived extracellular matrix (ECM)-based substrate: Matrigel™ [48]
has been extensively studied. Though these strategies are partially successful in
maintaining undifferentiated hPSC cultures, they do not completely eliminate the use of
non-human derived products, thus still posing risks of xenogenic contamination.
Taking into consideration that adherent cell lines require extracellular matrix (ECM) for
adhesion and proliferation, we hypothesize that the ECM components generated by the
feeder layer fibroblasts will be sufficient in maintaining the undifferentiated state of
hPSCs. Towards testing this hypothesis, we propose to characterize ECM substrates
derived from different fibroblasts and their capability to support self-renewal of hPSCs.
Further analysis of the ECM substrates will permit the identification of the major
constituents in the matrix deposited by mouse and human fibroblasts that might be
responsible for the maintenance of self-renewal of hESCs. The results from this analysis
will allow the generation of a protein based substrate.
Our long term goal is the development of feeder-free conditions that utilize the selfrenewal sustainability of ECM to engineer substrates that will provide hPSCs with the
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appropriate physical and chemical cues required for long term undifferentiated
propagation. The core hypothesis is that human ECM in controlled microenvironments
provides sufficient physical cues to maintain hPSCs in their undifferentiated state
The experiments outlined under three different specific aims to test the hypothesis will
determine the efficacy of acellular (ECM based) substrates, protein combinations (matrix
composition based) and in-direct culture systems in supporting the undifferentiated
proliferation of hPSCs.
Specific Aim 1) To characterize human fibroblast cell derived ECM as suitable acellular
substrates for sustained undifferentiated propagation of hPSCs.
To address this aim, hPSCs will be propagated on two human fibroblasts as feeders.
Characterization of the hPSCs after 15 passages will involve analyzing the expression of
key pluripotent markers based on immunocytochemistry and real time PCR. The rationale
behind using these fibroblast cell lines is based on their human origin and their capacity for
excessive ECM secretion.
Specific Aim 2) To formulate a protein substrate based on the proteomic analysis of the
extracellular matrix (ECM) composition of the acellular substrates
Proteomic analysis of the acellular ECM substrates that have demonstrated the capability
of maintaining long term undifferentiated propagation of hPSCs will identify proteins that
play a role in adhesion and key signaling pathways for self-renewal maintenance. Based on
results from the proteomic analysis protein based substrates will be formulated and tested
for hPSC propagation. hPSCs cultured on such protein combinations will be characterized
for expression of standard pluripotent markers.
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Specific Aim 3) To incorporate acellular substrates on microporous membranes in an
indirect co-culture system and assess their capability for hPSC propagation.
The use of microporous membranes coated with acellular substrates in addition to the
presence of a physically separated feeder layer will allow for synergistic effects of the
biochemical and biophysical cues necessary for self renewal maintenance. Such a system
will allow for scale up of hPSCs without feeder cell contamination. hPSCs cultured in such
controlled microenviroments will be characterized for expression of standard pluripotent
markers.
General experimental analyses of a culture system across the three specific aims involve
sustained propagation of undifferentiated hPSCs on the substrates for 15 passages,
followed by characterization studies. Characterization will involve a) morphological
analyses: high nuclear-cytoplasmic ratio for pluripotent cells b) immunocytochemical
analyses for pluripotent markers (Alkaline phosphatase, AP, Octamer Binding
Transcription Factor-4, OCT4, and Stage specific embryonic antigen-4, SSEA4) c) in vitro
differentiation potential by embryoid body formation and test for the presence of germ
layer specific markers from all three germ layers (ectoderm, endoderm and mesoderm)
from pluripotent hPSCs d) Real time RT-PCR analysis for pluripotent and germ-layer
specific markers and e) karyotype analysis for chromosome number
Overall, the studies conducted as part of this dissertation research project are expected to
contribute to the development of propagation systems and controlled microenvironments
for sustained propagation of undifferentiated and stable hPSCs.

CHAPTER 2: Stable propagation of human embryonic and induced pluripotent stem
cells on decellularized human substrates

Abstract
Human pluripotent stem cells (hPSCs) that include human embryonic stem cells (hESCs)
and human induced pluripotent stem cells (hiPSCs) have gained enormous interest as
potential sources for regenerative biomedical therapies and model systems for studying
early development. Traditionally, mouse embryonic fibroblasts (MEFs) have been used as
a supportive feeder layer for the sustained propagation of hPSCs. However, the use of nonhuman derived feeders presents concerns about the possibility of xenogenic contamination,
labor intensiveness and variability in experimental results in hPSC cultures. Towards
addressing some of these concerns, we report the propagation of three different hPSCs on
feeder-free extracellular matrix-based substrates derived from human fibroblasts. hPSCs
propagated in this setting were indistinguishable by multiple criteria, including colony
morphology, expression of pluripotency protein markers, tri-lineage in-vitro differentiation
and gene expression patterns, from hPSCs cultured directly on a fibroblast feeder layer.
Further, hPSCs maintained a normal karyotype when analyzed after fifteen passages in this
setting. Development of this ECM-based culture system is a significant advance in hPSC
propagation methods as it could serve a critical component in the development of
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humanized propagation systems for the production of stable hPSCs and its derivatives for
research and therapeutic applications.
Introduction
Human embryonic stem cells (hESCs) and more recently human induced
pluripotent stem cells (hiPSCs) are primary examples of human pluripotent stem cells
(hPSCs) and have garnered a lot of attention in the past decade due to their inherent
properties of indefinite self renewal and differentiation into multiple cell types [1, 2, 4, 5].
Since their derivation, the preferred method of hPSC expansion has been the use of
mitotically inactivated mouse embryonic fibroblasts (MEF) as feeder layers [2, 189]. The
success of MEFs as a feeder layer is largely attributed to the presence of a cellular
substrate for stem cell adhesion mimicking physiological milieu and the nutrients released
into the medium providing a suitable microenvironment for undifferentiated propagation of
hPSCs. However, the use of non-human cells as a substrate poses risks of xenogenic
contamination by the possible introduction of animal retroviruses and other pathogens,
which could potentially be transmitted to patients when used in biomedical therapies. This
possibility is reinforced by the report of the presence a non-human carbohydrate moiety on
the surface of hESCs propagated on MEFs, with the potential of eliciting an immune
response when used in humans [17]. Additionally, the need to maintain two cell lines
simultaneously and the mechanical passaging techniques employed to ensure normal
karyotype in hPSCs [190] renders this culture methodology time consuming and labor
intensive. The use of a live feeder layer has also presented researchers with challenges
concerning feeder contamination of experimental data in downstream analysis [191].
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Extensive research has introduced various alternate culture conditions; however the key
factors responsible for the maintenance of the hPSC self-renewal capabilities are not
evident [48, 192-194]. Studies have implicated the bFGF, Wnt, activin/Nodal pathways in
the maintenance of pluripotency [192-194], however the interaction of these pathways with
transcription factors that mediate self-renewal (OCT-4, SOX2, NANOG) is not clear [33].
The development of controlled propagation systems to maintain and expand stable hPSC
populations is key to creating bankable populations of cells required for future research
geared towards regenerative therapies [195].
Apart from MEFs, several human fibroblast cell lines have been tested and proven
suitable feeders [22-25, 196]. It is realistic to state that adhesion based culture of hPSCs
depend extensively on the extracellular matrices deposited by the feeder cells for their
attachment and proliferation. Based on this principle, hPSCs were cultured and
successfully propagated on mouse sarcoma derived protein mix: Matrigel™ and human
serum deposits [48, 52]. However, such substrates are expensive and also require
supplementation by way of MEF-conditioned medium (MEF-CM).
In order to address some of these challenges, our study focused on the potential of
extracellular matrix (ECM) based substrates from human fibroblasts in the long-term
maintenance of three different hPSCs in their undifferentiated state. In this study, we report
the use of two human immortalized fibroblast (foreskin and dermal) lines as sources for the
ECM-based substrates, thus avoiding the need for recurrent isolations of primary
fibroblasts as is the case with MEFs. Our studies demonstrate the unique potential of these
ECM-based substrates in promoting the stable propagation of undifferentiated hPSCs,
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based on the assessment of multiple criteria for pluripotency. Additionally, this is the first
report of hPSC propagation in a feeder-free, all human setting without the need for
conditioned medium of any kind.
Materials & methods
Generation of inactivated feeder layers and extracellular matrix-based substrates. Mouse
embryonic fibroblasts (MEFs) were isolated from embryos derived from 13.5d pregnant
CF1 mice and maintained in Dulbecco’s modified Eagle’s medium with 4.5 g/L glucose,
2mM L-Glutamine, 1% Penicillin/Streptomycin and 10% fetal bovine serum. Human
foreskin fibroblasts (HFFs) were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) with 4.5 g/L glucose, 2mM L-Glutamine, 1% Penicillin/Streptomycin and 10%
cosmic calf serum and 2% Medium 199 (10x) to create a blend of basal medium
comprising of M199 and DMEM. Human dermal fibroblasts (HDFs) were maintained in
Minimum Essential medium supplemented with 2mM L-Glutamine, 1%
Penicillin/Streptomycin, 15% fetal bovine serum, non-essential and essential amino acids,
sodium pyruvate and vitamins. Inactivation of the three fibroblast lines was achieved by
incubation in 10μg/ml of Mitomycin C, a mitotic inhibitor, for a period of two hours. Postincubation, the cells were thoroughly washed with PBS 6 times, followed by trypsinization
and additional three washes in growth medium to fully remove the mitomycin C. The cells
were subsequently plated at a density of 300,000 cells/35mm dish.
Acellular extracellular matrix based substrates were generated by allowing the
cultures (HFFs and HDFs) to proliferate 6 to 8 days past 100% confluency. The plates
were washed with sterile distilled water to remove traces of growth medium followed by a
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short exposure to 20mM NH3 solution to expose the deposited ECM. The substrates were
thoroughly washed with phosphate buffered saline (PBS) to avoid the deleterious effects of
the alkaline ammonia solution [197]. For the purposes of application in our different
experiments, the acellular HFFs (aHFFs) and acellular HDFs (aHDFs) once generated were
stored at 37°C and used within a week.
Long term propagation of hPSCs. Karyotypically normal diploid hESC (WA09,
http://stemcells.nih.gov) [2] and hiPSC (WiCell Research Institute, Madison, WI) [5] were
routinely passaged on MEFs and transferred onto human feeders and acellular matrices in
35mm dishes. A rapidly dividing, karyotypically aneuploid cell line BG01v (Bresagen,
Athens, GA) [198, 199] was also routinely passaged on MEFs and transferred onto human
feeders and acellular matrices. WA09 and hiPSCs were passaged as colonies by
mechanical dissociation while BG01v was enzymatically passaged every 3-4 days at
subculturing ratios of 1:4. All the hPSCs were maintained in DMEM/F12 supplemented
with 20% knockout serum replacement, 0.1mM β-mercaptoethanol, 1% non-essential
amino acids, 100U/ml penicillin, 100mg/ml streptomycin and 4ng/ml basic fibroblast
growth factor (bFGF). All reagents were obtained from Invitrogen (Carlsbad, CA) unless
otherwise noted.
Alkaline Phosphatase assay. Staining for alkaline phosphatase was performed as per
manufacturer instructions (Vector Labs, Burlingame, CA). Briefly, the hPSCs were
washed with deionized water to remove traces of growth medium. The final solution was
prepared by the addition of the three constituents in 0.2M Tris HCl buffer, pH 8.0. The
hPSCs were incubated in the final mixture for 40 minutes in the dark and images were
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acquired using a Nikon Coolpix 5000 camera mounted on a Nikon TS100 Microscope
(Nikon, Melville, NY).
Antibodies and Immunocytochemical analysis. hPSCs cultured on the acellular substrates
were transferred onto 4 chambered glass slides. 4% paraformaldehyde in PBS was used for
fixation, permeabilization for intracellular markers was achieved with 0.2% Triton X-100
in PBS and blocked with normal goat serum. Fixed cells were incubated with primary
antibodies: OCT4 (Santa Cruz Biotechnology, Santa Cruz, CA) and SSEA-4 (Millipore,
Temecula, CA). Goat anti-mouse IgG conjugated to Alexa 488 (Molecular Probes, Eugene,
OR) were used as secondary antibodies. Fluorescent images were acquired using a
CoolSnap EZ camera (Photometrics, Tucson, AZ) mounted on a Nikon Eclipse TE 2000-S
inverted microscope (Nikon, Melville, NY) with attached image analysis software. All
image settings were controlled for uniform acquisition between samples. Specifically,
uniform exposure time was maintained for images acquired from experimental samples as
well as negative controls for background subtraction.
In vitro differentiation of hPSCs and histology of hPSC-derived embryoid bodies. To
generate embryoid bodies (EBs), hPSCs were dissociated using collagenase and
resuspended in growth medium devoid of bFGF. EB formation was facilitated using
suspension culture by a hanging drop method, where cells at a density of 25,000 cells/ml
were suspended from a petri-dish lid in 20μl droplets. After 5 days, the EBs were
transferred to agarose plates at a density of 25 – 30 EBs per 10mls to facilitate further
differentiation with media changes every 3-4 days for a total differentiation duration of 15
days. EBs were prepared for morphological analysis by fixation in 3.7% paraformaldehyde
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(PFA) in 1.5ml microfuge tubes at approximately 15-25 EBs per tube. Once fixed
overnight, EBS were rinsed with PBS to remove PFA, resuspended in 200μl melted 4%
low melting point agarose (Sigma Aldrich) at 42ºC and incubated for 2 hours to allow
settling. Final pelleting and agarose solidification was performed with brief room
temperature centrifugation at 500g. Agarose embedded samples were removed as single
plugs and processed by dehydration with increasing ethanol concentration to 100%
followed by xylene and paraffination in a Leica TP1020 tissue processor. Hematoxylin and
Eosin (H&E) staining was performed on microscope slide mounted 5μm sections in a
Leica Autostainer XL workstation (Leica Microsystems, Richmond, IL). Images were
acquired using an Olympus BX51 microscope (Olympus, Center Valley, PA) using the
default imaging parameters.
RNA isolation, real time reverse transcription polymerase chain reaction and gene
expression analysis. RNA was isolated from hPSCs propagated for 15 passages under
different conditions and from EBs after 15 days in suspension using Trizol (Invitrogen,
Carlsbad, CA) and quantified using BioMate3 UV-VIS Spectrophotometer (Thermo
Scientific, Waltham, MA). cDNA was synthesized from 1μg of RNA using cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA). Expression of pluripotent genes
and differentiation markers (Table 3) within undifferentiated and differentiated samples
were analyzed using quantitative real time RT-PCR (QPCR). QPCR was performed in an
ABI HT7900 system (Applied Biosystems, Foster City, CA) and the data was acquired
using Sequence Detection System software (SDS v2.2.1, Applied Biosystems, Foster City,
CA).
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Table 3
List of primers used for determination of relative gene expression of pluripotency and
germ-layer specific genes as part of quantitative real-time PCR analysis

Gene
Name
Forward
POU5F1/
OCT-4

Primer sequence
Reverse

NANOG

GAAGGTATTCAGCCAAAC
GATCGGGCCCGCCACCATGAGTGTG
GATCCAGCTTG

CTTAATCCAAAAACCCTGG
GATCGAGCTCCATCTTCACAC
GTCTTCAGGTTG

SOX2

GCGGAAAGCGTTTTCTTTG

TAATCTGACTTCTCCTCCC

Neuro D

GTCCTTCGATAGCCATTCAC

CTTTGATCCCCTGTTTCTTCC

IGF2

TCCTCCCTGGACAATCAGAC

AGAAGCACCAGCATCGACTT

AFP

AGAACCTGTCACAAGCTGTG

GACAGCAAGCTGAGGATGTC
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Gene expression data (three replicates) were acquired and SDS software was used to
estimate differential gene expression using ΔCT quantification methods. Endogenous 18S
ribosomal RNA was used for normalization. Relative gene expression for hPSCs
propagated on acellular substrates was assessed against hPSCs propagated on MEFs.
Relative gene expression of differentiated EBs obtained from different conditions was
assessed against hPSCs propagated under the original condition. Expression Index (EI)
was used to determine the relative differentiation state of cells [200] and was based on the
average CT values from triplicate measurements. An expression ratio of two or more genes
was determined using a mathematical model based on the geometric average of assessed
genes, previously described in detail [201], given by the following equation:

EI = K RS

m

(1 + E gene1m ) Ctgene1m .(1 + E gene 2 m ) Ctgene 2 m ...(1 + E genem ) Ctgenem

n

(1 + E gene1n ) Ctgene1n .(1 + E gene 2 n ) Ctgene 2 n ...(1 + E genen ) Ctgenen

E is the PCR efficiency calculated from dilution series of purified PCR products, CT is the
threshold cycle, and m and n are the numbers of genes that are up and down regulated upon
differentiation respectively. KRS is the relative sensitivity constant and was not determined
as it does not affect relative comparisons between samples.
Preparation of hPSC for karyotype analysis. hPSCs propagated on acellular substrates for
> 15 passages were subjected to cytogenetic karyotype analysis as per earlier published
protocols [190]. Briefly, hPSCs were incubated with Ethidium Bromide (12 μg/ml) for 40
min at 37ºC, 5% CO2, followed by 120ng/ml of colcemid (Invitrogen, Carlsbad, CA)
treatment for 20 min. The cells were treated with 0.25% trypsin, and dislodged cells were
centrifuged at 200g for 8 min at room temperature. The cell pellet was gently resuspended
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in 0.075 M KCl solution, and fixed in a solution containing 3:1 of methyl alcohol and
glacial acetic acid. Fixed cells were dropped on wet slides, air dried and baked at 90°C for
1 hour. G-banding was performed for visualizing chromosomes using Trypsin-EDTA and
Lieshman Stain (Giemsa/Trypsin/Lieshman technique, GTL) by immersing slides in 1X
Trypsin-EDTA with 2 drops of 0.4N Sodium Phosphate (Na2HPO4) for 20 to 30 seconds,
rinsed in distilled water and stained with Lieschman Stain (Sigma) for 1.5 minutes, rinsed
in distilled water, and air dried. Twenty metaphases of each sample were examined.

Results
Extracellular matrix based decellularized substrates allows expansion of hPSCs.

Decellularization using ammonia solution lyses the cells leaving behind an extensive
ECM-based network that contributes to hPSC adhesion and propagation. A schematic of
the procedure for generating extracellular matrix-based substrate is shown in Figure 3.
Karyotypically normal hPSCs (WA09 and hiPSC) used in this study were cultured on
MEFs for < 60 passages, while the aneuploid BG01v was cultured on MEFs for <75
passages prior to transfer onto acellular substrates. Upon transition of the three hPSCs onto
the acellular substrates, minimal spontaneous differentiation was observed during culture
condition transition. hPSCs formed both undifferentiated colonies with tight boundaries as
well as heterogeneous colonies containing a population of differentiated cells at the colony
boundaries and between colonies as seen in earlier studies [20, 48]. However, the transition
effect diminished within 2-3 passages and undifferentiated colonies with tight boundaries
were observed that continued through subsequent passages. The culture conditions permit
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Figure 3:
Schematic of the preparation of acellular substrates for hPSC propagation. Feeder cells are
allowed to grow past 100% confluency for ECM deposition. Treatment with 20mM
ammonia solution for 5 min lyses the cells to expose the ECM layer onto which hPSCs are
seeded
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uniform hPSC propagation during subsequent passages, resulting in very few differentiated
cells in the later passages. The aneuploid BG01v cultured on acellular substrates did not
exhibit typical morphological characteristics as when propagated on MEFs. BG01v formed
a continuous layer of spindle shaped or fibroblastic cells on acellular substrates, without
losing any of its core pluripotent characteristics (Appendix A). The normal hPSC lines
(WA09 and hiPSC) however exhibited similar morphology on acellular substrates when
compared to their respective MEF based cultures (Figure 4 a-f). The hPSCs formed
colonies with distinct boundaries and demonstrated high nuclear to cytoplasmic ratio. This
difference in cell morphology between the two types could be due to the difference in
passaging techniques; BG01v cells were enzymatically passaged leading to formation of
single cell suspension, whereas the normal lines were maintained as clusters during
passaging. It was observed that the hPSC colonies were flat and enlarged compared to
those propagated on feeders. The larger size of the colony, while maintaining normal
morphology on the acellular substrates, could be attributed to the availability of more
surface area for spreading and propagation. hPSCs were successfully cultured on
inactivated HFFs and HDFs feeder layers for 15 passages (Figure 5); however, in all our
analyses, cultures of the three different hPSCs on MEF feeders were used as controls.
Under the passage conditions adopted, the doubling time for the hPSCs passaged on
acellular substrates was in the range of 24-30 hours, which is comparable to what was
observed in other MEF and feeder-free studies [20, 48, 202].
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Figure 4:
hPSCs maintain embryonic characteristics on acellular substrates: WA09 hESCs and
hiPSCs maintain high nuclear to cytoplasmic ratio and tight boundaries on control, MEFs
(a, d) and on acellular HFF (b,e) and HDF substrates (c, f). Positive expression of alkaline
phosphatase in WA09 (g, h, i) and hiPSC (j, k, l) propagated for 15 passages on MEF (g,j),
aHFF (h,k) and aHDF (i,l) was observed, Scale bar = 100 μm
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Figure 5:
WA09 hESCs maintain high nuclear to cytoplasmic ratio and tight boundaries on
inactivated HFFs (iHFFs) (A) and on inactivated HDFs (iHDFs) (B). Positive expression
of alkaline phosphatase in WA09 (C) propagated for 15 passages on iHFFs (C) and iHDF
(D) was observed, Scale bar = 100 μm
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hPSCs cultured on MatrigelTM (as a negative control) without the additional
supplementation of the growth medium led to heterogeneous populations of
undifferentiated and differentiated colonies (Figure 6 ), similar to what has been observed
in previous studies [192].
Acellular substrates maintains undifferentiated state of hPSCs

Validation of the acellular substrates for stable undifferentiated hPSC propagation was
based on alkaline phosphatase staining and immunocytochemical analysis for expression
of transcription factor OCT4 and the cell surface marker SSEA4. hPSCs propagated on
different acellular substrates were assessed for their expression at 5, 10 and 15 passages
post-transfer from feeders. Positive robust expression of alkaline phosphatase, a reliable
marker of pluripotency [203], is indicative of sustained maintenance of the undifferentiated
state of hPSCs (Figure 4). At intermittent passages as well as on passage 15, positive
expression for pluripotency markers tested was observed (Figure 7). Further, monitoring
the expression of the nuclear marker 4',6-diamidino-2-phenylindole (DAPI) under all the
acellular conditions served the purpose of staining any nuclear/DNA material left behind
from the decellularization process. The absence of additional staining within the substrate
was indicative of an efficient lysis and post-decellularization wash procedure (Figure 8).
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Figure 6:
Differentiation seen in hPSC maintained on Matrigel: WA09 hESCs maintained on
MatrigelTM in growth medium without additional supplementation produce (A)
heterogeneous undifferentiated and differentiated cells within the colonies (A) and stain
positive/negative for alkaline phosphatase (B). Scale bar = 100 μm.
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Figure 7:
Pluripotent markers expressed in hPSCs maintained on acellular substrates: Positive
expression of stage specific embryonic antigen (SSEA4) (a-f) in WA09 (a, b, c) and hiPSC
(d, e, f) propagated for 15 passages on MEF (a, d), aHFF (b, e) and aHDF (c, f).
Expression of OCT4 (g-l) in WA09 (g, h, i) and hiPSC (j, k, l) propagated for 15 passages
on MEF (g,j), aHFF (h,k) and aHDF (i,l) was observed. All slides were stained with DAPI
(blue) to identify cell nuclei. Scale bar = 50 μm.
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Figure 8:
Decellularization causes loss of nuclear material. (A) Fibroblasts stain positive for DAPI
indicating intact nuclei. (B) Acellular fibroblasts and (C) MatrigelTM exhibit minimal
staining for DAPI, indicating absence of nuclear material. Scale bar = 50 μm.
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Gene expression analysis validates acellular substrates for stable undifferentiated hPSC
propagation

Differential expression of pluripotency markers (POU5F1, NANOG and SOX2) was
expressed as CT values normalized against the 18S rRNA housekeeping gene for each
sample. For the purposes of the comparisons across the different experimental conditions,
the ΔCT values of each marker within each experimental sample are presented against that
of MEFs, as this eliminates the requirement for normalization with the calibrator.
Comparable ΔCT values of all the pluripotent genes across different culture conditions and
cell lines are indicative of the maintenance of undifferentiated state of hPSCs on acellular
substrates (Figure 9). Statistical analyses indicated no significant difference (p>0.05) in the
12 different comparisons for the pluripotency markers tested between hPSCs propagated
on the acellular substrates and those propagated on MEFs. However, a significant
difference (p<0.05) was observed for only one comparison in the case of POU5F1
expression within hiPSCs grown on aHFFs. In this particular case, there was a three-fold
decrease in POU5F1 expression; however the expression of NANOG and SOX2 within
this experimental condition was comparable to that of those on MEFs.
Acellular substrates maintains in vitro differentiation potential

Functional pluripotency of the hPSCs was assessed by in vitro differentiation (ectoderm,
endoderm and mesoderm) via formation of embryoid bodies. Differential expression of
germ layer specific markers Neurogenic differentiation 1 (NEUROD1), Insulin-like
Growth Factor 2 (IGF2) and α-Fetoprotein (AFP) were expressed as CT values normalized
against the 18S rRNA housekeeping gene for each sample.
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Figure 9:
Normalized gene expression of undifferentiated markers in WA09 (a) on MEFs (A);
WA09 on acellular HFF (B) and WA09 on acellular HDFs (C). Normalized gene
expression of undifferentiated markers in hIPSCs (b) on MEFs (A’); hiPSCs on acellular
HFF (B’) and hiPSCs (b) on acellular HDFs (C’). Significant difference (p<0.05) between
the group is indicated by the asterisk.
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Statistical analyses indicated that the EBs generated from the WA09 and hiPSC on the
different acellular substrates demonstrated significantly greater expression (p<0.01) of all
three germ layer specific markers analyzed (Figure 10 a, b) compared to their
undifferentiated cells cultured in the same experimental conditions. Here, it is important to
note that ΔCT values (normalized against 18S) should be interpreted counter-intuitively;
where a lower value indicated higher expression. Comparative gene expression analysis
based on fold change calculations also demonstrate increased expression of germ-layer
specific markers in EBs generated from the WA09 and hiPSC on the different acellular
substrates (Table 4). Further, the differentiation state of the hPSCs was quantified using the
‘expression index’ as a metric to compare the undifferentiated hPSCs against the EBs
generated from the hPSCs grown under the same condition. For the two cell lines (WA09
and hiPSC) analyzed, the expression index of the undifferentiated sample (15 passages)
was 251 and 612 on aHFFs (Figure 11 a, b) and 180 and 50 on aHDFs (Figure 11c, d),
while the expression index of the 15-day old EBs was found to be 1.5 and 2 on aHFFs
(Figure 11a, b) and 1.1 and 2.3 on aHDFs (Figure 11c, d).
In addition to the gene expression of markers indicative of germ layer formation in
EBs, histological studies were performed to assess the morphology of the differentiated
tissue. As shown in Figure 12 (a-r), histologic evidence of tri-lineage maturation was
present in the EB-sections from hPSCs propagated on acellular substrates and on MEFs.
Specifically, neuroepithelial differentiation was observed as mature-type neuroepithelial
rosettes (Figure 12, a, d, g, j, m and p). Mesodermal differentiation was evident as fibrous
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connective tissue (Figure 12 b, e, h, k, n and q), while endodermal differentiation was
evident as secretory intestinal-type epithelia (Figure 12 c, f, i, l, o and r).
Cytogenetic analysis confirms feasibility of acellular substrates for stable hPSC
undifferentiated.

In order to determine the stability of hPSCs propagated continuously on the acellular
substrates, cytogenetic analysis was performed on twenty G-banded metaphase spreads
from WA09 and hiPSC cells after 15 passages on acellular substrates. Nineteen cells from
the WA09 sample demonstrated a normal female karyotype of 46,XX (Figure 13a), while
one cell demonstrated a non-clonal chromosome aberration; 46,X,t(X;19)(q22, q13.3),
which is most likely a technical artifact. In the case of hiPSCs, all twenty cells
demonstrated a normal male karyotype of 46,XY (Figure 13b). None of the samples
exhibited trisomies for chromosome 12 and/or 17, which are considered to be the common
abnormalities observed in hPSC cultures [190].
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Figure 10:
Normalized gene expression of germ layer specific markers in (a) WA09 on acellular
HFFs (P); EBs generated from WA09 on acellular HFFs (Q); hiPSC on acellular HFFs (R);
and EBs generated from hiPSC on acellular HFFs (S). Normalized gene expression of
germ layer specific markers in (b) WA09 on acellular HDFs (P’); EBs generated from
WA09 on acellular HDFs (Q’); hiPSC on acellular HDFs (R’); and EBs generated from
hiPSC on acellular HDFs (S’). Significant differential gene expression (p<0.01) in all three
lineage specific markers was observed.
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Table 4:
Increase in gene expression of germ layer specific markers in embryoid bodies compared
to their undifferentiated counterparts on different substrates is represented as fold change
values. FC = Fold change, SD = Standard deviation

Fold change values of germ layer specific genes in embryoid bodies
compared to their undifferentiated counterparts.
Substrates/Cell Line
FC ± SD

α-Fetoprotein -- Endodermal marker
aHFF – WA09

34.61 ± 3.47

aHDF –WA09

523.9 ± 204.2

aHFF – hiPS

87.67 ± 2.51

aHDF - hiPS

9.26 ± 0.72

Insulin like growth factor 2 -- Mesodermal marker
aHFF – WA09

1.58 ± 0.28

aHDF – WA09

25.9 ± 8.7

aHFF – hiPS

240 ± 33.9

aHDF - hiPS

5.9 ± 0.04

Neurogenic Differentiation marker 1-- Ectodermal marker
aHFF – WA09

30.9 ± 1.7

aHDF – WA09

18866.4 ± 7266.3

aHFF – hiPS

1.5 ± 0.35

aHDF - hiPS

12.7 ± 1.4
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Figure 11:
QPCR analysis of undifferentiated hPSCs and differentiated EBs derived from hPSCs.
Differential expression index of a) WA09 hPSC and WA09-derived EBs from acellular
HFFs, b) WA09 hPSC and WA09-derived EBs from acellular HDFs, c) hiPSC and hiPSCderived EBs from acellular HFFs and d) from acellular HDFs based on analysis of six
genes (POU5F1, NANOG, SOX2, AFP, IGF2 and NEUROD1).
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Figure 12:
Histologic evidence of tri-lineage differentiation in embryoid bodies generated from hPSCs.
Shown are images of hematoxylin and eosin-stained histologic sections of EBs from WA09
propagated on MEFs as a positive control (top row, a-c); WA09 cells propagated on the acellular
HFFs (second row, d-f) and acellular HDFs (third row, g-i) and hiPSC propagated on MEFs (fourth
row, j-l) hiPSC propagated on acellular HFFs (fifth row m-o) and hiPSC propagated on acellular
HDFs (bottom row p-r). Tri-lineage potential is demonstrated as ectodermal (neuroepithelial)
differentiation (a, d, g, j, m and p); mesodermal (fibrous connective) differentiation (b, e, h, k, n
and q) and endodermal (intestinal) differentiation (c, f, I, l, o and r). Magnification is 200x total
(10x ocular, 20x objective). Each scale bar represents 50 μm in length.
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Figure 13:
Cytogenetic analysis on 20 metaphase spreads was performed on WA09 (a) and hiPSC (b)
cultured on acellular HFFs. The G-banding karyotype of WA09 hESC after 15 passages on
decellularized HFFs was 46,XX and that of hiPSCs was 46,XY.
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Discussion

This study involves the development of a feeder-free system for stable undifferentiated
hPSC propagation that demonstrates several significant steps towards the improvement of
hPSC culture systems. The system developed was effective in its generation of a substrate
of human origin and offered a viable alternative to traditional mouse feeder layer based
systems. Further, other feeder-free systems have relied heavily on supplementation with
excess basic fibroblast growth factor (bFGF) or MEF-CM for long term maintenance of
hPSCs in their undifferentiated state. Given the cost inffectiveness and the use of nonhuman derived components in those systems, our study has utilized growth medium
without the need for conditioning prior to use on the acellular substrates. Furthermore,
previous studies have reported the variability that exists between different hPSCs and the
usefulness of comparing experimental outcomes across distinct hPSCs [202]. To
demonstrate the efficacy of the acellular substrates, we used hPSCs from two embryonic
(BG01v and WA09) in addition to an induced pluripotent stem cell from human fibroblasts
in our studies. Positive expression of key pluripotent markers based on quantitative PCR
and immunocytochemical analyses is a clear indicator of the sustained maintenance of self
renewal of hPSCs on the acellular substrates. Quantitative PCR experimental outcomes
validate the comparable expression of pluripotent genes, within the two hPSCs evaluated
on the two different acellular substrates. Gene expression values of germ-layer specific
markers analyzed within undifferentiated populations of cells related to high CT values are
indicative of low differentiation within the hPSC colonies. Furthermore, the values based
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on the EI demonstrate high values for undifferentiated hPSCs compared to differentiated
samples (EBs) obtained from the hPSCs on the different substrates. A collective expression
index based on up and down-regulated genes at any stage of hPSC culture is an attempt to
quantify the level of differentiation in cells grown in different culture conditions. In this
study, six markers; three pluripotency and three germ layer makers were used, with the
robustness of such a metric increasing with the inclusion of more reporter genes. This
method of PCR data representation is not susceptible to small changes in CT values and
delivers a quality control indicator for the optimization of novel substrates in stable
undifferentiated hPSC propagation. The expression indexes of hPSCs maintained on
feeder-free substrates is comparatively lower than that of hPSCs propagated on MEFs
(data not shown), as observed in this study and elsewhere [200]. The reason for this
discrepancy is unknown; however the hPSCs maintained on acellular substrates display all
characteristics of self-renewal and pluripotency that include tri-lineage differentiation
potential as shown by histological analysis and are indistinguishable from each other in
that regard.
In this study, we have used MEF-based feeder systems as a control for evaluating
the usefulness of the human acellular substrates developed. Two immortalized human
fibroblasts (foreskin and dermal) and decellularized substrates derived from the human
fibroblasts were extensively characterized for stable hPSC propagation. Since MEFs have
been used for the isolation, derivation and expansion of many of the existing hPSCs, we
speculate that most of the hPSCs have developed a dependency on MEFs and MEF
secreted components. The observed temporary transition effect related to some detectable

64
background differentiation during the early passages on the acellular substrates could have
been a direct result of the period required for acclimatization of the hPSCs to the acellular
substrates. However these transition effects subside for all hPSCs after the third passage on
all the acellular substrates evaluated. In our culture system, the hPSCs were propagated in
standard medium supplemented with 4ng/ml of bFGF, as opposed to 50-100 ng/ml bFGF
in other reported feeder-free systems that have used MEF-CM or more defined medium
[20, 192, 204]. The minimal requirement of supplementation demonstrates the efficacy of
the acellular substrates in maintaining the undifferentiated state of the hPSCs without the
need for conditioning of the medium or addition of higher bFGF concentrations. However,
future efforts with regard to optimization of medium formulations might improve the
propagation of stable hPSCs on the acellular substrates.
Previous studies have demonstrated the relevance of culture and passaging
conditions on the genomic stability of hPSCs. Aneuploid cells have been observed in longterm culture of hESCs under feeder-free conditions, with trisomy 20 as the most frequent
mutation [202], and trisomy 12 and 17 under feeder-based conditions [190]. In our studies,
cytogenetic analyses conducted on hPSCs propagated on the acellular substrates
demonstrate the absence of gross chromosomal abnormalities.
In conclusion, we have demonstrated the development and characterization of a
human acellular substrate based feeder-free system as providing unique and functional
benefits for stable undifferentiated hPSC propagation, as opposed to the common murinebased MatrigelTM substrate, that include reduced contamination potential due to extensive
culture manipulations of parallel stem and feeder cultures, the potential for xeno-free scale-
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up based on a thorough characterization of the substrate components and the reduced need
for factor additives or medium conditioning. Further, the acellular substrate based system
is devoid of non-human derived products and actively promotes long term propagation of
hPSCs while maintaining self-renewal, and pluripotent characteristics and most
importantly the genomic stability. It is possible that the matrix proteins might bind and
sequester essential growth factors from the culture medium or might contain factors from
fibroblasts which aid in the maintenance of self-renewal. Though this study does not
eliminate the need for an additional cell line to be maintained in parallel, we are in the
process of characterizing the core components of the ECM that will permit us to create
defined matrices leading to elimination of maintenance of dual cultures. Alternately,
lyophilization of the extracted substrates permit long-term storage for incorporation in
hPSC culture as and when desired (Appendix D). Further understanding of the mechanism
of action, modifications and optimization of the system will rely on a detailed
characterization of the components of the extracellular matrix of the substrates and will
contribute to a better understanding of the key physical cues required for hPSC selfrenewal and for routine adaptation of the substrates for stable hPSC propagation.

CHAPTER 3: Characterization and application of human fibroblast-derived
extracellular matrix for human pluripotent stem cell propagation

Abstract

Recent studies from our laboratory have shown that acellular substrates generated from
human fibroblasts successfully maintained human pluripotent stem cells (hPSCs) in their
undifferentiated state for extended periods. Towards better characterization of the core
components in the substrates, we conducted proteomic analyses to identify the extracellular
matrix (ECM) proteins in mouse embryonic and two human fibroblasts. Our studies
identified heparan sulfate proteoglycan (HSPG) along with other major ECM proteins as
core components of the substrates derived from mouse and human fibroblasts, these results
were validated immunocytochemically. In our attempt to synthesize substrates that mimic
the biological activity of fibroblast-deposited ECM, combinations of HSPG and other core
ECM proteins were formulated and assessed for hPSC self-renewal. WA09 and BG01v
hPSCs maintained on these substrates exhibit multiple characteristics of pluripotency that
include (a) tight colony formation with typical stem cell morphology (b) positive
expression of alkaline phosphatase (c) positive expression of SSEA3, SSEA4 and OCT4
based on immunocytochemical analyses (d) POU5F1, NANOG and SOX2 mRNA
expression and (e) in-vitro differentiation and expression of germ-layer specific markers.
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Our studies also reveal that although HSPG by itself does not support hPSC self-renewal, a
substrate that combines HSPG and fibronectin is sufficient for undifferentiated propagation
of hPSCs. These studies form the basis for identification and development of appropriate
ECM components in a substrate that synergistically promotes activation of adhesion and
signaling pathways responsible for hPSC self-renewal.
Introduction

Human pluripotent stem cells (hPSCs) that include human embryonic stem cells (hESCs)
and human induced pluripotent stem cells (hiPSCs) have the capacity to self-renew
indefinitely or differentiate into the three primary germ layers and subsequently form
specialized cell types [1, 2, 4, 5]. These unique characteristics of hPSCs make them
suitable for use in regenerative biomedical therapies, drug testing platforms and as in vitro
models for developmental biology studies. However, one of the major hurdles facing stem
cell researchers is the ability to efficiently produce stable hPSCs prior to their use in
different applications. Current methodologies provide limited opportunities for generating
stable hPSC populations due to the lack of a thorough understanding of biochemical and
biophysical cues required for unlimited self-renewal. Identification and characterization of
key signaling factors, molecular pathways and extracellular matrix components responsible
for self-renewal thus provide opportunities for the development of bioprocessing strategies
for hPSC propagation systems [195].
Traditional methods for the derivation and subsequent propagation of hPSCs have
involved the use of mouse embryonic fibroblasts (MEFs) as feeder layers, supplemented

68
with culture medium containing non-human derived serum [2, 189] . The risk of
contamination with xenogenic pathogens under these culture conditions have led to the
incorporation of growth factors such as basic fibroblast growth factor (bFGF) and serum
replacers in hPSC propagation systems. Culture systems that use human feeders have also
been identified to minimize association of hPSCs with nonhuman factors so as to develop
propagation systems suitable for therapeutic applications [20]. Within an hPSC culture
system, signaling molecules like basic fibroblast growth factor (FGF2) [34], Activin A
[205], and noggin [206] have been shown to repress spontaneous differentiation rather than
maintain self-renewal. Given that Activin A has also been shown to induce hPSC
differentiation to the mesodermal lineage [106], there is a definite need for a better
understanding of the mechanisms employed by the hPSCs to self-renew and/or
differentiate.
Successful use of culture medium conditioned by mouse or human feeder cells in
the maintenance of hPSCs demonstrates that the trophic factors secreted in the growth
medium or the matrix deposited by the feeder layers [48], [207] play an important role in
hPSC self-renewal. Proteomic analysis of mouse and human fibroblast conditioned
medium have provided some preliminary insights into the feeder-derived factors that
contribute to hPSC self-renewal[208, 209]. In these studies, a number of proteins of
extracellular and intracellular origin of known biological functions have been detected,
with the overall goal of identification of biological pathways responsible for hPSC selfrenewal. However, given the consensus in the stem cell community of the absence of a

69
defined system for hPSC maintenance, it is believed that a number of unidentified factors
may be required to maintain hPSC self-renewal [210].
Our current study utilized proteomic approaches to isolate and identify the proteins
within the extracellular matrix in three well characterized feeder layers, human foreskin
fibroblasts (HFF), human dermal fibroblasts (HDF) and mouse embryonic fibroblasts
(MEF). Peptide identification involved two step liquid chromatography (LC) separation
utilizing strong cation exchange (SCX) and reverse-phase sequential step elution followed
by peptide sequence analysis using tandem mass spectrometry. Immunocytochemical
analysis was used to validate the presence of key extracellular matrix proteins in the
different feeder layers. To assess the efficacy of the ECMs identified, commercially
available proteins were used to formulate ECM-protein based substrates (EPBS) and their
ability to maintain undifferentiated hPSCs based on multiple evaluation criteria for
pluripotency was studied. Our studies identified heparan sulfate proteoglycan (HSPG) as a
core component of the EPBS developed for hPSC self-renewal with additional studies
indicating that a combination of HSPG and fibronectin as being sufficient for hPSC selfrenewal. Our results suggest that ECM components that contribute to adhesion and
activation of pluripotency-related signaling pathways will play a critical role in the
development of substrates for long-term stable hPSC propagation.
Materials and Methods

2.1 Preparation of acellular substrates from mouse and human feeders
Mouse embryonic fibroblasts (MEFs) were isolated from embryos derived from 13.5d CF1
pregnant mice, and maintained in Dulbecco’s modified Eagle’s medium with 4.5 g/L
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glucose, 2mM L-Glutamine, 1% Penicillin/Streptomycin and 10% fetal bovine serum.
Human foreskin fibroblasts (HFFs) were maintained in Dulbecco’s modified Eagle’s
medium with 4.5 g/L glucose, 2mM L-Glutamine, 1% Penicillin/Streptomycin and 10%
cosmic calf serum and 2% Medium 199 (10x) to create a blend of basal medium
comprising of M199 and DMEM. Human dermal fibroblasts (HDFs) were maintained in
Minimum Essential medium supplemented with 2mM L-Glutamine, 1%
Penicillin/Streptomycin, 15% fetal bovine serum, non-essential and essential amino acids,
sodium pyruvate and vitamins.
Acellular substrates were generated by allowing the cultures (HFFs and HDFs) to
proliferate 6 to 8 days past 100% confluency. In the case of MEFs, inactivated 6-8-day old
MEFs seeded at a density of 300,000/ 35mm dish was used to generate acellular substrates.
The plates were washed with sterile distilled water to remove traces of growth medium
followed by a short exposure to 20mM NH3 solution to lyse the fibroblasts leaving behind
the deposited ECM. The substrates were thoroughly washed with phosphate buffered
saline (PBS) to avoid the deleterious effects of the alkaline ammonia solution.
2.2 Preparation of samples derived from acellular substrates for proteomic analysis
Post acellularization as described above, the exposed extracellular protein matrix was
scrapped off the tissue culture plate for processing. Given that different methodologies
developed for protein processing and analysis can lead to different results, we decided to
employ two independent methodologies as part of our proteomic analysis on the ECM
substrates and pool together the data obtained. However, for the purposes of our studies,
we only focused on ECM-proteins that were common in all three substrates that were

71
analyzed. The first method involved processing of the protein pellets and analysis based on
previously published protocols [211, 212]. Proteins were denatured with 8M urea, reduced
with DTT, alkylated with iodoacetamide and then digested overnight with trypsin in
ammonium bicarbonate buffer. Resulting tryptic peptides were desalted on C8 cartridges
(Michrom BioResources) and subjected to 2D Nano LC/MS/MS analyses on a Dionex
nano LC system. For the first dimension separation we used 300 μm ID SCX column
(PolyLC Polysulfoethyl A 150X.3mm, 5 um, 200 A) using a 15 ammonium formate (inhouse made, 0.8M solution) step gradient (0-100%, pH3.6-6.5) at flow rate 5 μl/min.
Peptides eluted from SCX column are trapped on C4 precolumn (Dionex PepMap300, 5
μm, 300A, 300μm ID X 5 mm), desalted (0.1% formic acid, 2% ACN) and then separated
on 75 μm ID C18 column (Dionex NAN75-15-03-C18 PepMap100 stationary phase, 3
μm) using acetonitrile gradient at flow rate 200 nl/min and electrospayed to LCQDeca XP
Plus ion trap mass spectrometer. The mass spectrometer was operated in data-dependent
mode. Survey full scan MS spectra were acquired from m/z 350 to 2000 and the four most
abundant ions in were selected and fragmented to produce tandem mass spectra. The target
ions already selected twice for MS/MS were dynamically excluded for 3 min. A
normalized collision energy of 35% was used for peptide dissociation. The MS/MS spectra
were recorded in the profile mode. The MS/MS data were analyzed using the SEQUEST
search algorithm (Bioworks 3.2, Thermo) program against NCBI human and mouse
protein database and its reversed complements, with a 1% false-positive rate used to obtain
the peptide IDs. Spectra were searched allowing maximum mass deviation of 3 amu and 2
missed cleavage sites and only peptides showing fully tryptic termini were considered.
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As part of the second independent method employed for proteomic analyses, the
protein pellets were dissolved using 8M Urea in 10mM Tris Buffer at pH 8.0 followed by
separation in 10% SDS-PAGE gel to filter out cellular debris. The gel section with the
separated proteins was then divided into four pieces, for a crude reduction of sample
complexity for use in mass spectrometric analysis. The gel pieces were transferred to a
siliconized tube, washed and destained in 200 µL 50% methanol overnight. The pieces
were subsequently dehydrated in acetonitrile, rehydrated in 30 µL of 10 mM dithiolthreitol
(DTT) in 0.1 M ammonium bicarbonate and reduced at room temperature for 0.5 h. After
removal of the DTT solution, samples were alkylated in 30 µL 50 mM iodoacetamide in
0.1 M ammonium bicarbonate at room temperature for 30 min. This was followed by
dehydration of the gel pieces in 100 µL acetonitrile, and rehydration in 100 µL 0.1 M
ammonium bicarbonate, followed by complete drying by vacuum centrifugation. Further
rehydration in 50 mM ammonium bicarbonate (20 ng/µL trypsin) on ice for 10 min was
followed by removal of excess trypsin solution and addition of 20 µL 50 mM ammonium
bicarbonate solution. The sample was digested overnight at 37 oC and the peptides formed
extracted from the polyacrylamide in two 30 µL aliquots of 50% acetonitrile/5% formic
acid. These extracts were combined and evaporated to 15 µL for MS analysis.
2.3 Proteomic analysis
The Liquid Chromatography-Mass spectrometry (LC-MS) system consisted of a Thermo
Electron Deca XP Plus mass spectrometer system with a nanospray ion source interfaced
to a self-packed 8 cm x 75 μm ID Phenomenex Jupiter (Torrance, CA) 10 μm C18
reversed-phase capillary column. 5 µL of the extract was injected onto the column using
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pressure and the peptides eluted from the column by an acetonitrile/0.1 M acetic acid
gradient at a flow rate of 0.4 µL/min over 80 minutes. The nanospray ion source was
operated at 2.8 kV. The digest was analyzed using the double play capability of the
instrument acquiring full scan mass spectra to determine peptide molecular weights and
product ion spectra to determine amino acid sequence in sequential scans. The data were
analyzed by database searching using the Sequest search algorithm (Bioworks 3.2,
Thermo) against IPI human and IPI mouse database (European Bioinformatics Institute).
2.4 Immunocytochemical validation of extracellular matrix proteins
Fibroblasts and acellular substrates derived from the fibroblasts were fixed using 4%
paraformaldehyde in PBS. Fixed cells and substrates were incubated with primary
antibodies: collagen I, collagen III, fibronectin and heparan sulfate proteoglycan (Abcam,
Cambridge, MA). Goat anti-mouse IgG conjugated to Alexa 488 (Molecular Probes,
Eugene, OR) was used as the secondary antibody for the collagens and fibronectin. Goat
anti rat IgG conjugated to Alexa 594 (Molecular Probes, Eugene, OR) was used for HSPG.
Fluorescent images were acquired using CoolSnap EZ camera (Photometrics, Tucson, AZ)
mounted on a Nikon Eclipse TE 2000-S inverted microscope (Nikon, Melville, NY) with
attached image analysis software. All image settings were controlled for uniform
acquisition between samples. Specifically, uniform exposure time was maintained for
images acquired from experimental samples as well as negative controls for background
subtraction. All primary antibodies were obtained from Santa Cruz (Santa Cruz, CA),
unless otherwise stated.
2.5 Formulation of different ECM-protein based substrates for hPSC propagation.
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Commercially available proteins corresponding to basement membrane of EngelbrethHolm-Swarm mouse sarcoma derived heparan sulfate proteoglycan (HSPG) and laminin at
concentrations of 10ng/cm2 and 1mg/cm2 respectively; human plasma derived Fibronectin
(Fn) (Millipore, Billerica, MA) and Vitronectin (Vn) at concentrations of 3μg/cm2 and
10ng/cm2 respectively were used to formulate the combinatorial ECM protein based
substrates (EPBS) for evaluation in hPSC propagation. Different concentrations of the
ECM proteins were initially tested to determine the appropriate combinations for use in the
testing for hPSC maintenance. Tissue culture plates were treated with the different
formulations and allowed to incubate for one hour at room temperature prior to seeding
with hPSCs. The different combinations of the four ECM proteins tested were HSPG-Fn
(HF), HSPG-Ln (HL), HSPG-Vn (HV), HSPG-Fn-Ln (HFL), HSPG-Fn-Vn (HFV),
HSPG-Ln-Vn (HLV) and HSPG-Fn-Ln-Vn (HFLV). The purpose of this combinatorial
study was to examine the specific effects of HSPG in promoting adhesion and maintenance
of pluripotent capabilities of two different hPSCs. All proteins were acquired from Sigma
unless otherwise specified.
2.6 Evaluation of pluripotent capabilities of hPSCs on ECM-based substrates
Human pluripotent stem cells (karyotypically normal WA09s and karyotypically abnormal
BG01v) were routinely maintained in direct co-culture with MEFs in DMEM/F12
supplemented with 20% knockout serum replacement, 0.1mM β-mercaptoethanol, 1% nonessential amino acids, 100U/ml penicillin, 100mg/ml streptomycin and 4 ng/ml basic
fibroblast growth factor. For the purposes of testing, WA09 and BG01v hPSCs were
transferred from MEFs onto 35mm dishes coated with different EPBS in growth medium
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supplemented with 100ng/ml of bFGF, and subcultured by treatment with collagenase for
upto 5 passages.
Routine staining for alkaline phosphatase was performed as per manufacturer
instructions (Vector Labs) and as published previously [213]. Immunostaining of hPSCs
on the EPBS and in suspension for cytospin applications was also based on previously
published protocols [214]. Fixed cells were incubated with primary antibodies: OCT4
(Santacruz Biotechnology, Santa cruz, CA), SSEA3 and SSEA-4 (Millipore, Temecula,
CA). Goat anti-mouse IgG conjugated to Alexa 488 for OCT4 and SSEA4 and goat antimouse IgM conjugated to Alexa flour 594 for SSEA3 (Molecular Probes, Eugene, OR)
were used as secondary antibodies. Fluorescent images were acquired using a Nikon
Eclipse TE 2000-S inverted microscope (Nikon) with attached image analysis software.
All image settings were controlled for uniform acquisition between samples. Specifically,
uniform exposure time was maintained for images acquired from experimental samples as
well as negative controls for background subtraction.
The cytospin apparatus was assembled and used based on previously published protocols
[215]. A plastic slide, in this case the plastic base of a 4 well Permanox® chamber slide
was used, holes were punched to facilitate the formation of a monolayer of cells onto a
cleaned glass slide. 3MM filter paper (Whatman Int. Ltd., Maidstone, England) with holes
corresponding to those on the plastic slide with 0.1-10 μl micropipette cut in half was
wedged between the slides. A second uncut micropipette tip is inserted into the first and a
small volume of the cell suspension was deposited into the apparatus followed by
centrifugation at 1000rpm for the generation of the monolayer. Fluorescent images were
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acquired using a Nikon Eclipse TE 2000-S inverted microscope (Nikon) with attached
image analysis software. All image settings were controlled for uniform acquisition
between samples as described earlier. For a quantitative analysis of SSEA3/SSEA4
expression on two different EPBS, the number of positively stained cells within three
independent regions of interest was counted and the mean values reported. (Appendix D)
In vitro differentiation potential of hPSCs propagated on EPBS was assessed by the
generation of embryoid bodies (EBs). To generate embryoid bodies (EBs), hPSC colonies
were divided into clumps of about 100-300 cells and resuspended in ultra-low attachment
conditions, in growth medium devoid of bFGF, with media changes every 3-4 days for 15
days.
mRNA for gene expression analyses was isolated from hPSCs propagated under different
conditions and from EBs after 15 days in suspension using Trizol (Invitrogen, Carlsbad,
CA) and quantified using BioMate3 UV-VIS Spectrophotometer (Thermo Scientific,
Waltham, MA). cDNA was synthesized from 1μg of RNA using cDNA reverse
transcription kit (Applied Biosystems, Foster City, CA). Expression of pluripotent genes
Octamer Binding Transcription Factor-4 (POU5F1), SRY (Sex Determining Region-Y)
Box-2 (SOX2), NANOG, and germ layer specific genes, Neurogenic differentiation 1
(NEUROD1), Insulin-like Growth Factor 2 (IGF2) and α-Fetoprotein (AFP) (Table 3) was
analyzed using quantitative real time RT-PCR. (qPCR). qPCR was performed in an ABI
HT7900 system and the data was acquired using Sequence Detection System software
(SDS v2.2.1, Applied Biosystems). Gene expression data (three replicates) were acquired
and SDS software was used to estimate relative fold change values using ΔCT quantitation
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methods. Endogenous 18S ribosomal RNA was used for normalization in all the samples.
Relative gene expression for hPSCs propagated on EPBS was assessed against hPSCs
propagated on MEFs. Relative gene expression of differentiated EBs obtained from
different conditions was assessed against undifferentiated hPSCs propagated under the
original condition. Expression Index (EI) was used to determine the relative differentiation
state of cells, and was based on the average CT values from triplicate measurements.
Expression Index (EI) was used to determine the relative differentiation state of cells [200,
201] and was based on the average CT values from triplicate measurements. An expression
ratio of two or more genes was determined using a mathematical model based on the
geometric average of assessed genes, previously described in detail,[201] given by the
following equation:
EI = K RS

m

(1 + E gene1m ) Ctgene 1m .(1 + E gene 2 m ) Ctgene 2 m ...(1 + E genem ) Ctgenem

n

(1 + E gene1n ) Ctgene 1n .(1 + E gene 2 n ) Ctgene 2 n ...(1 + E genen ) Ctgenen

E is the PCR efficiency calculated from dilution series of purified PCR products, CT is the
threshold cycle, and m and n are the numbers of genes that are up and down regulated upon
differentiation respectively. KRS is the relative sensitivity constant and was not determined
as it does not affect relative comparisons between samples.
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Results

Proteomic analysis of acellular substrates.
Proteomic analysis of acellular MEFs, HFFs and HDFs were conducted given the ability of
these acellular substrates to maintain multiple hPSCs in their undifferentiated state [207].
In our previous study, hPSCs propagated on acellular substrates were indistinguishable by
multiple criteria, including colony morphology, expression of pluripotency protein
markers, tri-lineage in-vitro differentiation potential and gene expression patterns, from
hPSCs cultured directly on a fibroblast feeder layer. It was thus postulated that proteomic
analyses of ECM components of the feeders would provide insights into proteins involved
in adhesion and activation of key signaling pathways. ECM proteins were acquired by
decellularizing post-confluent feeder cells, followed by digestion with urea, and analysis
using LC – MS/MS.
A total of 519, 426 and 514 proteins were identified in acellular MEF, HFFs and
HDFs respectively, with only peptides identified as possessing fully tryptic termini with
cross-correlation scores greater than 1.8 for singly charged peptides, 2.25 for doubly
charged peptides, 3.0 for triply charged peptides and 3.75 for quadruple charged and higher
used for peptide identification. The proteins were GO annotated into broad classifications
of cellular compartment (CC), biological function (BP) and molecular function (MF) using
PIPE (Protein Information and Property Explorer at http://pipe.systemsbiology.net [216]
Further annotation of the identified proteins to increasing levels of specificity was
performed using PIPE (Figure 14).
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Figure 14:
Functional biological and cellular profiles of the proteins identified in the three acellular
substrates of MEF, HFFs and HDFs. The circles in the figure depict the molecular function
(a), biological function (b) and cellular compartment (c) in acellular HDF (inner circle),
acellular HFF (middle circle) and acellular MEFs (outer circle).

80
Our analysis primarily focused on membrane and extracellular matrix proteins in
order to identify key proteins and signaling pathways involved in the maintenance of hPSC
self- renewal. We observed that 75, 16 and 25 of the cellular compartment annotated
proteins originated from the extracellular matrix, while 132, 114, 66 proteins were
annotated as membrane proteins in MEFs, HFFs and HDFs respectively. The remaining
proteins identified and annotated were non-membranous, originating from intracellular
organelles. In each substrate analyzed, there were approximately 100 proteins that did not
correspond to a GO annotation and it is expected that in-depth annotation will reveal their
biological relevance within the cell.
In total, acellular MEFs, HFFs and HDFs had 112 proteins in common, among which 20, 8
and 8 were extracellular matrix proteins and 30, 24 and 24 were membrane proteins
respectively. Our analysis seems to indicate that the mouse substrate is richer in
extracellular and membranous proteins than the human substrates analyzed. Proteins
common to all three substrates constituted 11.8%, those that were common to two
substrates ranged between 5.1 to 10.7%, where proteins common between HDF-HFF
constituted 5.1%, between HDF-MEF 6.3% and between HFF-MEF 10.7% of the total
proteins identified Figure 15 .
The three broad categories were further classified into a) cellular processes,
developmental processes, metabolism, stimulus response and transport in BP; b) binding,
structural molecular activity and catalytic activity in MF; and c) extracellular space and
matrix, intracellular and cell parts, membrane and macromolecular complex in CC.
Comparisons within each functional group clearly indicate the similarities between the
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human substrates (Figure 14, inner circles). This study was primarily conducted to identify
extracellular matrix proteins involved in self-renewal and maintenance of pluripotency
within both mouse and human substrates. Table 5 lists several proteins that constituted the
extracellular matrix and plasma membrane of the feeder layers. Based on the
comprehensive list of proteins, a summary of the ECM proteins as well as
growth/differentiation factors that might actively contribute to long term pluripotentiality
of hPSCs was also generated (Table 6).
Immunocytochemical validation of ECM components
Since mass spectrometry is at best a semi-quantitative analytical method, we have
attempted to corroborate the results obtained using immunostaining for some of the major
ECM proteins identified. Antibodies were used against major ECM proteins identified in
all three substrates; Collagen I, Collagen III, Fibronectin and HSPG. Results confirmed the
presence of these proteins using immunofluroscence within the ECM of the human
fibroblast feeders and their acellular substrates (Figure 16 i,ii). Our results also indicate
that minimal residual nuclear material was observed based on the absence of 4',6diamidino-2-phenylindole (DAPI) stain within the acellular substrates (Figure 16 iii,iv).
Similar results were observed in MEF and MEF derived acellular substrates (Figure 17 ).
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Figure 15:
Distribution of 1015 proteins identified in the three acellular substrates, acellular HDFs,
acellular HFFs and acellular MEFs. (A). Distribution of 109 extracellular matrix proteins
found in the acellular substrates of HDFs, HFFs, MEFs. (B).
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Table 5:
List of proteins in the three acellular substrates pertaining to cellular compartment
identified using LC-MS/MS
Protein identified and biological classification
(In all three substrates)
Extracellular
matrix,
space and
plasma
membrane

Collagen, type I, alpha 1
Collagen, type I, alpha 2
Collagen, VI, alpha 3
Collagen, XII, alpha 1
Fibronectin 1
Gelsolin
Integrin beta 1 (fibronectin receptor
beta)
Keratin 1
Keratin 2
Keratin 8
Keratin 10
Lectin, galactose binding, soluble 3
Thrombospondin 1
Heparan sulfate proteoglycan/Perlacan
Serpin peptidase inhibitor
Scavenger receptor class B, member 2

Heat Shock
proteins

Heat shock 70kDa protein 1-like
Heat shock 70kDa protein 2
Heat shock 70kDa protein 5
Heat shock 70kDa protein 8
Heat shock protein 90kDa alpha
Heat shock 60kDa protein 1
Heat shock protein 90, beta

Extracellular
matrix,
space and
plasma
membrane
Heat Shock
proteins

Intracellular
and
cytoplasm

Actin, alpha 2,
Actin, beta,
Actin, gamma 1
Annexin A1
Annexin A2
Annexin A5
Annexin A6
Calreticulin
Calumenin
Calnexin
Caveolin 1
Cofilin 1
Filamin A
Filamin C
Glyceraldehyde-3-phosphate dehydrogenase
Lamin A/C
Septin 2
Plectin 1
Transgelin
Vimentin
Elastin microfibril interfacer 1

Protein identified and biological classification
(In aHFF and aHDF)
Activated leukocyte cell adhesion
Intracellular Actin, gamma 2
molecule
and
Actinin, alpha 1
CD 44 molecule
cytoplasm
Actinin, alpha 4
CD59 molecule
Eukaryotic translation elongation factor 1
CD99 molecule
gamma
CD26
Filamin B, beta
Tenascin C (hexabrachion)
Lactate dehydrogenase A
Protein kinase C substrate
Heat shock 70kDa protein 7
Keratin 9
Heat shock 70kDa protein 9
Heat shock 27kDa protein 1
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Table 6:
Proteins of interest that might contribute to the maintenance of self renewal in hPSCs

Collagens

TGFb family

Thrombospondin

Biglycan

Periostin

Follistatin

Required for the structural integrity of the matrix.
Previously used in ES cultures both as an additive to the
growth medium and a substrate. Found in secreted
medium as well as the deposited ECM layer
Related signaling proteins latent TGFb binding protein
(LTBP) 2 and 3 were found to be present in the
substrates and have been implicated in the critical role
of controlling and targeting TGFb to sites of storage or
activation. The TGFb superfamily include: Bone
morphogenetic proteins (BMPs), Growth and
differentiation factors (GDFs), Anti-müllerian hormone
(AMH), Activin, Nodal and TGFβ's, with several of
these implicated in the maintenance of hPSC selfrenewal
Thrombospondin 1 is an adhesive glycoprotein,
mediates cell-cell and cell-matrix interactions. Multiple
domains bind to a number of ECM proteins including
fibronectin and collagens. Associated with various
biologial functions such as cell attachment, cell
aggregation and angiogenesis and involved in the
activation of TGFβ.Increased expression of
thrombospondin1 has been observed in response to
platelet derived growth factor, FGF2 and TGFβ
Biglycan and decorin are small proteoglycans known to
interact with collagens and growth factors as
TGFβ. Interactions of these proteoglycans with growth
factors are known to modulate the function of growth
factors.
Osteoblast specific factor was found in proteomic
analyses of both feeder layer conditioned medium and
deposited ECM. Perisotin is known to bind to heparin
and induces cell attachment and spreading
Follistatin is known to bind and regulate the activity of
TGFb family members

[208-210,
217]
[194,
205, 206,
218-221]

[208,
222, 223]

[224-228]

[208,
209, 229,
230]
[231,
232]
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Figure 16:
Immunocytochemical validation of the presence of major constituents of the extracellular
matrix; Collagen I (A), Collagen III (B), Fibronectin (C), and heparan sulfate proteoglycan
(D) on HFFs (i), acellular HFFs (ii), HDFs (iii) and acellular HDFs (iv).
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Figure 17:
Immunocytochemical validation of the presence of major constituents of the extracellular
matrix; Collagen I (A ), Collagen IV (B), Fibronectin (C), and heparan sulfate
proteoglycan (D), on MEFs (i), acellular MEFs (ii).
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3.3. hPSC adhesion and propagation on ECM-protein based substrates.
Furthermore, we attempted to generate a combinatorial EBPS of commerically available
proteins that mimic naturally deposited ECM, and test their ability to maintain
pluripotency in hPSCs for extended periods. In our study, given that HSPG and Fn was
identified in all three substrates, we used these proteins in combination with other
previously tested ECM proteins; Ln [233] and Vn[234]. Different combinations of HSPG,
Fn, Ln and Vn was investigated with the primary focus on HSPG. Karyotypically normal
WA09 and aneuploid BG01v hPSCs were cultured on MEFs prior to transfer onto the
EPBS substrates. The hPSCs propagated on specific EPBS maintained a high nuclear to
cytoplasmic ratio, representative of actively dividing cells (Figure 18). Positive expression
of alkaline phosphatase (AP) at each passage is indicative of the ability of the EPBS to
maintain hPSCs for extended periods (Figure 18). Of all the different combinations tested,
HF showed the maximum colony attachment and proliferation based on quantitative
analysis of AP expression (Figure 19). In the combinations that did not include Fn, (HL,
HV, HLV), cell attachment progressively decreased over passaging time. Our results
suggest that the addition of Ln and Vn to the HF mixture (i.e. HFL, HFV and HFLV)
presented suitable substrates for propagation however did not contribute to the
enhancement of the attachment and proliferative properties of the HF mixture. The number
of AP positive colonies in the HFLV substrate was similar to that on HF, hence we can
conclude that the use of HF is sufficient for a suitable and a cost-effective ECM substrate
for hPSC propagation. Individual testing of HSPG and Fn for their attachment and
proliferation capabilities demonstrated that HSPG alone did not support attachment
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whereas although Fn permitted hPSC adhesion, in the absence of any other ECM protein
tgreater differentiation was observed within the colonies (Figure 20). Our preliminary
studies involving hPSC propagation on EPBS was conducted in growth medium containing
4ng/ml of bFGF. However, the hPSC colonies did not express the standard pluripotent
characteristic of in vitro differentiation potential. In order to ensure the maintenance of
pluripotent characteristics, higher concentrations of bFGF were used in our studies.
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Figure 18:
Phase constrast images of human pluripotent stem cells, WA09 (a,e) and BG01v (c,g) and
positive expression of alkaline phosphatase in WA09 (b.f) and BG01v (d,h) grown on
ECM-based protein substrates Heparan sulfate proteoglycan – Fibronectin (HF) (a-d) and
Heparan sulfate proteoglycan-Fibronectin-Laminin-Vitronectin, (HFLV) (e-h).
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Figure 19:
Percentage of Alkaline Phosphatase positve colonies within different combinatorial-ECMprotein based substrates namely Heparan sulfate proteoglycan-Fibronectin (HF), Heparan
sulfate proteoglycan-Fibronectin-Laminin (HFL), Heparan sulfate proteoglycanFibronectin-Vitronectin (HFV) and Heparan sulfate proteoglycan-Fibronectin-Laminin –
Vitronectin (HFLV)
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Figure 20:
Progressive differentiation of hPSCs propagated on fibronectin substrates. The absence of
alkaline phosphatase staining in sections of the colony is indicative of loss of stemness.
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Characterization of hPSCs on ECM-protein based substrates.
Further characterization of the hPSCs cultured on the different EPBS was based on
immunocytochemical analysis for detection of pluripotent markers SSEA4 and OCT4.
Results demonstrate that WA09 cells maintained tight colony boundaries while BG01v
cells were observed to have taken a more fibroblastic spindle shape (Figure 21 a,c,e,g).
Though BG01v cells do not appear morphologically similar to normal hPSCs,
characterization using immunocytochemistry and gene expression using qPCR indicate no
loss of stemness. Using the cytospin apparatus, we also quantified the percentage of hPSCs
that were positive for cell surface markers SSEA3 and SSEA4 expression. Results showed
comparable expression of these markers in hPSCs grown on both HF and HFLV
substrates. WA09 cells cultured on HF showed that 91% and 89.7% of the cell population
stained for SSEA3 and SSEA4, whereas 81.4% and 80.4% were positively stained on
HFLV substrates (Figure 22 a). Similarly, in BG01v hPSCs, 98.2 and 93% were positive
for SSEA3 and SSEA4 on HF substrates and 94.9 and 89.6% for SSEA3 and SSEA4 on
HFLV substrates (Figure 22 b).
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Figure 21:
Immunofluorescence staining of hPSCs for pluripotency markers stage specfic embryonic
antigen 4 (SSEA4) in WA09 (a,e) and BG01v (c,g) and transcription factor OCT4 WA09
(b.f) and BG01v (d,h) grown on ECM-protein based substrates Heparan sulfate
proteoglycan-Fibronectin (HF) (a-d) and Heparan sulfate proteoglycan-FibronectinLaminin –Vitronectin (HFLV) (e-h). Scale bar = 50μm.
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Figure 22:
Quantitative expression of pluripotency markers SSEA3 and SSEA4 on ECM-protein
based substrates Heparan sulfate proteoglycan-Fibronectin (HF) and Heparan sulfate
roteoglycan-Fibronectin-Laminin-Vitronectin (HFLV) in WA09 (A) and BG01v (B)
hPSCs.
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Differential expression of pluripotency markers (POU5F1, NANOG and SOX2) was
presented as CT values normalized against the 18S rRNA housekeeping gene for each
experimental condition. For the purposes of the comparisons, the ΔCT values of each
marker within the different experimental sample are presented against that of MEFs. This
eliminates the requirement for normalization with the calibrator. Comparable ΔCT values
of OCT4 and SOX2 genes were seen across different culture conditions and are indicative
of the maintenance of the undifferentiated state of hPSCs on protein substrates; HF and
HFLV (Figure 23 a). Statistical analyses using Student’s t-test indicated no significant
difference (p>0.05) in the different comparisons for the pluripotency markers tested
between hPSCs propagated on the EPBS and those propagated on MEFs. However in the
case of NANOG,there was reduced expression on both the HF and HFLV substrates when
compared to those propagated on MEFs (Figure 23 a). Functional pluripotency of the
hPSCs via the formation of embryoid bodies was assessed by in vitro differentiation
(ectoderm, endoderm and mesoderm). Differential expression of germ layer specific
markers NEUROD1 (ectoderm), IGF2 (mesoderm) and AFP (endoderm) were presented as
CT values normalized against the 18S rRNA housekeeping gene for each sample and
further compared to undifferentiated cells cultured in the same experimental conditions.
Statistical analyses indicated that the EBs generated from the WA09 on the different ECM
protein substrates demonstrated significantly greater expression (p<0.01) of all three germ
layer specific markers analyzed (Figure 23 b) compared to the undifferentiated cells. Here,
it is important to note that ΔCT values (normalized against 18S) should be interpreted
counter-intuitively; where a lower value indicated higher expression and vice versa.
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Figure 23:
Normalized gene expression of undifferentiated markers in WA09 on MEFS (A) WA09 on
Heparan sulfate proteoglycan-Fibronectin (HF) (B) and WA09 on Heparan sulfate
proteoglycan-Fibronectin-Laminin –Vitronectin (HFLV) (C). Significant difference
(p<0.05) between the group is shown by (*). (b) Normalized gene expression of germ layer
specific markers in WA09 on Heparan sulfate proteoglycan-Fibronectin (P), EB generated
from WA09 on Heparan sulfate proteoglycan-Fibronectin (Q), WA09 on Heparan sulfate
proteoglycan-Fibronectin-Laminin –Vitronectin and EB generated from WA09 on Heparan
sulfate proteoglycan-Fibronectin-Laminin –Vitronectin. Significant differential gene
expression (p<0.01) in all three lineage specific markers was observed
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Further, the differentiation state of the hPSCs was quantified using the ‘expression index’
as a metric to compare the undifferentiated hPSCs against the EBs generated from the
hPSCs grown under the same condition as well as across different culture conditions. For
the karyotypically normal WA09 hPSC, the expression index of the undifferentiated
sample was 2859 on HF and 3411 on HFLV while the expression index of the 15-day old
EBs derived from WA09 was found to be 0.03 and 0.02 on HF and HFLV respectively
(Figure 24). Although the EI values for hPSCs on HFLV were higher when compared to
those grown on HF substrates, there is no difference in the potential of HF substrates for
hPSC maintenance compared to HFLV substrates, based on all other characterization
studies. A summary of the different protein combinations tested and the response of hPSCs
to the substrates is tabulated in Table 7
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Figure 24:
Differential expression index of a) WA09 hPSC and WA09 EBs derived from Heparan
sulfate proteoglycan-Fibronectin (HF) substrates and b) WA09 hPSC and WA09 derived
EBs from Heparan sulfate proteoglycan-Fibronectin-Laminin –Vitronectin (HFLV) based
on analysis of six genes (POU5F1, NANOG, SOX2, AFP, IGF2 and NEUROD1).
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Table 7:
A tabulated summary of the different ECM combination tested and hPSC response to these
substrate with respect to adhesion, differentiation and pluripotency markers
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Discussion

Till date, there have been few reports that have focused on the identification and
characterization of secreted factors from MEFs, HFFs, HDFs [208, 209] that contribute to
hPSC self-renewal. Our study is the first to employ a proteomics approach to identify
components of the ECM that maintain hPSC self-renewal. The substrates revealed a
complex network of extracellular and intracellular proteins of varying biological functions.
The presence of cytosolic and nuclear proteins in our results is indicative of the difficulties
in isolating a pure ECM sample. In conditioned medium proteomic studies, the highest
percentage of proteins identified comprised of ECM components [208, 209]. Of the
proteins identified in the conditioned medium, heparan sulfate proteoglycan (HSPG),
Biglycan, Periostin, Fibronectin and Collagens were concurrently found within the
acellular substrates (Table 5). Since both acellular substrates and conditioned media can
support hPSC self- renewal independently of each other and has the aforementioned
proteins in common, we can speculate that core ECM proteins in the human fibroblasts are
sufficient in promoting hPSC self-renewal. In our studies, HSPG was found to be present
in all three substrates and a critical component of the ECM substrate that promoted hPSC
self-renewal. HSPGs are present in the extracellular matrix and cell membranes
ubiquitously and covalently attach to several core proteins[235]. Several growth factors,
cytokines and physiological revelant molecules have been shown to bind to the sulfated
regions of HS chains[236]. HS chains have also been shown to regulate various biological
signaling pathways such as fibroblast growth factors (FGFs), Wnt and hedgehog (Hh) and
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BMP[237], pathways that have been implicated in maintenance of hPSC self-renewal.
FGF2 has been previously shown to be extremely important in maintaining pluripotency in
hPSCs[192]. HS increases the affinity of FGF2 to its receptor [238-240] and allows for
stabilization of FGF2 within the growth medium, which is subsequently responsible for
maintenance of hPSC self-renewal [241]. Additionally, HSPG regulates the extrinsic
signaling pathways of the βcatenin/Wnt pathway required for the expression of NANOG,
which is essential for the maintenance of pluripotency in mESCs[242], and a core
component of the pluripoteny transcription network in hESCs [243].
In our studies, fibronectin was found to be present in all three substrates and a
critical component of the ECM substrate that promoted hPSC self-renewal. Fibronectin is a
high molecular weight glycoprotein secreted and organised by fibroblast cells into an
insoluble component of the extracellular matrix[244]. The ability of fibronectin to maintain
undifferentiated hPSCs has been previously reported with supplementation using
conditioned medium or high FGF2 concentrations in growth medium [20, 245]. The
interaction between fibronectin and hPSC has been demonstrated to be through integrin
α5β1, a major receptor for fibronectin [246]. Several integrins subunits (α5, α6, αv, β1
and β2) were shown to be highly expressed in hPSCs indicating the active role of several
ECM proteins in the cell-extracellular matrix interaction for attachment and propagation
[20, 48, 234, 247, 248].
Other important adhesive proteins and signaling molecules were identified in our
analysis are listed in Table 6 [194, 217-232]. In our studies, immunocytochemical analyses
validated the presence of multiple ECM proteins in both the cellular as well as acellular
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substrates and allows us to qualitatively conclude that the decellularization process causes
minimal lose of ECM (Fn, Collagens and HSPG). From all the different EPBS
combinations tested, our results suggest that the combinatorial use of HSPG and Fn is
sufficient for the maintenance of hPSC self-renewal. Although previous studies have
shown that Ln and Vn individually [233, 234], as well as in combination with HSPG and
Fn in our studies have been shown to support self renewal, the use of HSPG-Fn as a
substrate provides a cost-effective and sufficient alternative to the use of feeder layer or
feeder conditioned medium. The property of Fn to elicit an adhesion response from most
fibroblasts is attributed to intergrin binding domains, however heparan binding domains on
Fn is known to contribute to the adhesion of normal fibroblasts, in melanoma and
neuroblastoma cells[249-251]. Integrins such as α5β1 are the key mediators of integrinligand interaction in Fn through primary receptors as the RGD motif of repeat III10[252].
Signaling through proteoglycans such as syndecan-4 in addition to integrin signaling is
required for rearrangement of the actin cytoskeleton into bundled stress fibers and focal
adhesion formation[253, 254]. Focal adhesions are signaling complexes that result in stable
cell-matrix interactions and contributes not only to cell adhesion but to dynamic changes in
gene expression, apoptosis regulation, and control of the cell cycle[255]. In addition to
HSPG as a co-factor in FGF signaling, recent studies have shown that the addition of HS
increases the binding affinity of FGF to its receptors by several fold [238, 241].Several
modeling studies describe the interaction as a dimer of FGF ligands bound to a dimer of
FGF receptors stabilized by a cell surface-anchored HSPG[256, 257]. Thus, the presence of
HSPG in the EBPS as well as endogenous cell surface HSPG that contribute to FGF2
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sequestration and cell-matrix focal adhesion formations might be an important component
of the substrate involved in hPSC self-renewal (Figure 25).
Conclusions

This study provides the first detailed characterization of acellular substrates that have
demonstrated the propensity to maintain hPSC self-renewal for extended periods, followed
by generation of EPBS based on the data obtained from proteomic analyses. In an attempt
to design a substrate that mimics naturally occurring biological substrates, we have
observed that HSPG plays an important role in the maintenance of hPSC self-renewal. In
conjunction with Fn, HSPG yields a substrate that can maintain hPSCs in their
undifferentiated state over multiple passages. Our results also showed that the presence of
other ECM proteins in the EPBS did not contribute to any additional benefit to the HSPGFn combination. However any EBPS combination lacking Fn did not support hPSC
adhesion and propagation without any supplementation of the growth medium. Our
understanding is that the combinatorial effects of the interactions of HSPG with Fn to
create a matrix on the tissue culture polystyrene (TCPS) surface, cell membrane bound
HSPG with Fn that allow for focal adhesion contacts on the matrix as well as the ability of
HSPG sequester growth factors such as FGF2 and TGFβ which in turn activate various
downstream self-renewal activators play a critical role in the ability of HSPG-Fn substrate
to maintain undifferentiated hPSCs (Figure 25). Growth factors and other cytokines that
are present in small quantities are not detected either due to the stringent search parameters
or due to the MS instrument selecting only the most abundant ions for sequencing. It is
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known that hPSC pluripotency relies heavily on exogenous supplementation of the culture
medium with growth factors. Thus the identification of growth factors present in the
acellular substrates and sequestered within the matrix is vital. Further analysis of the
substrates that maintain hPSC pluripotency using techniques involving the quantification
of proteins such as isotope-coded affinity tags (ICAT) or isobaric tag for relative and
absolute quantitation (iTRAQ) would allow for better understanding of the dose dependent
effects of proteins and growth factors. Furthermore, information on the relative abundance
of proteins and their inhibitors would be of great significance in the development of
substrates that synergistically promotes activation of adhesion and signaling pathways
responsible for hPSC self-renewal.
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CHAPTER 4: Propagation of human embryonic and induced pluripotent stem cells
in an indirect co-culture system

Abstract

We have developed and validated a microporous poly(ethylene terephthalate) membranebased indirect co-culture system for human pluripotent stem cell (hPSC) propagation,
which allows real-time conditioning of the culture medium with human fibroblasts while
maintaining the complete separation of the two cell types. The propagation and pluripotent
characteristics of the hESC human embryonic stem cell (hESC) line and a human induced
pluripotent stem cell (hiPSC) line were studied in prolonged culture in this system. We
report that hPSCs cultured on membranes by indirect co-culture with fibroblasts were
indistinguishable by multiple criteria from hPSCs cultured directly on a fibroblast feeder
layer. Thus this co-culture system is a significant advance in hPSC culture methods,
providing a facile stem cell expansion system with continuous medium conditioning while
preventing mixing of hPSCs and feeder cells. This membrane culture method will enable
testing of novel feeder cells and differentiation studies using co-culture with other cell
types, and will simplify stepwise changes in culture conditions for staged differentiation
protocols
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Introduction

Human pluripotent stem cells (hPSCs) that include human embryonic stem cells
(hESCs) and human induced pluripotent stem cells (hiPSCs) are capable of self-renewal
and differentiation into multiple cell types [1, 2, 4, 5]. Traditional culturing of hPSCs
involves direct contact with a supporting feeder cell layer, such as mouse embryonic
fibroblasts (MEFs), to support their undifferentiated growth [258]. These feeder cells not
only secrete extracellular matrix (ECM) components crucial for attachment of hPSCs, but
also contribute yet unidentified essential nutrients and growth factors to help maintain
hPSCs in a pluripotent state. Because of their potential in tissue engineering and clinical
applications, there is a great deal of interest in improving methods for the scalable
expansion and differentiation of hPSCs. Feeder cell layers provide an excellent growth
substrate for the proper attachment of hPSCs that generally do not adhere to tissue culture
treated plastic. One issue of hESC and hiPSC lines propagation in direct contact with a
feeder layer however, is that it allows for the intermixing of cell types [17]. Recent culture
improvements include using human rather than mouse fibroblasts as feeder layers [20, 22,
23, 259] to eliminate potential cross-species pathogen contamination, however separation
of the feeder from the stem cells for passage or other manipulations still remains a
technical challenge. On this front, progress in the development of feeder-free methods has
been made using purified substrates such as Matrigel, fibronectin or laminin to allow for
attachment [48]. In these feeder-free culture systems, hPSCs are propagated in growth
medium previously pre-conditioned separately by fibroblast feeder cells then transferred to
the hPSC culture. Commercially available culture media have recently been offered as
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alternatives to conditioned medium[204]. However, these media are expensive and use
exceedingly high levels of synthetic growth factors (e.g., as much as 100 ng/mL bFGF,
IGF, BMPs, etc) to achieve maintenance of undifferentiated hPSC cultures limiting their
cost effectiveness for scale-up. In addition to cost concerns of these additives, there
remains concern that prolonged continuous culture in completely feeder-free culture may
lead to undesirable changes in hPSC karyotype or phenotype [260].
In an effort to simplify hPSC culture without compromising the quality of the cells,
we have evaluated a microporous membrane-based indirect co-culture (MBIC) system that
physically separates hPSCs from the feeder layer, while allowing for continuous
conditioning of the medium by the feeder cells. It was recently reported that
undifferentiated hESCs could be successfully cultured on microporous membranes
separated from a MEF feeder layer attached directly to the opposite side of the membranes
[261]. In their study, the investigators concluded that direct contact was still necessary
where a membrane pore size of 3.0 μm was required that allowed direct contact between
the feeders and the hESCs through cellular extensions across the pores.
In this study, we report the first use of an MBIC method for maintaining
undifferentiated hPSCs, in which cell type mixing between the stem cells and the feeder
cells is eliminated due to the absence of physical contact between the two. We show that
hPSCs cultured across a membrane from human feeder cells are indistinguishable from
those cultured in contact with the feeders, based on colony morphology, expression of
pluripotency protein markers, in-vitro differentiation into the three different germ layers
and global gene expression profiles. Use of a MBIC system for the expansion of human
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hPSCs, where the stem cells and the feeder cells are separated by a microporous membrane
partition, allows for an economical alternative to synthetic media-based feeder free system
that is amenable to scale up. In addition, the complete separation of the feeders simplifies
the testing of multiple culture conditions for optimal hPSC growth, by enabling rapid
changes in conditions, such as testing differentiation factors and/or other types of cocultured cells, without having to dissociate and replate the cells
Materials and methods

Generation of inactivated human feeder layers and acellular substrates from human
feeders. Human foreskin fibroblasts (HFFs) were maintained in Dulbecco’s modified
Eagle’s medium with 4.5 g/L glucose, 2mM L-Glutamine, 1% Penicillin/Streptomycin and
10% cosmic calf serum (HyClone, Logan, UT) and 2% Medium 199 (10x) (Gibco,
Gaithersburg, MD) to create a basal media blend of DMEM and M199. Inactivation of the
feeders was achieved by incubation in 10μg/ml of Mitomycin C (MMc), a mitotic inhibitor
for 2 hours. Post-incubation, the cells were thoroughly washed with PBS 6 times, followed
by trypsinization and additional 3 washes in media. The cells were then plated at a density
of 300,000 cells/35mm dish.
Acellular substrates were generated by allowing the HFF cultures to proliferate 6-8 days
past 100% confluency within the 6-well tissue culture dishes (Sigma-Aldrich) of a
Millicell® 1.0µm polyethylene terephthalate (PET) inserts with hanging geometry
(Millipore, Billerica, MA). The inserts were washed with sterile distilled water to remove
traces of growth medium followed by a short exposure to 20mM NH3 solution to expose
the deposited ECM. The substrates were thoroughly washed with phosphate buffered
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saline (PBS) to avoid the deleterious effects of the alkaline ammonia solution. A schematic
depicting the microporous membrane culture system within a 6-well dish is shown in
Figure 26.
Propagation of hPSCs and hPSC-derived cells. Karyotypically normal diploid stem cell
lines WA09 and hiPSC (WiCell Research Institute, Madison, WI) were transferred from
mouse feeder layers onto the acellular matrices within the inserts. Parallel studies were also
carried out using fibronectin coating supporting BG01v cells (Bresagen, Athens, GA), a
rapidly dividing, karyotypically aneuploid cell line [198, 199, 213], within the inserts. For
fibronectin coating, the inserts were incubated for 24 hours at 37˚C with 30 μg/mL human
fibronectin (Millipore) diluted in 0.2% porcine gelatin (Sigma-Aldrich). The hPSCs were
maintained in DMEM/F12 supplemented with 20% knockout serum replacement, 0.1mM
β-mercaptoethanol, 1% non-essential amino acids, 100U/ml penicillin, 100mg/ml
streptomycin and 4ng/ml basic fibroblast growth factor, bFGF (Gibco, Gaithersburg, MD).
Cells were subcultured by either mechanical dissociation or by gentle trituration; the
colonies were split into clumps of 100-200 cells and transferred to a fresh substrate coated
insert.
WA09-derived extraembryonic endoderm-like (XE) cells utilized for global gene
expression comparisons were generated using the method described [262]. XE cells are
polygonal, flat cells that grow in monolayer and resemble fibroblasts in morphology. XE
cells were grown in DMEM+10% FBS at 37oC/5% CO2. XE cells were fed on alternate
days and passaged weekly with 0.05% trypsin (Gibco).
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Figure 26:
Schematic of a Microporous Membrane-based indirect co-culture system. HPSCs attach to
extracellular matrix (ECM) coated microporous membranes of transwell inserts, which
hang inside a 6-well tissue culture dish by plastic projections. HFF- Human foreskin
fibroblast.
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Alkaline Phosphatase assay. Staining for alkaline phosphatase was performed as per
manufacturer instructions (Vector Labs). Briefly, the cells were washed with deionized
water to remove traces of media. The final solution was prepared by the addition of the
three constituents provided in 0.2M Tris HCl buffer, pH 8.0. The hPSCs were incubated in
the final mixture for 40 minutes in the dark and images acquired using a Nikon TS100
Microscope.
Antibodies and Immunocytochemical analysis. hPSCs cultured on the acellular substrates
were transferred onto 4 chambered glass slides. 4% paraformaldehyde in PBS was used for
fixation, permeabilization for intracellular markers was achieved with 0.2% Triton X-100
in PBS and blocked with normal goat serum. Fixed cells were incubated with primary
antibodies: OCT4 (Santacruz Biotechnology) and SSEA-4 (Chemicon, Temecula, CA).
Goat anti-mouse IgG conjugated to Alexa 488 (Molecular Probes, Eugene, OR) was used
as secondary antibody Fluorescent images were acquired using a CoolSnap EZ camera
(Photometrics, Tucson, AZ) mounted on a Nikon Eclipse TE 2000-S inverted microscope
(Nikon, Melville, NY) with attached image analysis software. All image settings were
controlled for uniform acquisition between samples. Specifically, uniform exposure time
was maintained for images acquired from experimental samples as well as negative
controls for background subtraction
In vitro differentiation of hPSCs and histology of hPSC-derived embryoid bodies. To
generate embryoid bodies (EBs), hPSCs were dissociated using collagenase and
resuspended in growth medium devoid of bFGF. EB formation was facilitated using
suspension culture, where cells at a density of 25,000 cells/ml were suspended from a
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petri-dish lid in 20μl droplets. After 5 days, the EBs were transferred to agarose plates to
facilitate further differentiation with media changes every 3-4 days for a total
differentiation duration of 15 days. EBs were prepared for morphological analysis by
fixation in 3.7% paraformaldehyde (PFA) in 1.5ml microfuge tubes at approximately 1525 EBs per tube. Once fixed overnight, EBS were rinsed with PBS to remove PFA,
resuspended in 200μl melted 4% low melting point agarose (Sigma Aldrich) at 42ºC and
incubated for 2 hours to allow settling. Final pelleting and agarose solidification was
performed with brief room temperature centrifugation at 500g. Agarose embedded samples
were removed as single plugs and processed by dehydration with increasing ethanol
concentration to 100% followed by xylene and paraffination in a Leica TP1020 tissue
processor. Hematoxylin and Eosin (H&E) staining was performed on microscope slide
mounted 5μm sections in a Leica Autostainer XL workstation. Images were acquired using
an Olympus BX51 microscope using the default imaging parameters.
RNA isolation and real time reverse transcription polymerase chain reaction. RNA was
isolated from hPSCs and propagated for 15 passages under different conditions and from
EBs after 15 days in suspension using Trizol (Invitrogen, Carlsbad, CA) and quantified
using BioMate3 UV-VIS Spectrophotometer (Thermo Scientific, Waltham, MA). cDNA
was synthesized from 1μg of RNA using cDNA reverse transcription kit (Applied
Biosystems, Foster City, CA). Expression of pluripotent genes and differentiation markers
(Table 3) within undifferentiated and differentiated samples was analyzed using
quantitative real time RT-PCR. PCR was performed in an ABI HT7900 system and the
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data was acquired using Sequence Detection System software (SDS v2.2.1, Applied
Biosystems).
Gene expression data (three replicates) were acquired and SDS software was used
to estimate relative fold change values using ΔCT quantitation methods. Endogeneous 18S
ribosomal RNA was used for normalization. Relative gene expression for hPSCs
propagated in the MBIC system was assessed against hPSCs propagated on acellular HFFs.
However, relative gene expression of differentiated EBs obtained from different conditions
was assessed against hPSCs propagated under the original condition. Expression Index
(EI) was used to determine the relative differentiation state of cells [200]. EI was based on
the average CT values from triplicate measurements. An expression ratio of two or more
genes was determined using a mathematical model based on the geometric average of
assessed genes, previously described in detail [201], given by the following equation:
EI = K RS

m

(1 + E gene1m ) Ctgene1m .(1 + E gene 2 m ) Ctgene 2 m ...(1 + E genem ) Ctgenem

n

(1 + E gene1n ) Ctgene1n .(1 + E gene 2 n ) Ctgene 2 n ...(1 + E genen ) Ctgenen

E is the PCR efficiency calculated from dilution series of purified PCR products, Ct is the
threshold cycle, and m and n are the numbers of genes that are up and down regulated upon
differentiation respectively. KRS is the relative sensitivity constant and was not determined
as it does not affect relative comparisons between samples.
Scanning Electron Microscopy (SEM) analysis of membranes and hPSC colonies. To
verify that matrix coating did not clog the pores of the MBIC system, transwell insert
samples were prepared for SEM analysis. Briefly, PET insert membrane samples were
washed twice with PBS to remove any excess ECM, culture medium, or cell debris.
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Samples were then fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer and
subsequently dehydrated in increasing concentrations of ethanol. Following dehydration,
samples were dried, mounted on an aluminum stub, sputter coated with platinum, and
examined with a Zeiss EVO 50 XVP Scanning Electron Microscope (Zeiss, Thornwood,
NJ). SEM analysis of hPSC colonies was performed by fixation in 4% gluteraldehyde
followed by three washes in 0.1M Cacodylate Buffer pH 7.2 with 0.1M Sucrose. Cells
were treated with 1% Osmium Tetroxide in 0.1M Cacodylate Buffer pH 7.2 followed by a
0.1M Cacodylate Buffer pH 7.2 rinse. Samples were dried by incubation in increasing
percentage of ethanol (25 to 100%). SEM images were acquired by coating with ~ 150Å
gold for contrast enhancement and electrical continuity. Membranes were removed from
inserts with a scalpel before microscopy. Representative images were collected in the FEI
Quanta FEG ESEM 200 under high vacuum at 15 keV.
Gene expression profiling, data collection and analysis. Whole-genome gene expression
data was obtained in duplicate from karyotypically normal WA09 hESCs maintained for
10 passages in (a) direct co-culture with HFF, (b) microporous membrane-based indirect
co-culture with hFFs, and (c) feeder-free in HFF-conditioned medium. In addition, we
profiled three replicates of WA09-derived differentiated XE cells, and two replicates of
hFFs. Total RNA was extracted using the Mirvana Total RNA extraction kit (Ambion).
mRNA labeling and amplification was performed using the Totalprep kit. Whole-genome
gene expression profiling was then performed using Illumina human WGA-6 version 2
gene expression arrays according to the manufacturer’s protocol. Data processing and

116
normalization was performed in BeadStudio (Illumina). Clustering and statistical analyses
were performed using MATISSE, based on previously developed methods [263].
Results
In-direct co-culture allows expansion of hPSCs without feeder-cell contact

Our initial experiments focused on developing appropriate culture conditions in which the
hPSCs would successfully attach to the membranes, prior to use in MBIC studies. Our
studies showed that hPSC lines did not attach to tissue culture-treated 1.0 μm PET inserts
without prior treatment, whereas coating the inserts with 30 μg/mL fibronectin diluted in
0.2% porcine gelatin for 24 hours or generation of human acellular substrates within the
inserts allowed for hPSC attachment.
To test the feasibility of MBIC to support undifferentiated growth of WA09 hESC and iPS
lines using standard growth medium, we first demonstrated that both hPSC lines could be
successfully cultured for over 10 generations on 1.0 μm PET inserts in co-culture with
MEFs and subsequently with HFFs as shown in the SEM micrographs (Figure 27). In all of
our studies, the feeder cells were attached to the bottom of the well, rather than the bottom
of the microporous membrane. hPSCs cultured in the MBIC system retained cell and
colony morphology characteristics of undifferentiated cultures.
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Figure 27:
Scanning electron micrograph of WA09 hESCs co-cultured and passaged five times with
human foreskin fibroblasts on plastic (A), feeder free on plastic with conditioned media
(B) or by indirect co-culture on 1mm PET membrane (C).
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Specifically, these cells maintained a high nuclear to cytoplasmic ratio representative of
rapidly dividing undifferentiated hPSCs, and have distinct colony boundaries. Positive
expression of alkaline phosphatase, a reliable marker of pluripotency [264], is indicative of
sustained stemness in the hPSCs maintained on the inserts (Figure 28 a,b).
In-direct co-culture maintains undifferentiated state of three different hPSCs

Attachment and long term undifferentiated propagation of hPSCs on acellular substrates
within the MBIC system was validated by the expression of transcription factor OCT4 and
cell surface marker SSEA4 immunocytochemically and mRNA expression. At intermittent
passages as well as on passage 10, karyotypically normal hPSCs within the MBIC system
expressed all pluripotency markers (Figure 28 c, d e and f). To evaluate the relative gene
expression of pluripotency as well as germ layer specific genes, RNA from hPSCs
maintained within the MBIC system for 15 passages was isolated and analyzed by
quantitative RT-PCR. Samples were obtained in triplicates from hPSCs within the MBIC
system and directly compared to hPSCs propagated on acellular substrates on tissue culture
polystyrene (TCPS). Expression of pluripotency markers (OCT4, SOX2, NANOG) was
presented as CT values normalized against the 18S housekeeping gene for each sample. As
shown in Figure 29 c, comparable ΔCT values across different culture conditions and cell
lines is indicative of maintenance of the undifferentiated state in the MBIC system.
Statistical analyses indicated no significant difference (p>0.05) between hPSCs propagated
in the MBIC system and those propagated on acellular substrates on TCPS. Further, the
differentiation state of the hPSCs was quantified using the ‘expression index’ as a metric to
compare the undifferentiated hPSCs against EBs obtained in the MBIC system. Using the
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CT values and corresponding PCR efficiency for the transcript of interest, a ratio of the
geometric averages of the up-regulated and the down-regulated genes in the appropriate
undifferentiated/differentiated sample was obtained. For the two cell lines (WA09 and
hiPSC) analyzed, the expression index of the undifferentiated sample (15 passages) was 90
and 137, while the expression index of the 15-day old EBs was found to be 0.4 and 0.55
(Figure 29 a &b).
In-direct co-culture maintains in vitro differentiation potential

Functional pluripotency of the hPSCs cultured on acellular substrates was tested by in vitro
differentiation by embryoid body formation and germ layer identification (ectoderm,
endoderm and mesoderm). hPSC colonies were manually cut into clumps of about 100-300
cells and resuspended in ultra-low attachment conditions, an agarose coated Petri dish.
Within 5-6 days, cystic EBs were formed with high efficiency. After 15 days, total RNA
was isolated from the EBs and analyzed by real time PCR. Statistical analyses indicated
that the EBs generated under the MBIC system demonstrated significantly high expression
(p <0.01) of all germ layer specific markers analyzed (Figure 29d). In addition to the
expression of markers indicative of germ layer formation in the EBs, histological studies
were performed to assess the morphology of the differentiated tissue. Detailed examination
of the EB-sections from hPSCs propagated under direct co-culture and in the MBIC system
demonstrates the formation of complex structures such as neuroepithelial tubes, fibrous
connective tissue and intestinal gut (Figure 30).
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Figure 28:
Morphology and pluripotency markers on hPSCs grown within the millicell culture
system: WA09 hESCs and hiPSCs maintain alkaline phosphatase, Stage specific
embryonic antigen (SSEA4) and POU5F1 expression after 10 passages in membrane-based
culture. WA09 (a,c,e) and hiPSC (b,d,f) grown in direct co-culture with HFFs are positive
for alkaline phosphates (a,b), SSEA4 (c,d) and POU5F1 (e,f). Scale bar = 100 μm.
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Figure 29:
Quantitative real time polymerase chain reaction (QPCR) analysis of undifferentiated
hPSCs and differentiated EBs derived from hPSCs. Differential expression index of a)
WA09 hPSC and WA09-derived EBs and b) hiPSC and hiPSC-derived EBs, based on
analysis of six genes (OCT4, NANOG, SOX2, AFP, IGF2 and NEUROD1). (c)
Normalized gene expression of undifferentiated markers in WA09 on acellular HFF (A);
WA09 in MBIC system (B); hiPSC on acellular HFF (C) and hiPSC in MBIC system (D).
There is no significant difference (p>0.01) between the groups (n=3) indicating
comparable pluripotent gene expression. (d) Normalized gene expression of differentiated
markers in WA09 in MBIC system (A’); EBs generated from WA09 in MBIC system (B’);
hiPSC in MBIC system (C’); and EBs generated from hiPSC in MBIC system (D’).
Significant differential gene expression (p<0.01) in all three lineage specific markers was
observed.
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Figure 30:
Histologic Evidence of Tri-Lineage Differentiation in embryoid bodies generated from
hPSCs. Shown are images of hematoxylin and eosin-stained histologic sections of EBs
from WA09 propagated on MEFs as a positive control (top row, a-c); WA09 cells
propagated on the MBIC system (middle row, d-f) and hiPSC propagated in the MBIC
system (bottom row, g-i). Tri-lineage potential is demonstrated as ectodermal
(neuroepithelial) differentiation (a, d, and f); mesodermal (fibrous connective)
differentiation (b, e, and g) and endodermal (intestinal) differentiation (c, f, and i).
Magnification is 200x total (10x ocular, 20x objective). Each scale bar represents 50 μm
in length.
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Global gene expression analysis validates indirect co-culture for hPSC propagation.

Genome-wide gene expression profiles of undifferentiated karyotypically normal WA09
hESCs in direct co-culture with HFF feeder cells (standard), in indirect co-culture (MBIC),
and feeder-free in HFF-conditioned media (feeder-free) were very similar (Figure 31). The
correlation coefficients among the three culture conditions were very high (Table 8), with a
limited number of genes showing differential expression among them (Figure 32, top
diagram). The XE cells are fibroblast-like cells differentiated from the WA09 hESC line.
The numbers of differentially expressed genes (Figure 31) and the correlation coefficients
among the three cell types (Table 8) support the notion that the XE cells have a phenotype
between that of undifferentiated hESCs and HFFs, but more closely related to the HFF
phenotype. The large majority of the genes differentially expressed between
undifferentiated hESCs and XE cells are also differentially expressed between hESCs and
HFFs (2741 out of 3057, or 91%, Figure 32.). Similar results are found when the
comparisons are performed against hESCs grown under the three culture conditions
(Figure 32). The expression profiles for the hESCs grown under the MBIC and feeder-free
conditions were more closely related to each other than those grown under standard
conditions (Figure 31). This result is not entirely unexpected, as the hESCs in the feederfree and MBIC conditions are exposed to HFF-generated soluble factors without direct
contact with HFFs, while the hESCs in the standard condition have both access to soluble
factors and direct contact with HFFs. Differentially expressed genes were examined for
enrichment in GO categories and targets of ESC-related transcriptional regulators (14
transcriptional regulators examined, listed with references in Table 9).
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Figure 31:
Agglomerative hierarchical clustering by average distance, using the Pearson correlation
coefficient as the distance measure. The lengths of the branches on the dendrogram are
proportional to the average distance in global expression between sample types, and the
heatmap showing expression displays row-normalized intensity values for the 7,373 genes
significantly differentially expressed between at least two sample types. XE: WA09derived extraembryonic endoderm-like cells. HFF: human foreskin fibroblasts.
Undifferentiated WA09 hESCs were maintained with HFFs in indirect coculture
(Millicell), on Matrigel with HFF-conditioned media (Feeder-Free), and on an HFF feeder
layer (Standard).
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Table 8:
R2 correlation coefficients between expression profiles of different culture conditions (in
pink boxes) and numbers of significantly differentially expressed genes (FDR < 0.05,
minimum fold-change of 1.3) between pairs of culture conditions (in violet boxes).
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Figure 32:
Venn diagrams indicating the overlap between the sets of genes significantly differentially
expressed (FDR<0.05) between pairs of samples. The top diagram shows results for the
hESCs cultured in the three different conditions. The lower three diagrams show results
among hESCs, HFFs and XE cells, with the data for each hESC culture conditions shown
in a separate diagram. The sizes of the circles are proportional to the number of genes
represented
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Table 9:
14 transcriptional regulators examined in the enrichment analysis in Figure 6. Lists of
target genes were extracted from the referenced papers, which identified targets of
transcriptional regulators from ChIP-Chip data
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Two significantly enriched GO categories (Development and Cell communication) were
found (Table 10). Moreover, there was significant enrichment for targets of the
pluripotency-associated transcription factors OCT4/POU5F1, NANOG, DAX1, and TCF3
in the set of genes expressed at significantly higher levels in cells cultured under FeederFree or MBIC conditions compared to the Standard condition. OCT4/POU5F1 and
NANOG are of course two of the transcription factors most closely associated with
pluripotency. In mouse ES cells, DAX1 has been shown to physically interact with SOX2
and NANOG [243, 265], as well as to have predicted promoter binding sites for the core
pluripotency-associated transcription factors [266]. OCT4/POU5F1, NANOG, SOX2, and
TCF3 co-occupy the promoter regions of a large number of pluripotency-associated and
lineage-specific genes, and it has recently been suggested that TCF3 be added to the short
list of core transcription factors thought to be critical to the maintenance of the pluripotent
state [265, 267]. Although the number of differentially expressed genes between the
hESCs grown in standard vs. MBIC and Standard vs. feeder-free conditions were small,
the enrichment of targets of these transcription factors in the set of genes more highly
expressed in the MBIC and feeder-Free conditions suggests that, if anything, they are more
conducive to the maintenance of pluripotency than the standard condition involving direct
co-culture with feeders.
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Table 10:
TF-targets and GO categories enriched in sets of genes differentially expressed among the
three hESC culture conditions. The numbers of genes in each category are listed in the
second column (e.g. there are 36 genes expressed at significantly lower levels in the
Standard culture condition compared to the Feeder-Free condition). Enrichments for genes
in particular Gene Ontology (GO) categories are listed in column 3 (with the associated pvalues in column 4), and enrichments for targets of transcription factors are indicated in the
fifth column (with the associate p-values in column 6). p-values are Bonferroni corrected
for multiple testing. NS = not significant.
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Discussion

This study demonstrates several important steps towards hPSC culture improvement. First,
the MBIC system was effective in segregating hPSCs from feeder layers. Alkaline
phosphatase analysis of feeder layers below showed negative AP staining, thus indicating
that hPSCs did not traverse the microporous membranes (data not shown). In addition to
successful physical separation of cell types, we have demonstrated MEFs can be replaced
with HFFs, which eliminates any potential exposure to xenotropic pathogens. Previous
studies have reported the variability that exists between different pluripotent stem cells and
the need to compare experimental results between two distinct cell lines [271]. To
demonstrate the ubiquity of the MBIC methods, we used hPSCs from multiple embryonic
as well as an induced stem cell from human fibroblasts in our studies.
Furthermore, in contrast to conventional conditioned medium protocols, where feedersecreted nutrients and growth factors in the conditioned medium have a limited storage
capability once removed from the feeder cells resulting in the requirement to be produced
in parallel to the hPSCs culture in which they will be used, the MBIC system achieves a
dynamic and sustained conditioning of the medium – similar to that achieved by direct
contact cultures – while simultaneously achieving clean and thorough cell segregation.
While many of the essential nutritive factors secreted by feeder layers have not been
identified, this system demonstrates that hPSCs attached to a substrate only need access to
the nutrients in the medium, and do not require direct interaction with feeder cells. Another
important component of hPSC culture is the passaging technique used for expansion.
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Traditional methods have involved labor-intensive mechanical passaging or use of bulk
dissociation agents like collagenase, trypsin or EDTA-based reagents. There is published
data to demonstrate that bulk passaging methods, although easy to adopt for hPSC culture
has a tendency to result in chromosomal abnormalities in long-term culture. It is useful to
note that the passaging methodology developed in the MBIC system involves a simple step
of gently washing and triturating the hPSCs with medium and transfer onto fresh inserts.
This passaging methodology within the MBIC system has potential for the reduction of
chromosomal abnormalities on hPSCs in long-term culture and propagation. The bench
scale demonstration of feasibility of the MBIC culture system presented here has scope for
refinement and scale up that could facilitate the design of culture systems for both selfrenewal and differentiation of hPSCs.
Our findings are in contradiction to those presented in an earlier study, where results
suggested that a porous membrane based system only functions in the propagation of
hESCs plated to the apical (top) face of the membrane if the feeder cells are grown directly
on the basolateral (bottom) face of the insert[261]. Though the two studies are somewhat
similar, the previous study used different feeder layers (STO strain MEFs[261] vs. CF-1
strain MEFs derived in-house, used in our study), which could potentially contribute to the
differences observed between our two studies. The results from the previous MBIC based
study suggests that there exists intrinsic sensitivity to a variety of parameters such as cell
types, cell seeding densities, media change schedule, etc. that would require optimization.
However, the study presented here clearly demonstrates, based on multiple measured
experimental outcomes that the MBIC system can propagate hPSCs in long term culture
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without the feeder layer attached to the opposing membrane side as well as without any
physical contact.
Global gene expression profiling of our samples using whole-genome gene expression
microarrays revealed that hESCs cultured under Standard, Feeder-Free, and MBIC
conditions were very similar. However, a small but significant set of genes demonstrated
differences in gene expression among undifferentiated hESCs grown in the three different
conditions, particularly between cells cultured in the Standard vs. MBIC and Standard vs.
Feeder-Free conditions. Our results also suggest that the XE cell phenotype lies between
that of undifferentiated hESCs and HFFs, but is much closer to the HFF phenotype.
We envision cells as occupying discrete phenotypic states, stabilized by networks of
interacting regulatory molecules, such as transcription factors, epigenetic marks, and
miRNAs. If the cells are perturbed sufficiently (e.g. if undifferentiated cells are exposed to
chemicals such as retinoic acid or TPA), they can be induced to change phenotypic states.
However, small perturbations can be compensated for by subtle changes in the regulatory
network. We believe that we may be seeing evidence for these mechanisms at work in the
hPSCs cultured under different conditions, with the differences in culture conditions
causing small changes in gene expression of pluripotency-associated genes, but no change
in the overall pluripotent phenotype. The relative phenotypes of the cell types studied can
be illustrated in the model (Figure 33), where the hPSCs cultured under the Feeder-Free
and MBIC conditions lie at slightly different positions in the same general phenotypic state
as hPSC cultured under standard conditions, the HFFs occupy a markedly different
phenotypic state, and the XEs are located between the hPSCs and HFFs, but closer to the
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HFFs. Our findings also support the notion that global gene expression may be a more
sensitive method for detecting subtle but potentially biologically important differences
between cell populations than standard phenotypic assays [272]. There are several ways to
improve this new MBIC system, particularly in the area of cell attachment. In this study,
we used a mixture of fibronectin and gelatin for promoting cell attachment in our initial
assessment of the system. A traditional substrate used for hPSC involves use of Matrigel,
which includes laminin and peptidoglycans in addition to the collagen found in porcine
gelatin. [204]. Our study has demonstrated use of acellular substrates derived from human
fibroblasts that provide the relevant physical cues for attachment within the MBIC system.
We believe that the acellular substrates present the hPSCs with an environment that is
molecularly similar to what is used in direct co-culture systems. Furthermore, use of the
same fibroblast line as a feeder to provide the chemical cues for real time conditioning of
the media renders the MBIC system an economically feasible alternate to use of other
purified ECMs like fibronectin or laminin. It is important to note that during the transition
stages from direct co-culture to the MBIC system, a certain level of spontaneous
differentiation is observed, hPSCs formed both undifferentiated colonies with tight
boundaries as well as heterogeneous colonies containing a population of differentiated
cells at the colony boundaries and between colonies as seen in earlier studies [20, 48].
However, the hPSCs recovered quickly to maintain their undifferentiated state over many
passages in the MBIC system.
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Development and characterization of defined substrates for hPSC propagation should
greatly enhance the ability of hPSCs to attach to the insert surface [195].
Two considerations for improvement in the MBIC system are the polymer type that
constitutes the insert, and pore size. For this study, we used a PET membrane, but other
commercially available polymers deserve further analysis. As shown by the previous
study, [261] , pore size clearly can have an effect on the diffusion of nutrients across the
membrane, in addition to having an effect on the topography of the insert. The membrane
surface in the MBIC system is fundamentally different than the surface of TCPS dishes
that are widely used in tissue culture, and different polymer variations need to be explored
to develop an economically feasible system for hPSC propagation.
Importantly, the potential uses of the MBIC system extend beyond expansion of
undifferentiated hPSCs. It is expected that this system will find applications in expansion
of any pluripotent cell type as we have shown with hiPSC that are propagated under
similar culture conditions used for hESCs [4, 5]. In addition to the pluripotent expansion of
hPSCs, the applicability of the MBIC system is amenable to the directed differentiation to
adult stem cells into specific, mature cell types [273]. Similar methodologies could be
developed for controlling the differentiation of hPSCs, as well as gaining an increased
understanding of the nuances of the differentiation process such as defining cues that
require direct contact and/or soluble factors. For example, the use of OP9 mouse stromal
cell co-culture has been demonstrated for obtaining enriched populations of hESC-derived,
CD34+ hematopoietic progenitors [274]. The ability to utilize the MBIC system to induce
differentiation of hPSCs by co-culture with inducing cell types would eliminate the
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inevitable mixing of cells, resulting in a more purified cell population. Furthermore, if a
human stromal cell type or other inducing cell types could substitute the widely used
animal stromal lines for differentiation pathways, the MBIC system would assist with cell
segregation to a degree where the resulting hPSC derivatives might be clinically useful.

Conclusions

In conclusion, we have demonstrated the characterization of the MBIC system as providing
functional and unique benefits over prior innovations in the undifferentiated propagation of
hPSCs including reducing the burden of expensive purified factor additives, contamination
potential due to extensive culture manipulations of parallel stem and feeder cultures, and
the amenability to scale-up to larger culture systems composed of separated hPSC
expansion and media conditioning compartments separated by a porous membrane
partition. Thus, the MBIC system presented provides a versatile and cost-effective solution
for eliminating cell mixing in hPSC co-cultures while retaining the benefits of the presence
of feeder cells in their conditioning of the media and providing essential factors to promote
pluripotency. Further modifications and optimization of this system and a detailed
characterization of hPSCs in long-term cultures should allow for routine adaptation of the
MBIC system in hPSC propagation and directed differentiation.

CHAPTER 5: Conclusions and Future Directions

Conclusions

The impetus for this study was the identification and development of substrates that were
devoid of non-human components for long term undifferentiated propagation of human
pluripotent stem cells (hPSCs). To achieve this, the ECM deposited by mouse and human
feeder layers were analyzed and characterized for cellular compatibility. Further
characterization based on mass spectrometry revealed proteins involved in maintenance of
self-renewal. The information was in turn used to generate defined substrates from
commercially available proteins, and evaluated for maintenance of hPSC self-renewal. The
study was conducted in three parts.
First, the capability of the acellular substrates to maintain long term undifferentiated
propagation of two embryonic and one induced pluripotent stem cell lines was investigated
(Chapter 2 and Appendix A). Characterization studies were based on morphological,
immunocytochemical expression of pluripotent markers, gene expression of pluripotent
and germ layer specific markers and in vitro differentiation. Results from these
experiments supported the following conclusions:
•

Human fibroblast derived ECM based substrate can maintain undifferentiated
propagation of stable hPSCs.
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•

Absence of additional supplementation of the growth medium such as increased
concentration of growth factors or the use of conditioned medium suggests that
human acellular substrates are sufficient for maintenance of hPSC self-renewal in
the long-term.
Second, to elucidate the composition of the substrates and identify key proteins or

growth factors involved in hPSC self-renewal, proteomic analysis was performed on the
substrates derived from human fibroblasts. The results obtained from proteomic analysis
and further characterization of the ECM components supported the following conclusions:
•

Heparan sulfate proteoglycan and fibronectin are core components of the ECM in
all fibroblasts analyzed (MEFs, HFFs and HDFs).

•

The use of commercially available HSPG and Fn to synthesize ECM-based
substrates have demonstrated the potential to develop defined substrates that
exhibit equivalent capabilities to maintain hPSC self-renewal as that exhibited by
the acellular substrates.

•

The combination of HSPG and Fn contribute to the synergistic activation of
adhesion and signaling pathways that are necessary for hPSC self-renewal.

Third, the acellular substrates within microporous membrane-based inserts were
evaluated in the development of indirect co-culture systems and controlled
microenvironments for hPSC self-renewal. Results from these experiments supported the
following conclusions:
•

The application of acellular substrate coated microporous membranes provides a
microenvironment that contributes to the synergistic action of biophysical and
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biochemical cues (from the ECM coated membrane and real-time conditioning of
the growth medium) for hPSC self-renewal.
•

This system provides a versatile and cost-effective solution that prevents cell
mixing in hPSC co-cultures for pluripotency and differentiation studies without
feeder cell contamination.

Future directions

The studies conducted in this research have opened avenues for further investigation in the
following areas a) characterization of signaling molecules and ECM proteins that
contribute to hPSC self-renewal, b) design, synthesis and incorporation of peptides that
represent biologically active sites in key proteins within the culture system and c) design of
microenvironment that will contribute to efficient sub-culturing methodologies for hPSC
propagation. These studies could be accomplished through the following specific aims:

Specific Aim 1: Analyze the acellular substrates using methodologies capable of
measuring concentrations of relevant proteins across substrates.
The purpose of this aim will be to improve upon the results acquired from the
proteomic analyses presented in this dissertation. Concentration dependence of growth
factors such as bFGF on hPSC self-renewal is indicative of the need to detect
concentration of proteins and the growth factors in substrates. Results from quantification
techniques such as isotope-coded affinity tags (ICAT) or isobaric tag for relative and
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absolute quantitation (iTRAQ) might be useful in determining the abundance of proteins
and subsequent translation of that information to the synthesis of ECM substrates using
commercially available proteins[209].

Specific Aim 2: Design and generate peptide based substrates that support adhesion and
undifferentiated propagation of hPSCs
Based on results obtained from ECM-based substrates for hPSC attachment and
propagation, synthetic peptides can be designed that can recapitulate the different
combinations of protein required for hPSC self-renewal. A library of peptides based on the
active sites of core ECM proteins such as fibronectin, heparan sulfate proteoglycan,
vitronectin, laminin and collagens could be probed to arrive at the best combination that
engage the appropriate integrins and allow for hPSC adhesion. Engaging syndecan on
hPSC cell membranes have been shown to allow cell attachment onto peptide treated
surfaces and support undifferentiated hPSC propagation[275]. Results obtained from the
proposed experiments have the potential to provide further evidence in support of the
results presented in this dissertation (Chapter 3).

Specific Aim 3: Design controlled microenvironments for propagation and maintenance of
hPSCs within a 3D microwell based culture system.
Microwell slides that house 600 microwells of 100 x 100 μm lateral dimensions
coated with non-human Matrigel(TM) have been shown to be capable of supporting long
term undifferentiated cultures of hPSCs [72]. Preliminary studies using microwell slides

141
coated with murine fibroblast derived acellular substrates have demonstrated the potential
to sustain hPSCs for a period of 60 days (Appendix D). It is expected that use of human
fibroblast-derived acellular substrates or the appropriate combination of proteins/peptides
will elicit similar results and lead to the generation of a humanized system. Such a system
will also lead to the development of a viable alternative to current labor-intensive and
inefficient subculturing techniques used.
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Appendix A
Additional Figures for Chapter 2
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Figure 1: Karyotypically abnormal BG01v hESCs maintain high nuclear to cytoplasmic ratio and tight boundaries on
control, MEFs (a) and spread out to form a continuous layer on acellular HFF (b) and HDF substrates (c). Positive expression
of alkaline phosphatase in BG01v ES cells propagated for 15 passages on MEF (d), aHFF (e) and aHDF (f) was observed,
Scale bar = 100 μm.
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Figure 2: Positive expression of stage specific embryonic antigen (SSEA4) (a-c) in BG01v ES cells propagated for 15
passages on MEF (a), aHFF (b) and aHDF (c). Expression of OCT4 (d-f) in BG01v cells propagated for 15 passages on MEF
(d), aHFF (e) and aHDF (f) was observed, Scale bar = 100 μm.
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Figure 3: Normalized gene expression of undifferentiated markers in BG01v on MEFs (A); BG01v on acellular HFF (B) and
WA09 on acellular HDFs (C). There is no significant difference (p>0.01) between the groups (n=3) indicating comparable
pluripotent gene expression.
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Appendix B
Tables of proteins identified in proteomic analysis in all three substrates acellular MEFs, acellular HFFs and acellular HDFs.
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Results acquired from proteomic analysis of acellular MEFs
Proteins

Gene Symbol

Description

Biological Process_max

Molecular Function_max

Cellular Component_max

11459

Acta1

actin, alpha 1, skeletal muscle

muscle contraction (GO:0006936)

ATP binding (GO:0005524)

actin cytoskeleton (GO:0015629)

11461

Actb

actin, beta, cytoplasmic

ATP binding (GO:0005524)

cytosol (GO:0005829)

11657

Alb

albumin

transport (GO:0006810)

copper ion binding (GO:0005507)

11749

Anxa6

annexin A6
ATP synthase, H+ transporting, mitochondrial F1
complex, alpha subunit, isoform 1

calcium ion transport (GO:0006816)
ATP synthesis coupled proton transport
(GO:0015986)

calcium ion binding (GO:0005509)
hydrogen ion transporting ATP synthase
activity, rotational mechanism (GO:0046933)

cytoplasm (GO:0005737)
perinuclear region of cytoplasm
(GO:0048471)
mitochondrial inner membrane
(GO:0005743)

annexin A2
serine (or cysteine) peptidase inhibitor, clade H,
member 1

fibrinolysis (GO:0042730)

11946

Atp5a1

12306

Anxa2

12406

Serpinh1

13346

Des

desmin

muscle development (GO:0007517)

phospholipase inhibitor activity (GO:0004859)
serine-type endopeptidase inhibitor activity
(GO:0004867)
extracellular matrix structural constituent
(GO:0005201)
extracellular matrix structural constituent
(GO:0005201)
structural constituent of cytoskeleton
(GO:0005200)

13628

Eef1a2

eukaryotic translation elongation factor 1 alpha 2

anti-apoptosis (GO:0006916)

GTPase activity (GO:0003924)

response to stress (GO:0006950)

12842

Col1a1

collagen, type I, alpha 1

phosphate transport (GO:0006817)

12843

Col1a2

collagen, type I, alpha 2

phosphate transport (GO:0006817)

stress fiber (GO:0001725)
endoplasmic reticulum (GO:0005783)
cytoplasm (GO:0005737)
cytoplasm (GO:0005737)
Z disc (GO:0030018)

14115

Fbln2

fibulin 2

calcium ion binding (GO:0005509)

nucleus (GO:0005634)
proteinaceous extracellular matrix
(GO:0005578)

14118

Fbn1

fibrillin 1

calcium ion binding (GO:0005509)

microfibril (GO:0001527)

14268

Fn1

fibronectin 1

transmembrane receptor protein tyrosine kinase
signaling pathway (GO:0007169)

heparin binding (GO:0008201)

apical plasma membrane (GO:0016324)

endoplasmic reticulum (GO:0005783)

14735

Gpc4

glypican 4

14827

Pdia3

protein disulfide isomerase associated 3

positive regulation of apoptosis (GO:0043065)

protein disulfide isomerase activity
(GO:0003756)

anchored to membrane (GO:0031225)

15482

Hspa1l

heat shock protein 1-like

spermatogenesis (GO:0007283)

ATP binding (GO:0005524)

15530

Hspg2

perlecan (heparan sulfate proteoglycan 2)

protein localization (GO:0008104)

protein binding (GO:0005515)

16412

Itgb1

integrin beta 1 (fibronectin receptor beta)

sarcomere organization (GO:0045214)

integrin binding (GO:0005178)

integrin complex (GO:0008305)

16661

Krt10

keratin 10

protein binding (GO:0005515)

keratin filament (GO:0045095)

16691

Krt8

keratin 8

protein binding (GO:0005515)

Z disc (GO:0030018)

16905

Lmna

lamin A

lamin filament (GO:0005638)

16952

Anxa1

regulation of cell proliferation (GO:0042127)

17254

Slc3a2

annexin A1
solute carrier family 3 (activators of dibasic and
neutral amino acid transport), member 2

protein binding (GO:0005515)
phospholipase A2 inhibitor activity
(GO:0019834)

amino acid transport (GO:0006865)

cation binding (GO:0043169)

integral to membrane (GO:0016021)

17880

Myh11

myosin, heavy polypeptide 11, smooth muscle

striated muscle thick filament (GO:0005863)

17886

Myh9

myosin, heavy polypeptide 9, non-muscle

ATP binding (GO:0005524)
actin-dependent ATPase activity
(GO:0030898)
protein binding (GO:0005515)

neurofilament (GO:0005883)

heparin binding (GO:0008201)

extracellular space (GO:0005615)

tumor necrosis factor-mediated signaling pathway
(GO:0033209)
nuclear membrane organization and biogenesis
(GO:0006998)

19132

Prph

peripherin

smooth muscle contraction (GO:0006939)
meiotic spindle organization and biogenesis
(GO:0000212)
intermediate filament cytoskeleton organization and
biogenesis (GO:0045104)

21825

Thbs1

thrombospondin 1

negative regulation of angiogenesis (GO:0016525)

proteinaceous extracellular matrix
(GO:0005578)

nucleus (GO:0005634)

cell-cell adherens junction (GO:0005913)

191
21838

Thy1

thymus cell antigen 1, theta

22073

Prss3

22186

Uba52

protease, serine, 3
ubiquitin A-52 residue ribosomal protein fusion
product 1

22352

Vim

54652

Cacna1f

anchored to external side of plasma
membrane (GO:0031362)

retinal cone cell development (GO:0046549)

protein modification process (GO:0006464)

vimentin
calcium channel, voltage-dependent, alpha 1F
subunit

intermediate filament-based process (GO:0045103)
cellular calcium ion homeostasis (GO:0006874)

serine-type endopeptidase activity
(GO:0004252)
structural constituent of ribosome
(GO:0003735)
protein binding (GO:0005515)
voltage-gated calcium channel activity
(GO:0005245)

cellular_component (GO:0005575)
nucleus (GO:0005634)
type III intermediate filament (GO:0045098)
integral to membrane of membrane fraction
(GO:0000299)

66395

Ahnak

AHNAK nucleoprotein (desmoyokin)

intracellular signaling cascade (GO:0007242)

71853

Pdia6

protein disulfide isomerase associated 6

77579

Myh10

myosin, heavy polypeptide 10, non-muscle

81601

Htatip

HIV-1 tat interactive protein, homolog (human)

cell redox homeostasis (GO:0045454)
substrate-bound cell migration, cell extension
(GO:0006930)
positive regulation of transcription from RNA
polymerase II promoter (GO:0045944)

protein disulfide isomerase activity
(GO:0003756)
actin-dependent ATPase activity
(GO:0030898)
histone acetyltransferase activity
(GO:0004402)

intercellular junction (GO:0005911)

101706

Numa1

nuclear mitotic apparatus protein 1

tubulin binding (GO:0015631)

nucleus (GO:0005634)

109624

Cald1

caldesmon 1

regulation of smooth muscle contraction
(GO:0006940)

actin binding (GO:0003779)

actin cap (GO:0030478)

223915

Krt73

keratin 73

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

223917

Krt79

keratin 79

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

230594

Zcchc11

zinc finger, CCHC domain containing 11

negative regulation of NF-kappaB transcription factor
activity (GO:0032088)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)

236892

EG236892

238831

Ppwd1

predicted gene, EG236892
peptidylprolyl isomerase domain and WD repeat
containing 1

mRNA processing (GO:0006397)

peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)

spliceosome (GO:0005681)

11464

Actc1

actin, alpha, cardiac

muscle thin filament assembly (GO:0030240)

ATP binding (GO:0005524)

actin cytoskeleton (GO:0015629)

11632

Aip

aryl-hydrocarbon receptor-interacting protein

protein folding (GO:0006457)

transcription cofactor activity (GO:0003712)

membrane fraction (GO:0005624)

11750

Anxa7

annexin A7

cellular calcium ion homeostasis (GO:0006874)

calcium ion binding (GO:0005509)

nucleus (GO:0005634)

11757

Prdx3

peroxiredoxin 3

mitochondrion (GO:0005739)

Rhoc

11947

Atp5b

ras homolog gene family, member C
ATP synthase, H+ transporting mitochondrial F1
complex, beta subunit

GTP binding (GO:0005525)
hydrogen-exporting ATPase activity,
phosphorylative mechanism (GO:0008553)

nucleus (GO:0005634)
mitochondrial inner membrane
(GO:0005743)

12317

Calr

calreticulin

oxidation reduction (GO:0055114)
small GTPase mediated signal transduction
(GO:0007264)
ATP synthesis coupled proton transport
(GO:0015986)
cortical actin cytoskeleton organization and
biogenesis (GO:0030866)

identical protein binding (GO:0042802)

11853

zinc ion binding (GO:0008270)

microsome (GO:0005792)

12330

Canx

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

Cap1

calnexin
CAP, adenylate cyclase-associated protein 1
(yeast)

protein folding (GO:0006457)

12331

receptor-mediated endocytosis (GO:0006898)

cortical actin cytoskeleton (GO:0030864)

12336

Capns1

12345

Capzb

calpain, small subunit 1
capping protein (actin filament) muscle Z-line,
beta

actin binding (GO:0003779)
calcium-dependent cysteine-type
endopeptidase activity (GO:0004198)

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

12417

Cbx3

chromobox homolog 3 (Drosophila HP1 gamma)

chromatin assembly or disassembly (GO:0006333)

chromatin binding (GO:0003682)

intercalated disc (GO:0014704)
nuclear centromeric heterochromatin
(GO:0031618)

12419

Cbx5

chromobox homolog 5 (Drosophila HP1a)

chromatin assembly or disassembly (GO:0006333)

chromatin binding (GO:0003682)

nuclear heterochromatin (GO:0005720)

endoplasmic reticulum (GO:0005783)
stress fiber (GO:0001725)
chromatin (GO:0000785)

cytoplasm (GO:0005737)

12492

Scarb2

scavenger receptor class B, member 2

cell adhesion (GO:0007155)

receptor activity (GO:0004872)

lysosome (GO:0005764)

12540

Cdc42

cell division cycle 42 homolog (S. cerevisiae)

filopodium formation (GO:0046847)

GTPase activity (GO:0003924)

filopodium (GO:0030175)

192
12631

Cfl1

cofilin 1, non-muscle

12751

Tpp1

tripeptidyl peptidase I

proteolysis (GO:0006508)

12814

Col11a1

collagen, type XI, alpha 1

phosphate transport (GO:0006817)

12825

Col3a1

collagen, type III, alpha 1

phosphate transport (GO:0006817)

actin binding (GO:0003779)
serine-type endopeptidase activity
(GO:0004252)
extracellular matrix structural constituent
(GO:0005201)
extracellular matrix structural constituent
(GO:0005201)

12831

Col5a1

collagen, type V, alpha 1

phosphate transport (GO:0006817)

heparin binding (GO:0008201)

12866

Cox7a2

cytochrome c oxidase, subunit VIIa 2

cytochrome-c oxidase activity (GO:0004129)

collagen type V (GO:0005588)
mitochondrial inner membrane
(GO:0005743)

12903

Crabp1

cellular retinoic acid binding protein I

transport (GO:0006810)

retinal binding (GO:0016918)

cytoplasm (GO:0005737)

12934

Dpysl2

dihydropyrimidinase-like 2

nervous system development (GO:0007399)

mitochondrion (GO:0005739)

13030

Ctsb

cathepsin B

proteolysis (GO:0006508)

13040

Ctss

cathepsin S

proteolysis (GO:0006508)

hydrolase activity (GO:0016787)
cysteine-type endopeptidase activity
(GO:0004197)
cysteine-type endopeptidase activity
(GO:0004197)

13205

Ddx3x

DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked

ATP binding (GO:0005524)

nucleus (GO:0005634)

13207

Ddx5

DEAD (Asp-Glu-Ala-Asp) box polypeptide 5

mRNA processing (GO:0006397)

ATP binding (GO:0005524)

nucleus (GO:0005634)

13627

Eef1a1

eukaryotic translation elongation factor 1 alpha 1

translation (GO:0006412)

GTP binding (GO:0005525)

cytoplasm (GO:0005737)

13629

Eef2

eukaryotic translation elongation factor 2

translation (GO:0006412)

13885

Esd

esterase D/formylglutathione hydrolase

cytoplasm (GO:0005737)
cytoplasmic membrane-bounded vesicle
(GO:0016023)

14230

Fkbp10

FK506 binding protein 10

GTPase activity (GO:0003924)
S-formylglutathione hydrolase activity
(GO:0018738)
peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)

endoplasmic reticulum (GO:0005783)

14314

Fstl1

follistatin-like 1

heparin binding (GO:0008201)

extracellular space (GO:0005615)

14319

Fth1

ferritin heavy chain 1

cellular iron ion homeostasis (GO:0006879)

ferric iron binding (GO:0008199)

14376

Ganab

14678

Gnai2

GTPase activity (GO:0003924)

14679

Gnai3

N-glycan processing (GO:0006491)
G-protein signaling, adenylate cyclase inhibiting
pathway (GO:0007193)
G-protein coupled receptor protein signaling pathway
(GO:0007186)

14688

Gnb1

14693

Gnb2

14696

Gnb4

alpha glucosidase 2 alpha neutral subunit
guanine nucleotide binding protein (G protein),
alpha inhibiting 2
guanine nucleotide binding protein (G protein),
alpha inhibiting 3
guanine nucleotide binding protein (G protein),
beta 1
guanine nucleotide binding protein (G protein),
beta 2
guanine nucleotide binding protein (G protein),
beta 4

14824

Grn

granulin

actin filament organization (GO:0007015)

protein folding (GO:0006457)

phototransduction, visible light (GO:0007603)
G-protein coupled receptor protein signaling pathway
(GO:0007186)
G-protein coupled receptor protein signaling pathway
(GO:0007186)
positive regulation of epithelial cell proliferation
(GO:0050679)

glucosidase activity (GO:0015926)

cortical actin cytoskeleton (GO:0030864)
lysosome (GO:0005764)
cytoplasm (GO:0005737)
cytoplasm (GO:0005737)

lysosome (GO:0005764)
lysosome (GO:0005764)

endoplasmic reticulum (GO:0005783)

GTPase activity (GO:0003924)

heterotrimeric G-protein complex
(GO:0005834)
heterotrimeric G-protein complex
(GO:0005834)
heterotrimeric G-protein complex
(GO:0005834)
heterotrimeric G-protein complex
(GO:0005834)

phospholipase A2 activity (GO:0004623)

mitochondrion (GO:0005739)

GTPase activity (GO:0003924)
GTPase activity (GO:0003924)
GTPase activity (GO:0003924)

14828

Hspa5

heat shock protein 5

ER overload response (GO:0006983)

ATP binding (GO:0005524)

endoplasmic reticulum (GO:0005783)

15382

Hnrnpa1

heterogeneous nuclear ribonucleoprotein A1

mRNA processing (GO:0006397)

RNA binding (GO:0003723)

nucleus (GO:0005634)

15387

Hnrnpk

heterogeneous nuclear ribonucleoprotein K

mRNA processing (GO:0006397)

DNA binding (GO:0003677)

nucleus (GO:0005634)

15388

Hnrnpl

heterogeneous nuclear ribonucleoprotein L

RNA binding (GO:0003723)

pronucleus (GO:0045120)

15481

Hspa8

heat shock protein 8

mRNA processing (GO:0006397)
chaperone cofactor-dependent protein folding
(GO:0051085)

ATPase activity, coupled (GO:0042623)

15510

Hspd1

heat shock protein 1 (chaperonin)

protein folding (GO:0006457)

ATP binding (GO:0005524)

cytoplasm (GO:0005737)
mitochondrial inner membrane
(GO:0005743)

193
15512

Hspa2

response to stress (GO:0006950)

ATP binding (GO:0005524)

protein folding (GO:0006457)
positive regulation of cytotoxic T cell differentiation
(GO:0045585)

ATP binding (GO:0005524)

mitochondrion (GO:0005739)

Hsp90aa1

heat shock protein 2
heat shock protein 90kDa alpha (cytosolic), class
B member 1
heat shock protein 90, alpha (cytosolic), class A
member 1

15516

Hsp90ab1

15519

mitochondrion (GO:0005739)

ATP binding (GO:0005524)

cytosol (GO:0005829)

16211

Kpnb1

karyopherin (importin) beta 1

nucleus (GO:0005634)

Fabp5

fatty acid binding protein 5, epidermal

ribosomal protein import into nucleus (GO:0006610)
phosphatidylcholine biosynthetic process
(GO:0006656)

protein transporter activity (GO:0008565)

16592
16665

Krt15

16678
16681
16687

lipid binding (GO:0008289)

cytoplasm (GO:0005737)

keratin 15

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

Krt1

keratin 1

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

Krt2

keratin 2

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

Krt6a

keratin 6A

intermediate filament organization (GO:0045109)

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)
laminin-10 complex (GO:0043259)

16777

Lamb1-1

laminin B1 subunit 1

cell adhesion (GO:0007155)

enzyme binding (GO:0019899)

16852

Lgals1

lectin, galactose binding, soluble 1

myoblast differentiation (GO:0045445)

galactose binding (GO:0005534)

extracellular space (GO:0005615)

16854

Lgals3

lectin, galactose binding, soluble 3

skeletal development (GO:0001501)

IgE binding (GO:0019863)

nucleus (GO:0005634)

16976

Lrpap1

low density lipoprotein receptor-related protein associated protein 1

heparin binding (GO:0008201)

endoplasmic reticulum (GO:0005783)

17118

Marcks

myristoylated alanine rich protein kinase C substrate

actin binding (GO:0003779)

germinal vesicle (GO:0042585)

17534

Mrc2

mannose receptor, C type 2

integral to membrane (GO:0016021)

17931

Ppp1r12a

protein phosphatase 1, regulatory (inhibitor) subunit 12A

calcium ion binding (GO:0005509)
phosphoprotein phosphatase activity
(GO:0004721)

cytoplasm (GO:0005737)

17975

Ncl

DNA binding (GO:0003677)

nucleus (GO:0005634)

18102

Nme1

GTP biosynthetic process (GO:0006183)

ATP binding (GO:0005524)

microsome (GO:0005792)

18103

Nme2

nucleolin
non-metastatic cells 1, protein (NM23A)
expressed in
non-metastatic cells 2, protein (NM23B)
expressed in

ATP binding (GO:0005524)

mitochondrion (GO:0005739)

18148

Npm1

nucleophosmin 1

GTP biosynthetic process (GO:0006183)
regulation of DNA damage response, signal
transduction by p53 class mediator (GO:0043516)

18220

Nucb1

18451

P4ha1

18452

P4ha2

nucleobindin 1
procollagen-proline, 2-oxoglutarate 4dioxygenase (proline 4-hydroxylase), alpha 1
polypeptide
procollagen-proline, 2-oxoglutarate 4dioxygenase (proline 4-hydroxylase), alpha II
polypeptide

18453

P4hb

prolyl 4-hydroxylase, beta polypeptide

18477

Prdx1

peroxiredoxin 1

18483

Palm

endocytosis (GO:0006897)

rRNA binding (GO:0019843)

nucleus (GO:0005634)

calcium ion binding (GO:0005509)

Golgi apparatus (GO:0005794)

peptidyl-proline hydroxylation to 4-hydroxy-L-proline
(GO:0018401)

procollagen-proline 4-dioxygenase activity
(GO:0004656)

endoplasmic reticulum (GO:0005783)

peptidyl-proline hydroxylation to 4-hydroxy-L-proline
(GO:0018401)
peptidyl-proline hydroxylation to 4-hydroxy-L-proline
(GO:0018401)
regulation of NF-kappaB import into nucleus
(GO:0042345)
negative regulation of cAMP biosynthetic process
(GO:0030818)

procollagen-proline 4-dioxygenase activity
(GO:0004656)
procollagen-proline 4-dioxygenase activity
(GO:0004656)

endoplasmic reticulum (GO:0005783)
microsome (GO:0005792)

peroxiredoxin activity (GO:0051920)

nucleus (GO:0005634)
cytoplasm (GO:0005737)

protein amino acid methylation (GO:0006479)

D3 dopamine receptor binding (GO:0031750)
protein-L-isoaspartate (D-aspartate) Omethyltransferase activity (GO:0004719)

cytoplasm (GO:0005737)

glycolysis (GO:0006096)

pyruvate kinase activity (GO:0004743)

mitochondrion (GO:0005739)

serine carboxypeptidase activity (GO:0004185)

lysosome (GO:0005764)

18537

Pcmt1

paralemmin
protein-L-isoaspartate (D-aspartate) Omethyltransferase 1

18746

Pkm2

pyruvate kinase, muscle

19025

Ctsa

cathepsin A

proteolysis (GO:0006508)

19156

Psap

prosaposin

sphingolipid metabolic process (GO:0006665)

19170

Psmb1

proteasome (prosome, macropain) subunit, beta

ubiquitin-dependent protein catabolic process

lysosome (GO:0005764)
threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

194
type 1

(GO:0006511)
proteasomal ubiquitin-dependent protein catabolic
process (GO:0043161)
antigen processing and presentation of exogenous
antigen (GO:0019884)

19173

Psmb5

19186

Psme1

proteasome (prosome, macropain) subunit, beta
type 5
proteasome (prosome, macropain) 28 subunit,
alpha

19205

Ptbp1

polypyrimidine tract binding protein 1

19326

Rab11b

threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

proteasome activator activity (GO:0008538)

cytosol (GO:0005829)

mRNA processing (GO:0006397)
small GTPase mediated signal transduction
(GO:0007264)

RNA binding (GO:0003723)
GTP binding (GO:0005525)

nucleus (GO:0005634)
cytoplasmic membrane-bounded vesicle
(GO:0016023)

19656

Rbmxrt

RAB11B, member RAS oncogene family
RNA binding motif protein, X chromosome
retrogene

mRNA processing (GO:0006397)

RNA binding (GO:0003723)

nucleus (GO:0005634)

19983

Rpl5

ribosomal protein L5

translation (GO:0006412)

5S rRNA binding (GO:0008097)

20102

Rps4x

ribosomal protein S4, X-linked

translation (GO:0006412)

rRNA binding (GO:0019843)

nucleus (GO:0005634)
cytosolic small ribosomal subunit
(GO:0022627)

20194

S100a10

20333

Sec22b

S100 calcium binding protein A10 (calpactin)
SEC22 vesicle trafficking protein homolog B (S.
cerevisiae)

20334

Sec23a

20362

8-Sep

calcium ion binding (GO:0005509)

SEC23A (S. cerevisiae)

ER to Golgi vesicle-mediated transport (GO:0006888)
ER to Golgi vesicle-mediated transport
(GO:0006888)

Golgi membrane (GO:0000139)
zinc ion binding (GO:0008270)

COPII vesicle coat (GO:0030127)

septin 8

cell cycle (GO:0007049)

GTP binding (GO:0005525)

septin complex (GO:0031105)
fascia adherens (GO:0005916)

20740

Spna2

spectrin alpha 2

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

20742

Spnb2

spectrin beta 2

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

nucleus (GO:0005634)

20867

Stip1

response to stress (GO:0006950)
negative regulation of transcription from RNA
polymerase II promoter (GO:0000122)

binding (GO:0005488)

nucleus (GO:0005634)

receptor binding (GO:0005102)

nucleus (GO:0005634)

20901

Strap

stress-induced phosphoprotein 1
serine/threonine kinase receptor associated
protein

20911

Stxbp2

syntaxin binding protein 2

vesicle docking during exocytosis (GO:0006904)

syntaxin binding (GO:0019905)

21881

Tkt

transketolase

regulation of growth (GO:0040008)

transketolase activity (GO:0004802)

22027

Hsp90b1

heat shock protein 90, beta (Grp94), member 1

protein folding (GO:0006457)

ATP binding (GO:0005524)

endoplasmic reticulum (GO:0005783)

22074

Try4

trypsin 4

serine-type endopeptidase activity (GO:0004252)

cellular_component (GO:0005575)

22154

Tubb5

tubulin, beta 5

spindle assembly (GO:0051225)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

22240

Dpysl3

dihydropyrimidinase-like 3

nervous system development (GO:0007399)

22333

Vdac1

voltage-dependent anion channel 1

apoptosis (GO:0006915)

22334

Vdac2

anion transport (GO:0006820)

cytoplasm (GO:0005737)
mitochondrial outer membrane
(GO:0005741)
mitochondrial outer membrane
(GO:0005741)

22627

Ywhae

voltage-dependent anion channel 2
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, epsilon
polypeptide

hydrolase activity (GO:0016787)
voltage-gated anion channel activity
(GO:0008308)
voltage-gated anion channel activity
(GO:0008308)

negative regulation of protein amino acid
dephosphorylation (GO:0035308)

monooxygenase activity (GO:0004497)

mitochondrion (GO:0005739)

26388

Ifi202b

26433

Plod3

27041

G3bp1

interferon activated gene 202B
procollagen-lysine, 2-oxoglutarate 5-dioxygenase
3
proteasome (prosome, macropain) subunit, alpha
type 5
vesicle amine transport protein 1 homolog (T
californica)
Ras-GTPase-activating protein SH3-domain
binding protein 1

52398

SEPT11

septin 11

26442

Psma5

26949

Vat1

nucleus (GO:0005634)
protein modification process (GO:0006464)
ubiquitin-dependent protein catabolic process
(GO:0006511)

iron ion binding (GO:0005506)

endoplasmic reticulum (GO:0005783)

threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

oxidation reduction (GO:0055114)

zinc ion binding (GO:0008270)

transport (GO:0006810)

ATP binding (GO:0005524)

nucleus (GO:0005634)

cell cycle (GO:0007049)

GTP binding (GO:0005525)

septin complex (GO:0031105)

195
53328

Pgrmc1

progesterone receptor membrane component 1

53379

Hnrnpa2b1

heterogeneous nuclear ribonucleoprotein A2/B1

transition metal ion binding (GO:0046914)

microsome (GO:0005792)

mRNA processing (GO:0006397)
microtubule cytoskeleton organization and
biogenesis (GO:0000226)

RNA binding (GO:0003723)

nucleus (GO:0005634)

53857

Tuba8

54401

Ywhab

tubulin, alpha 8
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, beta
polypeptide

GTPase activity (GO:0003924)

microtubule (GO:0005874)

protein targeting (GO:0006605)

monooxygenase activity (GO:0004497)

cytoplasm (GO:0005737)

54609

Ubqln2

ubiquilin 2

protein modification process (GO:0006464)

55944

Eif3d

eukaryotic translation initiation factor 3, subunit D

translation (GO:0006412)

translation initiation factor activity (GO:0003743)

56085

Ubqln1

ubiquilin 1

protein modification process (GO:0006464)

intermediate filament binding (GO:0019215)

nucleus (GO:0005634)

56491

Vapb

integral to membrane (GO:0016021)

Map2k1ip1
Krt71

66073

Txndc12

kinase activity (GO:0016301)
structural constituent of cytoskeleton
(GO:0005200)
protein-disulfide reductase (glutathione) activity
(GO:0019153)

late endosome (GO:0005770)

56735

vesicle-associated membrane protein, associated protein B and C
mitogen-activated protein kinase kinase 1
interacting protein 1
activation of MAPKK activity (GO:0000186)
cytoskeleton organization and biogenesis
keratin 71
(GO:0007010)
thioredoxin domain containing 12 (endoplasmic
reticulum)
cell redox homeostasis (GO:0045454)

structural molecule activity (GO:0005198)

56692

66427

Cyb5b

cytochrome b5 type B

66870

Serbp1

Serpine1 mRNA binding protein 1

67300

Cltc

clathrin, heavy polypeptide (Hc)

intracellular protein transport (GO:0006886)

protein binding (GO:0005515)

67454

1200009F10Rik

RIKEN cDNA 1200009F10 gene

induction of apoptosis (GO:0006917)

protein binding (GO:0005515)

68585

Rtn4

reticulon 4

negative regulation of axon extension (GO:0030517)

protein binding (GO:0005515)

68682

Slc44a2

solute carrier family 44, member 2

transport (GO:0006810)

68794

Flnc

filamin C, gamma (actin binding protein 280)

actin filament-based process (GO:0030029)

transport (GO:0006810)

nucleus (GO:0005634)

iron ion binding (GO:0005506)
RNA binding (GO:0003723)

intermediate filament (GO:0005882)
endoplasmic reticulum (GO:0005783)
mitochondrial inner membrane
(GO:0005743)
nucleus (GO:0005634)
clathrin coat of trans-Golgi network
vesicle (GO:0030130)
endoplasmic reticulum (GO:0005783)
integral to endoplasmic reticulum
membrane (GO:0030176)
integral to membrane (GO:0016021)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

69162

Sec31a

SEC31 homolog A (S. cerevisiae)

protein transport (GO:0015031)

69386

Hist1h4h

71679

Atp5h

histone cluster 1, H4h
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit d

nucleosome assembly (GO:0006334)
ATP synthesis coupled proton transport
(GO:0015986)

DNA binding (GO:0003677)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)

nucleus (GO:0005634)
mitochondrial inner membrane
(GO:0005743)

endosome (GO:0005768)

intracellular protein transport (GO:0006886)

clathrin binding (GO:0030276)

transport vesicle (GO:0030133)

71770

Ap2b1

adaptor-related protein complex 2, beta 1 subunit

72333

Palld

palladin, cytoskeletal associated protein

77055

Krt76

keratin 76

80294

Pofut2

protein O-fucosyltransferase 2

81910

Rrbp1

ribosome binding protein 1

fucose metabolic process (GO:0006004)
intracellular protein transport across a membrane
(GO:0065002)

83397

Akap12

A kinase (PRKA) anchor protein (gravin) 12

protein targeting (GO:0006605)

93695

Gpnmb

glycoprotein (transmembrane) nmb

cell adhesion (GO:0007155)

heparin binding (GO:0008201)

97122

Hist2h4

histone cluster 2, H4

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

97908

Hist1h3g

histone cluster 1, H3g

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

98238

Lrrc59

leucine rich repeat containing 59

protein binding (GO:0005515)

microsome (GO:0005792)

actin binding (GO:0003779)

nucleus (GO:0005634)
intermediate filament (GO:0005882)

peptide-O-fucosyltransferase activity
(GO:0046922)
receptor activity (GO:0004872)
receptor signaling complex scaffold activity
(GO:0030159)

endoplasmic reticulum (GO:0005783)
integral to endoplasmic reticulum
membrane (GO:0030176)
cytoskeleton (GO:0005856)
integral to plasma membrane
(GO:0005887)

196
109168

5730596K20Rik

RIKEN cDNA 5730596K20 gene

109672

Cyb5

cytochrome b-5

109754

Cyb5r3

cytochrome b5 reductase 3

sterol biosynthetic process (GO:0016126)

110611

Hdlbp

high density lipoprotein (HDL) binding protein

steroid metabolic process (GO:0008202)

114228

Prss1

protease, serine, 1 (trypsin 1)

192176

Flna

filamin, alpha

early endosome to late endosome transport
(GO:0045022)

protein kinase C binding (GO:0005080)

trans-Golgi network (GO:0005802)

208263

Tor1aip1

torsin A interacting protein 1

lamin binding (GO:0005521)

nucleus (GO:0005634)

216197

Ckap4

cytoskeleton-associated protein 4

protein binding (GO:0005515)

endoplasmic reticulum (GO:0005783)

227613

Tubb2c

tubulin, beta 2c

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

229279

Hnrnpa3

heterogeneous nuclear ribonucleoprotein A3

mRNA processing (GO:0006397)

RNA binding (GO:0003723)

nucleus (GO:0005634)

230257

Rod1

ROD1 regulator of differentiation 1 (S. pombe)

mRNA processing (GO:0006397)

RNA binding (GO:0003723)

nucleus (GO:0005634)

235072

SEPT7

septin 7

cell cycle (GO:0007049)

GTP binding (GO:0005525)

synaptosome (GO:0019717)

4232

MEST

mesoderm specific transcript homolog (mouse)

mesoderm development (GO:0007498)

integral to membrane (GO:0016021)

fatty acid metabolic process (GO:0006631)

GTPase activity (GO:0003924)

integral to membrane (GO:0016021)

stearoyl-CoA 9-desaturase activity (GO:0004768)
cytochrome-b5 reductase activity (GO:0004128)

microsome (GO:0005792)
mitochondrial inner membrane
(GO:0005743)

RNA binding (GO:0003723)

nucleus (GO:0005634)

11363

Acadl

acyl-Coenzyme A dehydrogenase, long-chain

fatty acid metabolic process (GO:0006631)

protein binding (GO:0005515)
long-chain-acyl-CoA dehydrogenase activity
(GO:0004466)

11429

Aco2

aconitase 2, mitochondrial

tricarboxylic acid cycle (GO:0006099)

aconitate hydratase activity (GO:0003994)

mitochondrion (GO:0005739)

11465

Actg1

actin, gamma, cytoplasmic 1

sarcomere organization (GO:0045214)

11472

Actn2

actinin alpha 2

muscle contraction (GO:0006936)

ATP binding (GO:0005524)
thyroid hormone receptor coactivator activity
(GO:0030375)

Z disc (GO:0030018)

11475

Acta2

actin, alpha 2, smooth muscle, aorta

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)
nucleus (GO:0005634)

11555

G-protein signaling, adenylate cyclase activating
pathway (GO:0007189)

mitochondrion (GO:0005739)

actin cytoskeleton (GO:0015629)

Adrb2

adrenergic receptor, beta 2

11669

Aldh2

oxidation reduction (GO:0055114)

11740

Slc25a5

aldehyde dehydrogenase 2, mitochondrial
solute carrier family 25 (mitochondrial carrier,
adenine nucleotide translocator), member 5

beta2-adrenergic receptor activity (GO:0004941)
aldehyde dehydrogenase (NAD) activity
(GO:0004029)

transport (GO:0006810)

transporter activity (GO:0005215)

mitochondrion (GO:0005739)
mitochondrial inner membrane
(GO:0005743)

11746

Anxa4

annexin A4

kidney development (GO:0001822)

calcium ion binding (GO:0005509)

apical plasma membrane (GO:0016324)

11747

Anxa5

annexin A5

negative regulation of coagulation (GO:0050819)

calcium ion binding (GO:0005509)

11773

Ap2m1

adaptor protein complex AP-2, mu1

App

amyloid beta (A4) precursor protein

protein binding (GO:0005515)
serine-type endopeptidase inhibitor activity
(GO:0004867)

clathrin coat of coated pit (GO:0030132)

11820

intracellular protein transport (GO:0006886)
smooth endoplasmic reticulum calcium ion
homeostasis (GO:0051563)

11886

Asah1
Atp1a1

11938

Atp2a2

11944

Atp4a

11949

Atp5c1

11950

Atp5f1

ceramidase activity (GO:0017040)
sodium:potassium-exchanging ATPase activity
(GO:0005391)
calcium-transporting ATPase activity
(GO:0005388)
hydrogen:potassium-exchanging ATPase activity
(GO:0008900)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)

lysosome (GO:0005764)

11928

N-acylsphingosine amidohydrolase 1
ATPase, Na+/K+ transporting, alpha 1
polypeptide
ATPase, Ca++ transporting, cardiac muscle, slow
twitch 2
ATPase, H+/K+ exchanging, gastric, alpha
polypeptide
ATP synthase, H+ transporting, mitochondrial F1
complex, gamma polypeptide 1
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit b, isoform 1

12034

Phb2

prohibitin 2

regulation of cellular pH (GO:0030641)
cellular calcium ion homeostasis (GO:0006874)
potassium ion transport (GO:0006813)
ATP synthesis coupled proton transport
(GO:0015986)
ATP synthesis coupled proton transport
(GO:0015986)
regulation of transcription, DNA-dependent
(GO:0006355)

receptor activity (GO:0004872)

Golgi apparatus (GO:0005794)

microsome (GO:0005792)
microsome (GO:0005792)
integral to membrane (GO:0016021)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)

197
12304

Pdia4

protein disulfide isomerase associated 4

cell redox homeostasis (GO:0045454)

protein disulfide isomerase activity (GO:0003756)

12313

Calm1

calmodulin 1

calcium ion binding (GO:0005509)

12314

Calm2

calmodulin 2

positive regulation of DNA binding (GO:0043388)
G-protein coupled receptor protein signaling pathway
(GO:0007186)
G-protein coupled receptor protein signaling pathway
(GO:0007186)

12315

Calm3

calmodulin 3

12321

Calu

calumenin

12385

Ctnna1

catenin (cadherin associated protein), alpha 1

12387

Ctnnb1

catenin (cadherin associated protein), beta 1

12388

Ctnnd1

catenin (cadherin associated protein), delta 1

12389

Cav1

caveolin, caveolae protein 1

12390

Cav2

caveolin 2

12520

Cd81

CD 81 antigen

12527

Cd9

CD9 antigen

12797

Cnn1

12816

Col12a1

negative regulation of neuroblast proliferation
(GO:0007406)
negative regulation of osteoclast differentiation
(GO:0045671)
regulation of transcription, DNA-dependent
(GO:0006355)
inactivation of MAPK activity (GO:0000188)
negative regulation of endothelial cell proliferation
(GO:0001937)

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

cytoplasm (GO:0005737)

calcium ion binding (GO:0005509)

cytoplasm (GO:0005737)

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

actin filament binding (GO:0051015)

zonula adherens (GO:0005915)

double-stranded DNA binding (GO:0003690)

fascia adherens (GO:0005916)

protein binding (GO:0005515)

nucleus (GO:0005634)
integral to plasma membrane
(GO:0005887)
integral to plasma membrane
(GO:0005887)

protease activator activity (GO:0016504)
protein homodimerization activity (GO:0042803)

calponin 1

positive regulation of B cell proliferation (GO:0030890)
fusion of sperm to egg plasma membrane
(GO:0007342)
actomyosin structure organization and biogenesis
(GO:0031032)

actin binding (GO:0003779)

collagen, type XII, alpha 1

phosphate transport (GO:0006817)

protein binding (GO:0005515)
structural molecule activity (GO:0005198)

extracellular space (GO:0005615)

phosphate transport (GO:0006817)

protein binding (GO:0005515)

cytoplasm (GO:0005737)
mitochondrial inner membrane
(GO:0005743)

12835

Col6a3

collagen, type VI, alpha 3

12837

Col8a1

collagen, type VIII, alpha 1

integral to membrane (GO:0016021)
protein binding (GO:0005515)

integral to membrane (GO:0016021)

cytoplasm (GO:0005737)

12858

Cox5a

cytochrome c oxidase, subunit Va

iron ion binding (GO:0005506)

12861

Cox6a1

cytochrome c oxidase, subunit VI a, polypeptide 1

cytochrome-c oxidase activity (GO:0004129)

mitochondrion (GO:0005739)

12974

Cs
Ddost

tricarboxylic acid cycle (GO:0006099)
protein amino acid N-linked glycosylation via
asparagine (GO:0018279)

citrate (Si)-synthase activity (GO:0004108)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)

mitochondrion (GO:0005739)

13200

citrate synthase
dolichyl-di-phosphooligosaccharide-protein
glycotransferase

13382

Dld

dihydrolipoamide dehydrogenase

regulation of membrane potential (GO:0042391)

FAD binding (GO:0050660)

acrosomal matrix (GO:0043159)

endoplasmic reticulum (GO:0005783)

13427

Dync1i2

dynein cytoplasmic 1 intermediate chain 2

13717

Eln

elastin

stress fiber formation (GO:0043149)

motor activity (GO:0003774)
extracellular matrix structural constituent
(GO:0005201)

microtubule (GO:0005874)
proteinaceous extracellular matrix
(GO:0005578)

13849

Ephx1

epoxide hydrolase 1, microsomal

aromatic compound catabolic process (GO:0019439)

epoxide hydrolase activity (GO:0004301)

microsome (GO:0005792)

14089

Fap

fibroblast activation protein

proteolysis (GO:0006508)

serine-type endopeptidase activity (GO:0004252)

integral to membrane (GO:0016021)

14113

Fbl

fibrillarin

rRNA processing (GO:0006364)

methyltransferase activity (GO:0008168)

Cajal body (GO:0015030)

14119

Fbn2

fibrillin 2

embryonic limb morphogenesis (GO:0030326)

calcium ion binding (GO:0005509)

microfibril (GO:0001527)

14251

Flot1

flotillin 1

14433

Gapdh

glyceraldehyde-3-phosphate dehydrogenase

glycolysis (GO:0006096)

glyceraldehyde-3-phosphate dehydrogenase
(phosphorylating) activity (GO:0004365)

mitochondrion (GO:0005739)

14660

Gls

glutaminase

Glud1

glutamate dehydrogenase 1

glutamine catabolic process (GO:0006543)
transmembrane receptor protein tyrosine kinase
signaling pathway (GO:0007169)

glutaminase activity (GO:0004359)

14661

ATP binding (GO:0005524)

mitochondrial inner membrane
(GO:0005743)

14674

Gna13

guanine nucleotide binding protein, alpha 13

Rho protein signal transduction (GO:0007266)

GTPase activity (GO:0003924)

heterotrimeric G-protein complex

integral to membrane (GO:0016021)

198
(GO:0005834)
14694

Gnb2l1

14719

Got2

guanine nucleotide binding protein (G protein),
beta polypeptide 2 like 1
glutamate oxaloacetate transaminase 2,
mitochondrial

activation of protein kinase C activity (GO:0007205)

GTPase activity (GO:0003924)
aspartate transaminase activity (GO:0004069)

general transcription factor II I

aspartate biosynthetic process (GO:0006532)
regulation of transcription, DNA-dependent
(GO:0006355)

heterotrimeric G-protein complex
(GO:0005834)
mitochondrial inner membrane
(GO:0005743)

14886

Gtf2i

14919

Gucy2e

DNA binding (GO:0003677)

nucleus (GO:0005634)

guanylate cyclase 2e

cGMP biosynthetic process (GO:0006182)

ATP binding (GO:0005524)
aspartic-type endopeptidase activity
(GO:0004190)

integral to membrane (GO:0016021)
endoplasmic reticulum (GO:0005783)

14950

H13

histocompatibility 13

14957

Hist1h1d

histone cluster 1, H1d

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

14958

H1f0

H1 histone family, member 0

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)
beta-N-acetylhexosaminidase activity
(GO:0004563)

nucleus (GO:0005634)
lysosome (GO:0005764)

heparin binding (GO:0008201)

chromatin (GO:0000785)

15211

Hexa

hexosaminidase A

15289

Hmgb1

high mobility group box 1

15364

Hmga2

high mobility group AT-hook 2

ganglioside catabolic process (GO:0006689)
regulation of transcription, DNA-dependent
(GO:0006355)
regulation of transcription, DNA-dependent
(GO:0006355)

15369

Hmox2

heme oxygenase (decycling) 2

heme oxidation (GO:0006788)

15441

Hp1bp3

heterochromatin protein 1, binding protein 3

15502

Dnaja1

DnaJ (Hsp40) homolog, subfamily A, member 1

15951

Ifi204

interferon activated gene 204

16906

Lmnb1

lamin B1

16971

Lrp1

16997

Ltbp2

16998

Ltbp3

low density lipoprotein receptor-related protein 1
latent transforming growth factor beta binding
protein 2
latent transforming growth factor beta binding
protein 3

17150

Mfap2

microfibrillar-associated protein 2

17257

Mecp2

methyl CpG binding protein 2

DNA binding (GO:0003677)

nuclear chromosome (GO:0000228)

iron ion binding (GO:0005506)

microsome (GO:0005792)

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

androgen receptor signaling pathway (GO:0030521)
DNA damage response, signal transduction by p53
class mediator resulting in induction of apoptosis
(GO:0042771)

zinc ion binding (GO:0008270)

membrane (GO:0016020)

transcription cofactor activity (GO:0003712)

nucleus (GO:0005634)

structural molecule activity (GO:0005198)

lamin filament (GO:0005638)

apoptotic cell clearance (GO:0043277)

calcium ion binding (GO:0005509)

nucleus (GO:0005634)

metabolic process (GO:0008152)
transforming growth factor beta receptor signaling
pathway (GO:0007179)

calcium ion binding (GO:0005509)

extracellular region (GO:0005576)
proteinaceous extracellular matrix
(GO:0005578)

calcium ion binding (GO:0005509)

microfibril (GO:0001527)
negative regulation of transcription, DNA-dependent
(GO:0045892)

17276

Mela

melanoma antigen

transposition (GO:0032196)

mRNA binding (GO:0003729)
RNA-directed DNA polymerase activity
(GO:0003964)

17448

Mdh2

malate dehydrogenase 2, NAD (mitochondrial)

glycolysis (GO:0006096)

L-malate dehydrogenase activity (GO:0030060)

integral to membrane (GO:0016021)
mitochondrial inner membrane
(GO:0005743)

17470

Cd200

Cd200 antigen

protein binding (GO:0005515)

integral to membrane (GO:0016021)

copper ion binding (GO:0005507)

heterochromatin (GO:0000792)

17709

COX2

cytochrome c oxidase subunit II

transport (GO:0006810)

17758

Mtap4

negative regulation of microtubule depolymerization (GO:0007026)

17904

Myl6

microtubule-associated protein 4
myosin, light polypeptide 6, alkali, smooth muscle
and non-muscle

17995

Ndufv1

NADH dehydrogenase (ubiquinone) flavoprotein 1

muscle filament sliding (GO:0030049)
mitochondrial electron transport, NADH to ubiquinone
(GO:0006120)

calcium ion binding (GO:0005509)
NADH dehydrogenase (ubiquinone) activity
(GO:0008137)

microtubule (GO:0005874)
unconventional myosin complex
(GO:0016461)
mitochondrial inner membrane
(GO:0005743)

mitochondrion (GO:0005739)

18000

SEPT2

septin 2

cytokinesis (GO:0000910)

GTPase activity (GO:0003924)

synaptosome (GO:0019717)

18186

Nrp1

neuropilin 1

negative regulation of axon extension (GO:0030517)

Nsdhl

NAD(P) dependent steroid dehydrogenase-like

sterol biosynthetic process (GO:0016126)

semaphorin receptor activity (GO:0017154)
3-beta-hydroxy-delta5-steroid dehydrogenase
activity (GO:0003854)

integral to membrane (GO:0016021)

18194

integral to membrane (GO:0016021)

199
18242

Oat

regulation of peptidyl-tyrosine phosphorylation
(GO:0050730)

ornithine-oxo-acid transaminase activity
(GO:0004587)
vascular endothelial growth factor receptor activity
(GO:0005021)
growth factor activity (GO:0008083)

18596

Pdgfrb

ornithine aminotransferase
platelet derived growth factor receptor, beta
polypeptide

18654

Pgf

placental growth factor

ureteric bud branching (GO:0001658)

18673

Phb

18674

Slc25a3

prohibitin
solute carrier family 25 (mitochondrial carrier,
phosphate carrier), member 3

transport (GO:0006810)

18810

Plec1

plectin 1

18984

Por

P450 (cytochrome) oxidoreductase

19012

Ppap2a

phosphatidic acid phosphatase 2a

diacylglycerol biosynthetic process (GO:0006651)

19035

Ppib

peptidylprolyl isomerase B

protein folding (GO:0006457)

19223

Ptgis

prostaglandin I2 (prostacyclin) synthase

19353

Rac1

RAS-related C3 botulinum substrate 1

prostaglandin biosynthetic process (GO:0001516)
embryonic olfactory bulb interneuron precursor
migration (GO:0021831)

GTPase activity (GO:0003924)

endoplasmic reticulum (GO:0005783)
cytoplasmic membrane-bounded vesicle
(GO:0016023)

19384

Ran

RAN, member RAS oncogene family

protein import into nucleus (GO:0006606)

GTPase activity (GO:0003924)

nucleus (GO:0005634)

integral to membrane (GO:0016021)

symporter activity (GO:0015293)

extracellular space (GO:0005615)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

iron ion binding (GO:0005506)
phosphatidate phosphatase activity
(GO:0008195)
peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)

microsome (GO:0005792)
integral to plasma membrane
(GO:0005887)

DNA replication (GO:0006260)

oxidation reduction (GO:0055114)

mitochondrion (GO:0005739)

iron ion binding (GO:0005506)

endoplasmic reticulum (GO:0005783)

19672

Rcn1

reticulocalbin 1

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

19896

Rpl10a

ribosomal protein L10A

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

19899

Rpl18

ribosomal protein L18

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

cytoplasm (GO:0005737)
cytosolic large ribosomal subunit
(GO:0022625)

19921

Rpl19

ribosomal protein L19

translation (GO:0006412)

RNA binding (GO:0003723)

19944

Rpl29

ribosomal protein L29

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

19951

Rpl32

ribosomal protein L32

translation (GO:0006412)

RNA binding (GO:0003723)

ribosome (GO:0005840)
cytosolic large ribosomal subunit
(GO:0022625)

19988

Rpl6

ribosomal protein L6

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

19989

Rpl7

ribosomal protein L7

Rpn2

ribophorin II

RNA binding (GO:0003723)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)

large ribosomal subunit (GO:0015934)

20014

translation (GO:0006412)
protein amino acid N-linked glycosylation via
asparagine (GO:0018279)

20044

Rps14

ribosomal protein S14

translation (GO:0006412)

RNA binding (GO:0003723)

20068

Rps17

ribosomal protein S17

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

endoplasmic reticulum (GO:0005783)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)

20091

Rps3a

ribosomal protein S3a

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

nucleus (GO:0005634)

spermatogenesis (GO:0007283)

cytokine activity (GO:0005125)

cytoplasm (GO:0005737)
Golgi apparatus (GO:0005794)

organic anion transport (GO:0015711)

fibroblast growth factor binding (GO:0017134)
secondary active monocarboxylate
transmembrane transporter activity (GO:0015355)
GTP binding (GO:0005525)

endoplasmic reticulum (GO:0005783)

20116

Rps8

ribosomal protein S8

20195

S100a11

S100 calcium binding protein A11 (calgizzarin)

20340

Glg1

ribosome (GO:0005840)

20501

Slc16a1

golgi apparatus protein 1
solute carrier family 16 (monocarboxylic acid
transporters), member 1

20818

Srprb

signal recognition particle receptor, B subunit

21345

Tagln

transgelin

21402

Skp1a

S-phase kinase-associated protein 1A

21762

Psmd2

proteasome (prosome, macropain) 26S subunit, non-ATPase, 2

cytoskeleton organization and biogenesis (GO:0007010)
ubiquitin-dependent protein catabolic process
(GO:0006511)
kinase activity (GO:0016301)

integral to membrane (GO:0016021)

cytoplasm (GO:0005737)
SCF ubiquitin ligase complex
(GO:0019005)
cytosol (GO:0005829)

200
talin 1

cortical actin cytoskeleton organization and
biogenesis (GO:0030866)

actin binding (GO:0003779)

focal adhesion (GO:0005925)
chromatin (GO:0000785)

21894

Tln1

21917

Tmpo

thymopoietin

regulation of transcription (GO:0045449)

hormone activity (GO:0005179)

22004

Tpm2

tropomyosin 2, beta

muscle contraction (GO:0006936)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

22121

Rpl13a

ribosomal protein L13a

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

large ribosomal subunit (GO:0015934)

22143

Tuba1b

tubulin, alpha 1B

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

22146

Tuba1c

tubulin, alpha 1C

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

22187

Ubb

ubiquitin B

protein modification process (GO:0006464)

22335

Vdac3

voltage-dependent anion channel 3

nerve-nerve synaptic transmission (GO:0007270)

protein binding (GO:0005515)
voltage-gated anion channel activity
(GO:0008308)

22385

Baz1b

bromodomain adjacent to zinc finger domain, 1B

chromatin remodeling (GO:0006338)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)
mitochondrial outer membrane
(GO:0005741)
centromeric heterochromatin
(GO:0005721)

22608

Ybx1

Y box protein 1

mRNA processing (GO:0006397)

single-stranded DNA binding (GO:0003697)

nucleus (GO:0005634)

23825

Banf1

barrier to autointegration factor 1

provirus integration (GO:0019047)

DNA binding (GO:0003677)

nucleus (GO:0005634)

23876

Fbln5

fibulin 5

cell adhesion (GO:0007155)

calcium ion binding (GO:0005509)

extracellular space (GO:0005615)

23937

Mab21l2

mab-21-like 2 (C. elegans)

camera-type eye development (GO:0043010)

23943

Mbc2

membrane bound C2 domain containing protein

26914

H2afy

H2A histone family, member Y

26942

Spag1

sperm associated antigen 1

26961

Rpl8

ribosomal protein L8

27050

Rps3

ribosomal protein S3

translation (GO:0006412)

RNA binding (GO:0003723)

27061

Bcap31

B-cell receptor-associated protein 31

apoptosis (GO:0006915)

receptor activity (GO:0004872)

small ribosomal subunit (GO:0015935)
integral to plasma membrane
(GO:0005887)

27176

Rpl7a

ribosomal protein L7a

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

polysomal ribosome (GO:0042788)

27367

Rpl3

27425

Atp5l

translation (GO:0006412)
ATP synthesis coupled proton transport
(GO:0015986)
ATP synthesis coupled proton transport
(GO:0015986)

structural constituent of ribosome (GO:0003735)
hydrogen-exporting ATPase activity,
phosphorylative mechanism (GO:0008553)
hydrogen-exporting ATPase activity,
phosphorylative mechanism (GO:0008553)

cytoplasm (GO:0005737)
mitochondrial inner membrane
(GO:0005743)

nucleus (GO:0005634)
integral to membrane (GO:0016021)

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

Barr body (GO:0001740)

single fertilization (GO:0007338)

GTP binding (GO:0005525)

translation (GO:0006412)

rRNA binding (GO:0019843)

cytoplasm (GO:0005737)
cytosolic large ribosomal subunit
(GO:0022625)

28080

Atp5o

ribosomal protein L3
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit g
ATP synthase, H+ transporting, mitochondrial F1
complex, O subunit

28185

Tomm70a

translocase of outer mitochondrial membrane 70 homolog A (yeast)

28295

D10Jhu81e

DNA segment, Chr 10, Johns Hopkins University 81 expressed

30960

Vapa

50706

Postn

vesicle-associated membrane protein, associated protein A
extracellular matrix organization and biogenesis
periostin, osteoblast specific factor
(GO:0030198)

receptor activity (GO:0004872)

mitochondrion (GO:0005739)
mitochondrion (GO:0005739)
mitochondrion (GO:0005739)

structural molecule activity (GO:0005198)

endoplasmic reticulum (GO:0005783)
proteinaceous extracellular matrix
(GO:0005578)

50790

Acsl4

acyl-CoA synthetase long-chain family member 4

fatty acid metabolic process (GO:0006631)

heparin binding (GO:0008201)
long-chain-fatty-acid-CoA ligase activity
(GO:0004467)

51788

H2afz

H2A histone family, member Z

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

Barr body (GO:0001740)

52377

Rcn3

reticulocalbin 3, EF-hand calcium binding domain

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

calcium ion binding (GO:0005509)
P-P-bond-hydrolysis-driven protein
transmembrane transporter activity (GO:0015450)

endoplasmic reticulum (GO:0005783)

53322

Nucb2

nucleobindin 2

53421

Sec61a1

Sec61 alpha 1 subunit (S. cerevisiae)

cellular calcium ion homeostasis (GO:0006874)
intracellular protein transport across a membrane
(GO:0065002)

peroxisome (GO:0005777)

nuclear outer membrane (GO:0005640)

201
54637

Praf2

56334

Tmed2

PRA1 domain family 2
transmembrane emp24 domain trafficking protein
2

protein transport (GO:0015031)

56401

Lepre1

leprecan 1

protein metabolic process (GO:0019538)

56428

Mtch2

56451

Suclg1

mitochondrial carrier homolog 2 (C. elegans)
succinate-CoA ligase, GDP-forming, alpha
subunit

tricarboxylic acid cycle (GO:0006099)

binding (GO:0005488)
succinate-CoA ligase (ADP-forming) activity
(GO:0004775)

56454

Aldh18a1

proline biosynthetic process (GO:0006561)

glutamate 5-kinase activity (GO:0004349)

56457

Clptm1

RNA interference (GO:0016246)

nuclease activity (GO:0004518)

nucleus (GO:0005634)

nucleosome assembly (GO:0006334)
protein amino acid N-linked glycosylation
(GO:0006487)

DNA binding (GO:0003677)

nucleus (GO:0005634)
integral to endoplasmic reticulum
membrane (GO:0030176)

protein transport (GO:0015031)

transport (GO:0006810)

integral to membrane (GO:0016021)
protein binding (GO:0005515)
procollagen-proline 3-dioxygenase activity
(GO:0019797)

Golgi apparatus (GO:0005794)
nucleus (GO:0005634)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)

56463

Snd1

aldehyde dehydrogenase 18 family, member A1
cleft lip and palate associated transmembrane
protein 1
staphylococcal nuclease and tudor domain
containing 1

56702

Hist1h1b

histone cluster 1, H1b

57170

Dolpp1

dolichyl pyrophosphate phosphatase 1

57377

Gcs1

glucosidase 1

59021

Rab2a

RAB2A, member RAS oncogene family

64660

Mrps24

mitochondrial ribosomal protein S24

65019

Rpl23

ribosomal protein L23

ribosomal protein import into nucleus (GO:0006610)

structural constituent of ribosome (GO:0003735)

nucleolus (GO:0005730)

65106

Arl6ip5

ADP-ribosylation factor-like 6 interacting protein 5

L-glutamate transport (GO:0015813)

protein binding (GO:0005515)

endoplasmic reticulum (GO:0005783)

65970

Lima1

LIM domain and actin binding 1

65973

Asph

peptidyl-amino acid modification (GO:0018193)

actin cytoskeleton (GO:0015629)
integral to endoplasmic reticulum
membrane (GO:0030176)

66052

Sdhc

aspartate-beta-hydroxylase
succinate dehydrogenase complex, subunit C,
integral membrane protein

zinc ion binding (GO:0008270)
peptide-aspartate beta-dioxygenase activity
(GO:0004597)

tricarboxylic acid cycle (GO:0006099)

iron ion binding (GO:0005506)

mitochondrion (GO:0005739)

66141

Ifitm3

interferon induced transmembrane protein 3

negative regulation of cell proliferation (GO:0008285)

integral to membrane (GO:0016021)

66241

Tmem9

transmembrane protein 9

transport (GO:0006810)

lysosome (GO:0005764)

66480

Rpl15

66525

Timm50

translation (GO:0006412)
release of cytochrome c from mitochondria
(GO:0001836)

66656

Eef1d

ribosomal protein L15
translocase of inner mitochondrial membrane 50
homolog (yeast)
eukaryotic translation elongation factor 1 delta
(guanine nucleotide exchange protein)

66673

Sorcs3

sortilin-related VPS10 domain containing receptor 3

66861

Dnajc10

DnaJ (Hsp40) homolog, subfamily C, member 10

66881

Pcyox1

prenylcysteine oxidase 1

prenylcysteine catabolic process (GO:0030328)

prenylcysteine oxidase activity (GO:0001735)

lysosome (GO:0005764)

66890

Lman2

protein transport (GO:0015031)

66945

Sdha

lectin, mannose-binding 2
succinate dehydrogenase complex, subunit A,
flavoprotein (Fp)

calcium ion binding (GO:0005509)
succinate dehydrogenase (ubiquinone) activity
(GO:0008177)

67003

Uqcrc2

ubiquinol cytochrome c reductase core protein 2

proteolysis (GO:0006508)

metalloendopeptidase activity (GO:0004222)

Golgi apparatus (GO:0005794)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)

67040

Ddx17

DEAD (Asp-Glu-Ala-Asp) box polypeptide 17

ATP binding (GO:0005524)

nucleus (GO:0005634)

67097

Rps10

ribosomal protein S10

structural constituent of ribosome (GO:0003735)

cytoplasm (GO:0005737)

regulation of T cell differentiation in the thymus (GO:0033081)

oligosaccharide metabolic process (GO:0009311)
small GTPase mediated signal transduction
(GO:0007264)

dolichyldiphosphatase activity (GO:0047874)
mannosyl-oligosaccharide glucosidase activity
(GO:0004573)
GTP binding (GO:0005525)
structural constituent of ribosome (GO:0003735)

translational elongation (GO:0006414)

structural constituent of ribosome (GO:0003735)
phosphoprotein phosphatase activity
(GO:0004721)
translation elongation factor activity
(GO:0003746)

protein folding (GO:0006457)

heat shock protein binding (GO:0031072)

mitochondrion (GO:0005739)
external side of plasma membrane
(GO:0009897)

endoplasmic reticulum (GO:0005783)
endoplasmic reticulum (GO:0005783)
mitochondrial small ribosomal subunit
(GO:0005763)

ribosome (GO:0005840)
mitochondrion (GO:0005739)
eukaryotic translation elongation factor 1
complex (GO:0005853)
integral to membrane (GO:0016021)

tricarboxylic acid cycle (GO:0006099)

endoplasmic reticulum (GO:0005783)
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67115

Rpl14

ribosomal protein L14

translation (GO:0006412)
regulation of transcription, DNA-dependent
(GO:0006355)
small GTPase mediated signal transduction
(GO:0007264)

67154

Mtdh

Metadherin

67166

Arl8b

ADP-ribosylation factor-like 8B

67186

Rplp2

67273

Ndufa10

translational elongation (GO:0006414)
nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process (GO:0006139)

oxidation reduction (GO:0055114)

67458

Ergic1

ribosomal protein, large P2
NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex 10
endoplasmic reticulum-golgi intermediate
compartment (ERGIC) 1

67460

Decr1

2,4-dienoyl CoA reductase 1, mitochondrial

67552

H2afy3

H2A histone family, member Y3

67622

Mxra7

matrix-remodelling associated 7

67671

Rpl38

ribosomal protein L38

67834

Idh3a

isocitrate dehydrogenase 3 (NAD+) alpha

67891

Rpl4

ribosomal protein L4

67938

Mylc2b

myosin light chain, regulatory B

68028

Rpl22l1

ribosomal protein L22 like 1

68045

2700060E02Rik

RIKEN cDNA 2700060E02 gene

68117

Apool

68194

Ndufb4

apolipoprotein O-like
NADH dehydrogenase (ubiquinone) 1 beta
subcomplex 4

68294

Mfsd10

68428
68564

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

DNA binding (GO:0003677)

tight junction (GO:0005923)

GTP binding (GO:0005525)

lysosome (GO:0005764)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

ATP binding (GO:0005524)

mitochondrion (GO:0005739)

vesicle-mediated transport (GO:0016192)

endoplasmic reticulum (GO:0005783)
2,4-dienoyl-CoA reductase (NADPH) activity
(GO:0008670)
DNA binding (GO:0003677)

mitochondrion (GO:0005739)
nucleus (GO:0005634)
integral to membrane (GO:0016021)
ribosome (GO:0005840)

tricarboxylic acid cycle (GO:0006099)

structural constituent of ribosome (GO:0003735)
isocitrate dehydrogenase (NAD+) activity
(GO:0004449)

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

calcium ion binding (GO:0005509)

myosin complex (GO:0016459)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

transport (GO:0006810)

NADH dehydrogenase (ubiquinone) activity
(GO:0008137)

nucleus (GO:0005634)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)

major facilitator superfamily domain containing 10

apoptosis (GO:0006915)

transporter activity (GO:0005215)

integral to membrane (GO:0016021)

Steap3

STEAP family member 3

iron ion transport (GO:0006826)

ferric-chelate reductase activity (GO:0000293)

multivesicular body (GO:0005771)

Nufip2

nuclear fragile X mental retardation protein interacting protein 2
transmembrane emp24-like trafficking protein 10
(yeast)
vesicle targeting, to, from or within Golgi (GO:0048199)

68581

Tmed10

68796

1110039B18Rik

RIKEN cDNA 1110039B18 gene

69617

Pitrm1

pitrilysin metallepetidase 1

70152

Mettl7a1

methyltransferase like 7A1

70186

2310056P07Rik

70350

Basp1

RIKEN cDNA 2310056P07 gene
brain abundant, membrane attached signal
protein 1

70361

Lman1

lectin, mannose-binding, 1

70456

Brp44

brain protein 44

70508

Bbx

bobby sox homolog (Drosophila)
glucose-fructose oxidoreductase domain
containing 2

70575

Gfod2

70804

Pgrmc2

71514

Sfpq

progesterone receptor membrane component 2
splicing factor proline/glutamine rich
(polypyrimidine tract binding protein associated)

translation (GO:0006412)

translation (GO:0006412)

proteolysis (GO:0006508)

mitochondrion (GO:0005739)

nucleus (GO:0005634)
zymogen granule membrane
(GO:0042589)
calcium ion binding (GO:0005509)

integral to membrane (GO:0016021)

metalloendopeptidase activity (GO:0004222)

mitochondrion (GO:0005739)

methyltransferase activity (GO:0008168)
integral to membrane (GO:0016021)
regulation of transcription, DNA-dependent
(GO:0006355)
ER to Golgi vesicle-mediated transport
(GO:0006888)

DNA binding (GO:0003677)
sugar binding (GO:0005529)

nucleus (GO:0005634)
sarcomere (GO:0030017)
mitochondrion (GO:0005739)

regulation of transcription, DNA-dependent
(GO:0006355)
oxidation reduction (GO:0055114)

mRNA processing (GO:0006397)

DNA binding (GO:0003677)

nucleus (GO:0005634)

electron carrier activity (GO:0009055)

extracellular region (GO:0005576)

transition metal ion binding (GO:0046914)

integral to membrane (GO:0016021)

DNA binding (GO:0003677)

nucleus (GO:0005634)
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71960

Myh14

myosin, heavy polypeptide 14

regulation of cell shape (GO:0008360)

actin-dependent ATPase activity (GO:0030898)

72960

Top1mt

DNA topoisomerase 1, mitochondrial

DNA unwinding during replication (GO:0006268)

DNA topoisomerase type I activity (GO:0003917)

73124

Golim4

golgi integral membrane protein 4

transport (GO:0006810)

74122

Tmem43

transmembrane protein 43

stress fiber (GO:0001725)

endosome (GO:0005768)
integral to membrane (GO:0016021)

74205

Acsl3
Pck2

acyl-CoA synthetase long-chain family member 3
phosphoenolpyruvate carboxykinase 2
(mitochondrial)

fatty acid metabolic process (GO:0006631)

74551

gluconeogenesis (GO:0006094)

long-chain-fatty-acid-CoA ligase activity
(GO:0004467)
phosphoenolpyruvate carboxykinase (GTP)
activity (GO:0004613)

74776

Ppa2

pyrophosphatase (inorganic) 2

phosphate metabolic process (GO:0006796)

inorganic diphosphatase activity (GO:0004427)

mitochondrion (GO:0005739)

74840

Armet

arginine-rich, mutated in early stage tumors

growth factor activity (GO:0008083)

extracellular space (GO:0005615)

75909

Tmem49

transmembrane protein 49

integral to membrane (GO:0016021)
iron ion binding (GO:0005506)

endoplasmic reticulum (GO:0005783)

signal transduction (GO:0007165)

calcium ion binding (GO:0005509)

microfibril (GO:0001527)

serine-type endopeptidase activity (GO:0004252)

extracellular space (GO:0005615)

Fads1

fatty acid desaturase 1

76293

Mfap4

response to unfolded protein (GO:0006986)
proteolysis (GO:0006508)

76299

Txndc4

microfibrillar-associated protein 4
thioredoxin domain containing 4 (endoplasmic
reticulum)

76453

Prss23

protease, serine, 23

76577

Ubxd8

UBX domain containing 8

76808

Rpl18a

ribosomal protein L18A

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

76936

Hnrnpm

heterogeneous nuclear ribonucleoprotein M

mRNA processing (GO:0006397)
nuclear membrane organization and biogenesis
(GO:0006998)

transmembrane receptor activity (GO:0004888)

Unc84a

unc-84 homolog A (C. elegans)

77134

Hnrnpa0

endoplasmic reticulum (GO:0005783)

cytoplasm (GO:0005737)

zinc ion binding (GO:0008270)

78920

Dlst

heterogeneous nuclear ribonucleoprotein A0
dihydrolipoamide S-succinyltransferase (E2
component of 2-oxo-glutarate complex)

tricarboxylic acid cycle (GO:0006099)

nucleic acid binding (GO:0003676)
dihydrolipoyllysine-residue succinyltransferase
activity (GO:0004149)

80838

Hist1h1a

histone cluster 1, H1a

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

93736

Aff4

regulation of transcription, DNA-dependent (GO:0006355)

97212

Hadha

AF4/FMR2 family, member 4
hydroxyacyl-Coenzyme A dehydrogenase/3ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A
hydratase (trifunctional protein), alpha subunit

100494

Zfand2a

zinc finger, AN1-type domain 2A

100952

Emilin1

elastin microfibril interfacer 1

101739

Psip1

PC4 and SFRS1 interacting protein 1

103080

SEPT10

septin 10

mitochondrion (GO:0005739)

unsaturated fatty acid biosynthetic process
(GO:0006636)

76267

77053

peroxisome (GO:0005777)

fatty acid beta-oxidation (GO:0006635)

phosphate transport (GO:0006817)
regulation of transcription, DNA-dependent
(GO:0006355)
regulation of transcription, DNA-dependent
(GO:0006355)

ribosome (GO:0005840)
integral to plasma membrane
(GO:0005887)
integral to nuclear inner membrane
(GO:0005639)
ribonucleoprotein complex (GO:0030529)

nucleus (GO:0005634)

mitochondrion (GO:0005739)

nucleus (GO:0005634)

3-hydroxyacyl-CoA dehydrogenase activity
(GO:0003857)

mitochondrial inner membrane
(GO:0005743)

zinc ion binding (GO:0008270)
extracellular matrix constituent conferring
elasticity (GO:0030023)

cytoplasm (GO:0005737)

nucleus (GO:0005634)

DNA binding (GO:0003677)

nucleus (GO:0005634)
nucleus (GO:0005634)

103963

Rpn1

ribophorin I

protein amino acid glycosylation (GO:0006486)

GTP binding (GO:0005525)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)

104721

Ddx1

DEAD (Asp-Glu-Ala-Asp) box polypeptide 1

spliceosome assembly (GO:0000245)

ATPase activity (GO:0016887)

105245

Txndc5

thioredoxin domain containing 5

108037

Shmt2
Ltbp4

cell redox homeostasis (GO:0045454)
one-carbon compound metabolic process
(GO:0006730)
transforming growth factor beta receptor signaling
pathway (GO:0007179)

isomerase activity (GO:0016853)
glycine hydroxymethyltransferase activity
(GO:0004372)

108075

serine hydroxymethyltransferase 2 (mitochondrial)
latent transforming growth factor beta binding
protein 4

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

endoplasmic reticulum (GO:0005783)
mitochondrial inner membrane
(GO:0005743)
proteinaceous extracellular matrix
(GO:0005578)
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108989

Tpr

translocated promoter region

109154

2410014A08Rik

RIKEN cDNA 2410014A08 gene

nuclear envelope (GO:0005635)

109905

Rap1a

RAS-related protein-1a

110052

Dek

DEK oncogene (DNA binding)

110253

Triobp

TRIO and F-actin binding protein

110446

Acat1

transport (GO:0006810)
phospholipid biosynthetic process (GO:0008654)

FAD binding (GO:0050660)
phosphatidate cytidylyltransferase activity
(GO:0004605)

mitochondrion (GO:0005739)

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

protein targeting (GO:0006605)
small GTPase mediated signal transduction
(GO:0007264)

GTPase activity (GO:0003924)

intracellular (GO:0005622)

DNA binding (GO:0003677)

nucleus (GO:0005634)

actin binding (GO:0003779)
acetyl-CoA C-acetyltransferase activity
(GO:0003985)

nucleus (GO:0005634)
mitochondrial inner membrane
(GO:0005743)
mitochondrial electron transfer
flavoprotein complex (GO:0017133)

110842

Etfa

110911

Cds2

acetyl-Coenzyme A acetyltransferase 1
electron transferring flavoprotein, alpha
polypeptide
CDP-diacylglycerol synthase (phosphatidate
cytidylyltransferase) 2

110954

Rpl10

ribosomal protein 10

140481

Man2a2

195434

Utp14b

mannosidase 2, alpha 2
UTP14, U3 small nucleolar ribonucleoprotein,
homolog B (yeast)

216136

Ilvbl

ilvB (bacterial acetolactate synthase)-like

magnesium ion binding (GO:0000287)

integral to membrane (GO:0016021)

223650

Eppk1

epiplakin 1

structural molecule activity (GO:0005198)

223697

Unc84b

226646

Ndufs2

unc-84 homolog B (C. elegans)
NADH dehydrogenase (ubiquinone) Fe-S protein
2
NADH dehydrogenase (ubiquinone) Fe-S protein
1

cytoskeleton (GO:0005856)
condensed nuclear chromosome
(GO:0000794)

227197

Ndufs1

227753

Gsn

230709

Zmpste24

gelsolin
zinc metallopeptidase, STE24 homolog (S.
cerevisiae)

230753

Thrap3

thyroid hormone receptor associated protein 3

230866

C230096C10Rik

231086

Hadhb

RIKEN cDNA C230096C10 gene
hydroxyacyl-Coenzyme A dehydrogenase/3ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A
hydratase (trifunctional protein), beta subunit

231633

Tmem119

transmembrane protein 119

233870

Tufm

233908

Fus

235339

Dlat

Tu translation elongation factor, mitochondrial
fusion, derived from t(12;16) malignant
liposarcoma (human)
dihydrolipoamide S-acetyltransferase (E2
component of pyruvate dehydrogenase complex)

238880

Actbl2

actin, beta-like 2

metabolic process (GO:0008152)

integral to membrane (GO:0016021)

mannosidase activity (GO:0015923)
rRNA processing (GO:0006364)

nuclear membrane organization and biogenesis
(GO:0006998)

nucleus (GO:0005634)

transport (GO:0006810)
mitochondrial electron transport, NADH to ubiquinone
(GO:0006120)

protein binding (GO:0005515)
NADH dehydrogenase (ubiquinone) activity
(GO:0008137)
NADH dehydrogenase (ubiquinone) activity
(GO:0008137)

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

prenylated protein catabolic process (GO:0030327)
positive regulation of transcription from RNA
polymerase II promoter (GO:0045944)

metalloendopeptidase activity (GO:0004222)

endoplasmic reticulum (GO:0005783)

ATP binding (GO:0005524)

nucleus (GO:0005634)

fatty acid beta-oxidation (GO:0006635)

acetyl-CoA C-acyltransferase activity
(GO:0003988)

mitochondrial inner membrane
(GO:0005743)

mitochondrion (GO:0005739)
mitochondrion (GO:0005739)

integral to membrane (GO:0016021)

translational elongation (GO:0006414)
positive regulation of transcription from RNA
polymerase II promoter (GO:0045944)
glycolysis (GO:0006096)

GTPase activity (GO:0003924)

integral to membrane (GO:0016021)
mitochondrial inner membrane
(GO:0005743)

zinc ion binding (GO:0008270)
dihydrolipoyllysine-residue acetyltransferase
activity (GO:0004742)

nucleus (GO:0005634)
mitochondrial pyruvate dehydrogenase
complex (GO:0005967)

ATP binding (GO:0005524)

actin cytoskeleton (GO:0015629)
integrin complex (GO:0008305)

241226

Itga8

integrin alpha 8

positive regulation of transforming growth factor beta
receptor signaling pathway (GO:0030511)

242050

Igsf10

immunoglobulin superfamily, member 10

protein amino acid phosphorylation (GO:0006468)

calcium ion binding (GO:0005509)
vascular endothelial growth factor receptor activity
(GO:0005021)

268301

Ankrd57

268977

Ltbp1

ankyrin repeat domain 57
latent transforming growth factor beta binding
protein 1

transforming growth factor beta receptor signaling
pathway (GO:0007179)

calcium ion binding (GO:0005509)

proteinaceous extracellular matrix
(GO:0005578)

276770

Eif5a

eukaryotic translation initiation factor 5A

translational initiation (GO:0006413)

translation initiation factor activity (GO:0003743)

nucleus (GO:0005634)

extracellular region (GO:0005576)
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Hist1h2ah

histone cluster 1, H2ah

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

319178

Hist1h2bb

histone cluster 1, H2bb

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

319195

Rpl17

ribosomal protein L17

translation (GO:0006412)

6530401N04Rik

RIKEN cDNA 6530401N04 gene

D-amino acid catabolic process (GO:0019478)

structural constituent of ribosome (GO:0003735)
hydrolase activity, acting on ester bonds
(GO:0016788)

large ribosomal subunit (GO:0015934)

328092
338350

9330129D05Rik

RIKEN cDNA 9330129D05 gene

oxidation reduction (GO:0055114)

acyl-CoA dehydrogenase activity (GO:0003995)

extracellular space (GO:0005615)

384009

Glipr2

GLI pathogenesis-related 2

404634

H2afy2

H2A histone family, member Y2

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

cytoplasm (GO:0005737)

Golgi apparatus (GO:0005794)
Barr body (GO:0001740)

206
Results acquired from proteomic analysis of acellular HFF
Proteins

Gene
Symbol

37

ACADVL

Description
acyl-Coenzyme A dehydrogenase, very long
chain

59

ACTA2

actin, alpha 2, smooth muscle, aorta

60

ACTB

197

AHSG

231

AKR1B1

290

ANPEP

Biological Process_max
fatty acid beta-oxidation (GO:0006635)

Molecular Function_max
long-chain-acyl-CoA dehydrogenase activity
(GO:0004466)

Cellular Component_max
mitochondrial inner membrane
(GO:0005743)

ATP binding (GO:0005524)

actin, beta

sensory perception of sound (GO:0007605)

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)
NuA4 histone acetyltransferase complex
(GO:0035267)

negative regulation of bone mineralization (GO:0030502)

cysteine protease inhibitor activity (GO:0004869)

extracellular space (GO:0005615)

carbohydrate metabolic process (GO:0005975)

aldehyde reductase activity (GO:0004032)

cytosol (GO:0005829)

proteolysis (GO:0006508)

integral to plasma membrane
(GO:0005887)
mitochondrial inner membrane
(GO:0005743)

292

SLC25A5

alpha-2-HS-glycoprotein
aldo-keto reductase family 1, member B1 (aldose
reductase)
alanyl (membrane) aminopeptidase
(aminopeptidase N, aminopeptidase M,
microsomal aminopeptidase, CD13, p150)
solute carrier family 25 (mitochondrial carrier;
adenine nucleotide translocator), member 5

transport (GO:0006810)

aminopeptidase activity (GO:0004177)
adenine transmembrane transporter activity
(GO:0015207)

301

ANXA1

annexin A1

anti-apoptosis (GO:0006916)

phospholipase A2 inhibitor activity (GO:0019834)

cornified envelope (GO:0001533)

302

ANXA2

annexin A2

skeletal development (GO:0001501)

phospholipase inhibitor activity (GO:0004859)

melanosome (GO:0042470)

304

ANXA2P2

annexin A2 pseudogene 2

307

ANXA4

annexin A4

anti-apoptosis (GO:0006916)

phospholipase inhibitor activity (GO:0004859)

cytoplasm (GO:0005737)

308

ANXA5

annexin A5

anti-apoptosis (GO:0006916)

phospholipase inhibitor activity (GO:0004859)

cytoplasm (GO:0005737)

309

ANXA6

annexin A6

calcium ion binding (GO:0005509)

melanosome (GO:0042470)

310

ANXA7

annexin A7

voltage-gated calcium channel activity (GO:0005245)

311

ANXA11

476

ATP1A1

annexin A11
ATPase, Na+/K+ transporting, alpha 1
polypeptide
ATPase, Na+/K+ transporting, alpha 2 (+)
polypeptide

477

ATP1A2

483

ATP1B3

487

ATP2A1

488

ATP2A2

493

ATP2B4

498

ATP5A1

506

ATP5B

509

ATP5C1

513

ATP5D

521

ATP5I

522

ATP5J

539

ATP5O

immune response (GO:0006955)

ATP synthesis coupled proton transport (GO:0015986)

calcium ion binding (GO:0005509)
sodium:potassium-exchanging ATPase activity
(GO:0005391)
sodium:potassium-exchanging ATPase activity
(GO:0005391)
sodium:potassium-exchanging ATPase activity
(GO:0005391)
calcium-transporting ATPase activity
(GO:0005388)
calcium-transporting ATPase activity
(GO:0005388)
calcium-transporting ATPase activity
(GO:0005388)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)
hydrogen-exporting ATPase activity,
phosphorylative mechanism (GO:0008553)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)

mitochondrial ATP synthesis coupled proton transport
(GO:0042776)

hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)

regulation of cellular pH (GO:0030641)
regulation of cellular pH (GO:0030641)

ATPase, Na+/K+ transporting, beta 3 polypeptide
ATPase, Ca++ transporting, cardiac muscle, fast
twitch 1
ATPase, Ca++ transporting, cardiac muscle, slow
twitch 2

potassium ion transport (GO:0006813)
positive regulation of fast-twitch skeletal muscle fiber
contraction (GO:0031448)

ATPase, Ca++ transporting, plasma membrane 4
ATP synthase, H+ transporting, mitochondrial F1
complex, alpha subunit 1, cardiac muscle
ATP synthase, H+ transporting, mitochondrial F1
complex, beta polypeptide
ATP synthase, H+ transporting, mitochondrial F1
complex, gamma polypeptide 1
ATP synthase, H+ transporting, mitochondrial F1
complex, delta subunit
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit E
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit F6
ATP synthase, H+ transporting, mitochondrial F1
complex, O subunit (oligomycin sensitivity
conferring protein)

calcium ion transport (GO:0006816)

calcium ion transport (GO:0006816)

ATP synthesis coupled proton transport (GO:0015986)
ATP synthesis coupled proton transport (GO:0015986)
ATP synthesis coupled proton transport (GO:0015986)
mitochondrial ATP synthesis coupled proton transport
(GO:0042776)
ATP synthesis coupled proton transport (GO:0015986)

melanosome (GO:0042470)
melanosome (GO:0042470)
integral to membrane (GO:0016021)
melanosome (GO:0042470)
sarcoplasmic reticulum membrane
(GO:0033017)
microsome (GO:0005792)
integral to plasma membrane
(GO:0005887)
mitochondrial matrix (GO:0005759)
mitochondrial matrix (GO:0005759)
mitochondrial matrix (GO:0005759)
mitochondrial matrix (GO:0005759)
mitochondrion (GO:0005739)
mitochondrion (GO:0005739)

mitochondrial matrix (GO:0005759)
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ATP7B

ATPase, Cu++ transporting, beta polypeptide

567

B2M

beta-2-microglobulin

682

BSG

basigin (Ok blood group)

cellular copper ion homeostasis (GO:0006878)
antigen processing and presentation of peptide antigen
via MHC class I (GO:0002474)
cell surface receptor linked signal transduction
(GO:0007166)

811

CALR

calreticulin

cellular calcium ion homeostasis (GO:0006874)

813

CALU

calumenin

821

CANX

calnexin

836

CASP3

857

CAV1

871

SERPINH1

copper-exporting ATPase activity (GO:0004008)
protein binding (GO:0005515)

late endosome (GO:0005770)
early endosome membrane
(GO:0031901)

mannose binding (GO:0005537)

melanosome (GO:0042470)

zinc ion binding (GO:0008270)

endoplasmic reticulum (GO:0005783)

calcium ion binding (GO:0005509)

melanosome (GO:0042470)

protein folding (GO:0006457)

calcium ion binding (GO:0005509)

melanosome (GO:0042470)

caspase 3, apoptosis-related cysteine peptidase

induction of apoptosis (GO:0006917)

cysteine-type peptidase activity (GO:0008234)

caveolin 1, caveolae protein, 22kDa
serpin peptidase inhibitor, clade H (heat shock
protein 47), member 1, (collagen binding protein
1)

cholesterol homeostasis (GO:0042632)

cholesterol binding (GO:0015485)

nucleoplasm (GO:0005654)
integral to plasma membrane
(GO:0005887)

serine-type endopeptidase inhibitor activity
(GO:0004867)

endoplasmic reticulum (GO:0005783)

response to unfolded protein (GO:0006986)
cell surface receptor linked signal transduction
(GO:0007166)

919

CD247

CD247 molecule

960

CD44

CD44 molecule (Indian blood group)

966

CD59

CD59 molecule, complement regulatory protein

975

CD81

CD81 molecule

phosphatidylinositol biosynthetic process (GO:0006661)

protein binding (GO:0005515)

anchored to membrane (GO:0031225)
integral to plasma membrane
(GO:0005887)

989

SEPT7

septin 7

protein heterooligomerization (GO:0051291)
positive regulation of survival gene product expression
(GO:0045885)

GTP binding (GO:0005525)

stress fiber (GO:0001725)

calcium ion binding (GO:0005509)

caveola (GO:0005901)

anti-apoptosis (GO:0006916)

actin binding (GO:0003779)

transport (GO:0006810)

ATPase activity (GO:0016887)

respiratory gaseous exchange (GO:0007585)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)
integral to plasma membrane
(GO:0005887)
mitochondrial inner membrane
(GO:0005743)

cytochrome-c oxidase activity (GO:0004129)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)

1012

CDH13

cadherin 13, H-cadherin (heart)

1072

CFL1

1244

ABCC2

cofilin 1 (non-muscle)
ATP-binding cassette, sub-family C (CFTR/MRP),
member 2

1329

COX5B

1340

COX6B1

cytochrome c oxidase subunit Vb
cytochrome c oxidase subunit Vib polypeptide 1
(ubiquitous)

1345

COX6C

cytochrome c oxidase subunit VIc

cell-matrix adhesion (GO:0007160)
cell surface receptor linked signal transduction
(GO:0007166)

transmembrane receptor activity (GO:0004888)
hyaluronic acid binding (GO:0005540)
protein binding (GO:0005515)

cytochrome-c oxidase activity (GO:0004129)

integral to membrane (GO:0016021)
integral to plasma membrane
(GO:0005887)

1603

DAD1

defender against cell death 1

oxidation reduction (GO:0055114)
generation of precursor metabolites and energy
(GO:0006091)
protein amino acid N-linked glycosylation via asparagine
(GO:0018279)

mitochondrion (GO:0005739)
mitochondrial inner membrane
(GO:0005743)

1727

CYB5R3

cytochrome b5 reductase 3

iron ion transport (GO:0006826)

cytochrome-b5 reductase activity (GO:0004128)

1738

DLD

tricarboxylic acid cycle (GO:0006099)

FAD binding (GO:0050660)
dihydrolipoyllysine-residue succinyltransferase
activity (GO:0004149)

mitochondrial matrix (GO:0005759)

DLST

dihydrolipoamide dehydrogenase
dihydrolipoamide S-succinyltransferase (E2
component of 2-oxo-glutarate complex)

cell redox homeostasis (GO:0045454)

1743
1917

EEF1A2

translational elongation (GO:0006414)

GTPase activity (GO:0003924)

2197

FAU

eukaryotic translation elongation factor 1 alpha 2
Finkel-Biskis-Reilly murine sarcoma virus (FBRMuSV) ubiquitously expressed

RNA binding (GO:0003723)

2335

FN1

fibronectin 1

translational elongation (GO:0006414)
transmembrane receptor protein tyrosine kinase
signaling pathway (GO:0007169)

2597

GAPDH

glyceraldehyde-3-phosphate dehydrogenase

glycolysis (GO:0006096)

heparin binding (GO:0008201)
glyceraldehyde-3-phosphate dehydrogenase
(phosphorylating) activity (GO:0004365)

nucleus (GO:0005634)
cytosolic small ribosomal subunit
(GO:0022627)
ER-Golgi intermediate compartment
(GO:0005793)

2923

PDIA3

protein disulfide isomerase family A, member 3

protein import into nucleus (GO:0006606)

phospholipase C activity (GO:0004629)

3005

H1F0

H1 histone family, member 0

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

3006

HIST1H1C

histone cluster 1, H1c

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

integral to membrane (GO:0016021)
mitochondrial outer membrane
(GO:0005741)

mitochondrial matrix (GO:0005759)

cytoplasm (GO:0005737)
melanosome (GO:0042470)
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HIST1H1B

3032

HADHB

histone cluster 1, H1b
hydroxyacyl-Coenzyme A dehydrogenase/3ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A
hydratase (trifunctional protein), beta subunit

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

fatty acid beta-oxidation (GO:0006635)

acetyl-CoA C-acyltransferase activity
(GO:0003988)

mitochondrial matrix (GO:0005759)

3039

HBA1

hemoglobin, alpha 1

oxygen transport (GO:0015671)

iron ion binding (GO:0005506)

hemoglobin complex (GO:0005833)

3046

HBE1

hemoglobin, epsilon 1

iron ion binding (GO:0005506)

3105

HLA-A

hemoglobin complex (GO:0005833)
integral to plasma membrane
(GO:0005887)

3119

HLA-DQB1

oxygen transport (GO:0015671)
antigen processing and presentation of peptide antigen
via MHC class I (GO:0002474)
antigen processing and presentation of peptide or
polysaccharide antigen via MHC class II (GO:0002504)
antigen processing and presentation of peptide antigen
via MHC class I (GO:0002474)
nucleosome disassembly (GO:0006337)

3136

HLA-H

major histocompatibility complex, class I, A
major histocompatibility complex, class II, DQ
beta 1
major histocompatibility complex, class I, H
(pseudogene)

3159

HMGA1

high mobility group AT-hook 1

3309

HSPA5

heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)

ATP binding (GO:0005524)

endoplasmic reticulum (GO:0005783)

3329

HSPD1

heat shock 60kDa protein 1 (chaperonin)

protein import into mitochondrial matrix (GO:0030150)

ATP binding (GO:0005524)

mitochondrial matrix (GO:0005759)

3336

HSPE1

caspase activation (GO:0006919)

ATP binding (GO:0005524)

mitochondrial matrix (GO:0005759)

3673

ITGA2

integrin-mediated signaling pathway (GO:0007229)

magnesium ion binding (GO:0000287)

integrin complex (GO:0008305)

3688

ITGB1

heat shock 10kDa protein 1 (chaperonin 10)
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA2 receptor)
integrin, beta 1 (fibronectin receptor, beta
polypeptide, antigen CD29 includes MDF2,
MSK12)

integrin-mediated signaling pathway (GO:0007229)

protein heterodimerization activity (GO:0046982)

melanosome (GO:0042470)

3833

KIFC1

kinesin family member C1

microtubule-based movement (GO:0007018)

ATP binding (GO:0005524)

early endosome (GO:0005769)

3848

KRT1

receptor activity (GO:0004872)
structural constituent of cytoskeleton
(GO:0005200)

cytoskeleton (GO:0005856)

KRT2

keratin 1 (epidermolytic hyperkeratosis)
keratin 2 (epidermal ichthyosis bullosa of
Siemens)

fibrinolysis (GO:0042730)

3849
3855

KRT7

3857

KRT9

3858

KRT10

4000

LMNA

keratin 7
keratin 9 (epidermolytic palmoplantar
keratoderma)
keratin 10 (epidermolytic hyperkeratosis;
keratosis palmaris et plantaris)

epidermis development (GO:0008544)
DNA replication (GO:0006260)

MHC class I receptor activity (GO:0032393)
GTP binding (GO:0005525)
MHC class I receptor activity (GO:0032393)
ligand-dependent nuclear receptor transcription
coactivator activity (GO:0030374)

integral to membrane (GO:0016021)
integral to plasma membrane
(GO:0005887)
chromatin (GO:0000785)

intermediate filament (GO:0005882)

intermediate filament organization (GO:0045109)

protein binding (GO:0005515)
structural constituent of cytoskeleton
(GO:0005200)

intermediate filament (GO:0005882)

intermediate filament (GO:0005882)

epidermis development (GO:0008544)

protein binding (GO:0005515)

intermediate filament (GO:0005882)

G-protein signaling, coupled to cyclic nucleotide second
messenger (GO:0007187)

protein binding (GO:0005515)
adrenocorticotropin receptor activity
(GO:0004978)

nucleus (GO:0005634)
integral to plasma membrane
(GO:0005887)

L-malate dehydrogenase activity (GO:0030060)

mitochondrial matrix (GO:0005759)
proteinaceous extracellular matrix
(GO:0005578)
mitochondrial outer membrane
(GO:0005741)
integral to plasma membrane
(GO:0005887)

4158

MC2R

lamin A/C
melanocortin 2 receptor (adrenocorticotropic
hormone)

4191

MDH2

malate dehydrogenase 2, NAD (mitochondrial)

glycolysis (GO:0006096)

4256

MGP

matrix Gla protein

regulation of bone mineralization (GO:0030500)

4257

MGST1

microsomal glutathione S-transferase 1

4267

CD99

CD99 molecule

4513

COX2

4637

MYL6

4697

NDUFA4

4710

NDUFB4

4722

NDUFS3

cytochrome c oxidase II
myosin, light chain 6, alkali, smooth muscle and
non-muscle
NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 4, 9kDa
NADH dehydrogenase (ubiquinone) 1 beta
subcomplex, 4, 15kDa
NADH dehydrogenase (ubiquinone) Fe-S protein
3, 30kDa (NADH-coenzyme Q reductase)

calcium ion binding (GO:0005509)
glutathione transferase activity (GO:0004364)

cell adhesion (GO:0007155)
mitochondrial electron transport, cytochrome c to oxygen
(GO:0006123)
muscle filament sliding (GO:0030049)
mitochondrial electron transport, NADH to ubiquinone
(GO:0006120)
mitochondrial electron transport, NADH to ubiquinone
(GO:0006120)
induction of apoptosis (GO:0006917)

protein binding (GO:0005515)
copper ion binding (GO:0005507)
actin-dependent ATPase activity (GO:0030898)
NADH dehydrogenase (ubiquinone) activity
(GO:0008137)
NADH dehydrogenase (ubiquinone) activity
(GO:0008137)
NADH dehydrogenase (ubiquinone) activity
(GO:0008137)

mitochondrion (GO:0005739)
unconventional myosin complex
(GO:0016461)
mitochondrion (GO:0005739)
mitochondrion (GO:0005739)
mitochondrion (GO:0005739)

209
4907

NT5E

5033

P4HA1

5034

P4HB

5'-nucleotidase, ecto (CD73)
procollagen-proline, 2-oxoglutarate 4dioxygenase (proline 4-hydroxylase), alpha
polypeptide I
procollagen-proline, 2-oxoglutarate 4dioxygenase (proline 4-hydroxylase), beta
polypeptide
phosphodiesterase 4D, cAMP-specific
(phosphodiesterase E3 dunce homolog,
Drosophila)

nucleotide catabolic process (GO:0009166)

5'-nucleotidase activity (GO:0008253)

anchored to membrane (GO:0031225)

protein metabolic process (GO:0019538)

procollagen-proline 4-dioxygenase activity
(GO:0004656)

endoplasmic reticulum (GO:0005783)

peptidyl-proline hydroxylation to 4-hydroxy-L-proline
(GO:0018401)

procollagen-proline 4-dioxygenase activity
(GO:0004656)

melanosome (GO:0042470)

signal transduction (GO:0007165)

3',5'-cyclic-AMP phosphodiesterase activity
(GO:0004115)

histone deacetylation (GO:0016575)
generation of precursor metabolites and energy
(GO:0006091)
cytokine and chemokine mediated signaling pathway
(GO:0019221)

phosphate carrier activity (GO:0015320)
ion transmembrane transporter activity
(GO:0015075)

endoplasmic reticulum (GO:0005783)

5144

PDE4D

5245

PHB

5250

SLC25A3

prohibitin
solute carrier family 25 (mitochondrial carrier;
phosphate carrier), member 3

5355

PLP2

proteolipid protein 2 (colonic epithelium-enriched)

5375

PMP2

transport (GO:0006810)

lipid binding (GO:0008289)

cytoplasm (GO:0005737)

mismatch repair (GO:0006298)
protein folding (GO:0006457)

ATP binding (GO:0005524)
peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)

melanosome (GO:0042470)

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

5378

PMS1

peripheral myelin protein 2
PMS1 postmeiotic segregation increased 1 (S.
cerevisiae)

5479

PPIB

peptidylprolyl isomerase B (cyclophilin B)

5630

PRPH

peripherin
prostaglandin-endoperoxide synthase 1
(prostaglandin G/H synthase and
cyclooxygenase)

5742

PTGS1

5862

RAB2A

5879

RAC1

RAB2A, member RAS oncogene family
ras-related C3 botulinum toxin substrate 1 (rho
family, small GTP binding protein Rac1)

5908

RAP1B

RAP1B, member of RAS oncogene family

protein binding (GO:0005515)

centrosome (GO:0005813)
mitochondrial inner membrane
(GO:0005743)
mitochondrial inner membrane
(GO:0005743)

nucleus (GO:0005634)

prostaglandin biosynthetic process (GO:0001516)

iron ion binding (GO:0005506)

microsome (GO:0005792)

ER to Golgi vesicle-mediated transport (GO:0006888)

GTPase activity (GO:0003924)

melanosome (GO:0042470)

GTPase activity (GO:0003924)

melanosome (GO:0042470)

GTP binding (GO:0005525)

cytoplasm (GO:0005737)

protein binding (GO:0005515)

nucleus (GO:0005634)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
mitochondrial large ribosomal subunit
(GO:0005762)

5932

RBBP8

retinoblastoma binding protein 8

actin filament polymerization (GO:0030041)
small GTPase mediated signal transduction
(GO:0007264)
regulation of transcription from RNA polymerase II
promoter (GO:0006357)

6129

RPL7

ribosomal protein L7

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6141

RPL18

ribosomal protein L18

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6175

RPLP0

ribosomal protein, large, P0

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6181

RPLP2

ribosomal protein, large, P2

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6182

MRPL12

mitochondrial ribosomal protein L12

6184

RPN1

ribophorin I

RNA binding (GO:0003723)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)

6185

RPN2

ribophorin II

transcription from mitochondrial promoter (GO:0006390)
protein amino acid N-linked glycosylation via asparagine
(GO:0018279)
protein amino acid N-linked glycosylation via asparagine
(GO:0018279)

6201

RPS7

ribosomal protein S7

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6227

RPS21

ribosomal protein S21

translational elongation (GO:0006414)

RNA binding (GO:0003723)

endoplasmic reticulum (GO:0005783)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)

6233

RPS27A

ribosomal protein S27a

protein modification process (GO:0006464)

zinc ion binding (GO:0008270)
ryanodine-sensitive calcium-release channel
activity (GO:0005219)

ribosome (GO:0005840)
integral to plasma membrane
(GO:0005887)

6263

RYR3

ryanodine receptor 3

cellular calcium ion homeostasis (GO:0006874)

6275

S100A4

S100 calcium binding protein A4

epithelial to mesenchymal transition (GO:0001837)

calcium ion binding (GO:0005509)

6281

S100A10

S100 calcium binding protein A10

signal transduction (GO:0007165)

calcium ion binding (GO:0005509)

melanosome (GO:0042470)

210
6282

S100A11

S100 calcium binding protein A11

negative regulation of DNA replication (GO:0008156)

6342

SCP2

steroid biosynthetic process (GO:0006694)

6554

SLC10A1

sterol carrier protein 2
solute carrier family 10 (sodium/bile acid
cotransporter family), member 1

calcium ion binding (GO:0005509)
propanoyl-CoA C-acyltransferase activity
(GO:0033814)

sodium ion transport (GO:0006814)

bile acid:sodium symporter activity (GO:0008508)

peroxisome (GO:0005777)
integral to plasma membrane
(GO:0005887)

6648

SOD2

response to superoxide (GO:0000303)
cotranslational protein targeting to membrane
(GO:0006613)

mitochondrial matrix (GO:0005759)

SSR1

superoxide dismutase 2, mitochondrial
signal sequence receptor, alpha (transloconassociated protein alpha)
signal sequence receptor, delta (transloconassociated protein delta)

manganese ion binding (GO:0030145)

6745

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

intracellular protein transport (GO:0006886)

calcium ion binding (GO:0005509)

retinal cone cell development (GO:0046549)

Rho GTPase activator activity (GO:0005100)

endoplasmic reticulum (GO:0005783)
integral to plasma membrane
(GO:0005887)

6748

SSR4

7070

THY1

nucleus (GO:0005634)

7184

HSP90B1

Thy-1 cell surface antigen
heat shock protein 90kDa beta (Grp94), member
1

anti-apoptosis (GO:0006916)

ATP binding (GO:0005524)

melanosome (GO:0042470)

7385

UQCRC2

ubiquinol-cytochrome c reductase core protein II

proteolysis (GO:0006508)

7416

VDAC1

voltage-dependent anion channel 1

apoptotic program (GO:0008632)

7417

VDAC2

voltage-dependent anion channel 2

anion transport (GO:0006820)

mitochondrion (GO:0005739)
mitochondrial outer membrane
(GO:0005741)
mitochondrial outer membrane
(GO:0005741)

7431

VIM

vimentin

7855

FZD5

frizzled homolog 5 (Drosophila)

cell motility (GO:0006928)
G-protein coupled receptor protein signaling pathway
(GO:0007186)

metalloendopeptidase activity (GO:0004222)
voltage-gated anion channel activity
(GO:0008308)
voltage-gated anion channel activity
(GO:0008308)
structural constituent of cytoskeleton
(GO:0005200)
non-G-protein coupled 7TM receptor activity
(GO:0004926)

7857

SCG2

secretogranin II (chromogranin C)

induction of positive chemotaxis (GO:0050930)

cytokine activity (GO:0005125)

extracellular space (GO:0005615)

7879

RAB7A

RAB7A, member RAS oncogene family

endocytosis (GO:0006897)

GTPase activity (GO:0003924)

lysosome (GO:0005764)

8340

HIST1H2BL

histone cluster 1, H2bl

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

cytoskeleton (GO:0005856)
integral to plasma membrane
(GO:0005887)

8349

HIST2H2BE

histone cluster 2, H2be

nucleosome assembly (GO:0006334)

8803

SUCLA2

succinate-CoA ligase, ADP-forming, beta subunit

tricarboxylic acid cycle (GO:0006099)

DNA binding (GO:0003677)
succinate-CoA ligase (ADP-forming) activity
(GO:0004775)

mitochondrion (GO:0005739)

8904

CPNE1

9113

LATS1

copine I
LATS, large tumor suppressor, homolog 1
(Drosophila)

lipid metabolic process (GO:0006629)
negative regulation of cyclin-dependent protein kinase
activity (GO:0045736)

phosphatidylserine binding (GO:0001786)
protein serine/threonine kinase activity
(GO:0004674)

centrosome (GO:0005813)

9119

KRT75

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

FAD binding (GO:0050660)

nucleus (GO:0005634)

iron ion binding (GO:0005506)

integral to membrane (GO:0016021)
mitochondrial inner membrane
(GO:0005743)

9131

AIFM1

9341

VAMP3

9377

COX5A

keratin 75
apoptosis-inducing factor, mitochondrionassociated, 1
vesicle-associated membrane protein 3
(cellubrevin)

DNA damage response, signal transduction resulting in
induction of apoptosis (GO:0008630)
protein complex assembly (GO:0006461)

nucleus (GO:0005634)

9554

SEC22B

cytochrome c oxidase subunit Va
SEC22 vesicle trafficking protein homolog B (S.
cerevisiae)

ER to Golgi vesicle-mediated transport (GO:0006888)

protein binding (GO:0005515)

melanosome (GO:0042470)

9555

H2AFY

H2A histone family, member Y

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

Barr body (GO:0001740)

9902

MRC2

mannose receptor, C type 2

endocytosis (GO:0006897)

calcium ion binding (GO:0005509)

integral to membrane (GO:0016021)

protein folding (GO:0006457)

protein disulfide isomerase activity (GO:0003756)

melanosome (GO:0042470)

protein binding (GO:0005515)

melanosome (GO:0042470)

calcium ion binding (GO:0005509)

muscle myosin complex (GO:0005859)

10130

PDIA6

protein disulfide isomerase family A, member 6

10211

FLOT1

flotillin 1

10398

MYL9

myosin, light chain 9, regulatory

10409

BASP1

brain abundant, membrane attached signal protein 1

regulation of muscle contraction (GO:0006937)

cytoskeleton (GO:0005856)

211
10791

VAMP5

ATP synthase, H+ transporting, mitochondrial F0
complex, subunit G
vesicle-associated membrane protein 5
(myobrevin)

10857

PGRMC1

progesterone receptor membrane component 1

10874

NMU

neuromedin U

10960

LMAN2

lectin, mannose-binding 2

10970

CKAP4

cytoskeleton-associated protein 4

11161

C14orf1

chromosome 14 open reading frame 1

11331

PHB2

prohibitin 2

10632

ATP5L

ATP synthesis coupled proton transport (GO:0015986)

hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)

skeletal muscle development (GO:0007519)

mitochondrion (GO:0005739)
Golgi apparatus (GO:0005794)

transition metal ion binding (GO:0046914)

microsome (GO:0005792)

neuropeptide signaling pathway (GO:0007218)

receptor binding (GO:0005102)

extracellular region (GO:0005576)

protein transport (GO:0015031)

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)
integral to membrane (GO:0016021)

sterol biosynthetic process (GO:0016126)
regulation of transcription, DNA-dependent
(GO:0006355)

transport vesicle (GO:0030133)
mitochondrial inner membrane
(GO:0005743)

23049

SMG1

PI-3-kinase-related kinase SMG-1

phosphoinositide phosphorylation (GO:0046854)

estrogen receptor binding (GO:0030331)
protein serine/threonine kinase activity
(GO:0004674)

26135

SERBP1

SERPINE1 mRNA binding protein 1

regulation of mRNA stability (GO:0043488)

mRNA 3'-UTR binding (GO:0003730)

28958

CCDC56

coiled-coil domain containing 56

integral to membrane (GO:0016021)

29058

C20orf30

chromosome 20 open reading frame 30

integral to membrane (GO:0016021)

29123

ANKRD11

ankyrin repeat domain 11

29964

PRICKLE4

prickle homolog 4 (Drosophila)

51449

PCYOX1

prenylcysteine oxidase 1

prenylated protein catabolic process (GO:0030327)

prenylcysteine oxidase activity (GO:0001735)

51603

KIAA0859

metabolic process (GO:0008152)

methyltransferase activity (GO:0008168)

54732

TMED9

KIAA0859
transmembrane emp24 protein transport domain
containing 9

55035

NOL8

nucleolar protein 8

DNA replication (GO:0006260)

55379

LRRC59

leucine rich repeat containing 59

55697

VAC14

Vac14 homolog (S. cerevisiae)

55780

C6orf70

55970

GNG12

chromosome 6 open reading frame 70
guanine nucleotide binding protein (G protein),
gamma 12

56926

NCLN

nicalin homolog (zebrafish)

protein processing (GO:0016485)

57142

RTN4

reticulon 4

57486

NLN

neurolysin (metallopeptidase M3 family)

57620

STIM2

stromal interaction molecule 2

57653

KIAA1529

KIAA1529

58472

SQRDL

sulfide quinone reductase-like (yeast)

58505

DC2

DC2 protein

58528

RRAGD

Ras-related GTP binding D

GTP binding (GO:0005525)

nucleus (GO:0005634)

59338

PLEKHA1

nucleus (GO:0005634)

SPCS3

pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
signal peptidase complex subunit 3 homolog (S.
cerevisiae)
signal peptide processing (GO:0006465)

phospholipid binding (GO:0005543)

60559

nucleus (GO:0005634)
nucleus (GO:0005634)

nucleus (GO:0005634)
zinc ion binding (GO:0008270)

transport (GO:0006810)

lysosome (GO:0005764)

endoplasmic reticulum (GO:0005783)
RNA binding (GO:0003723)

nucleus (GO:0005634)

protein binding (GO:0005515)

microsome (GO:0005792)

signal transduction (GO:0007165)

receptor activity (GO:0004872)

cellular_component (GO:0005575)

G-protein coupled receptor protein signaling pathway
(GO:0007186)

signal transducer activity (GO:0004871)

integral to membrane (GO:0016021)
heterotrimeric G-protein complex
(GO:0005834)

negative regulation of axon extension (GO:0030517)

protein binding (GO:0005515)

endoplasmic reticulum (GO:0005783)
integral to endoplasmic reticulum
membrane (GO:0030176)

proteolysis (GO:0006508)
negative regulation of calcium ion transport via storeoperated calcium channel (GO:0032235)

metalloendopeptidase activity (GO:0004222)
calcium ion binding (GO:0005509)

mitochondrion (GO:0005739)
integral to endoplasmic reticulum
membrane (GO:0030176)
integral to membrane (GO:0016021)

oxidoreductase activity (GO:0016491)

mitochondrion (GO:0005739)
integral to membrane (GO:0016021)

microsome (GO:0005792)

212
79026

AHNAK

AHNAK nucleoprotein

79759

ZNF668

zinc finger protein 668

81855

SFXN3

sideroflexin 3

84669

USP32

ubiquitin specific peptidase 32

84709

OSAP

ovary-specific acidic protein

85235

HIST1H2AH

histone cluster 1, H2ah

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

90990

kinesin family member C2

microtubule-based movement (GO:0007018)

ATP binding (GO:0005524)

microtubule (GO:0005874)

91368

KIFC2
CDKN2AIP
NL

CDKN2A interacting protein N-terminal like

91662

NLRP12

NLR family, pyrin domain containing 12

release of cytoplasmic sequestered NF-kappaB
(GO:0008588)

ATP binding (GO:0005524)

cytoplasm (GO:0005737)

94081

SFXN1

sideroflexin 1

iron ion transport (GO:0006826)

iron ion binding (GO:0005506)

mitochondrion (GO:0005739)

94239

H2AFV

H2A histone family, member V

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

112752

C14orf179

chromosome 14 open reading frame 179

112802

KRT71

keratin 71

116496

FAM129A

family with sequence similarity 129, member A

121457

IKIP

126328

NDUFA11

IKK interacting protein
NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 11, 14.7kDa

139322

APOOL

140465

MYL6B

apolipoprotein O-like
myosin, light chain 6B, alkali, smooth muscle and
non-muscle

nervous system development (GO:0007399)
regulation of transcription, DNA-dependent
(GO:0006355)

protein binding (GO:0005515)

nucleus (GO:0005634)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)

iron ion transport (GO:0006826)
ubiquitin-dependent protein catabolic process
(GO:0006511)

iron ion binding (GO:0005506)

mitochondrion (GO:0005739)

ubiquitin thiolesterase activity (GO:0004221)

membrane (GO:0016020)
integral to membrane (GO:0016021)

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)
cellular_component (GO:0005575)

induction of apoptosis (GO:0006917)

protein binding (GO:0005515)

transport (GO:0006810)

endoplasmic reticulum (GO:0005783)
mitochondrion (GO:0005739)
extracellular region (GO:0005576)

162962

ZNF836

zinc finger protein 836

muscle filament sliding (GO:0030049)
regulation of transcription, DNA-dependent
(GO:0006355)

calcium ion binding (GO:0005509)

muscle myosin complex (GO:0005859)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)

221613

HIST1H2AA

histone cluster 1, H2aa

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

254528

C16orf73

chromosome 16 open reading frame 73

255626

HIST1H2BA

histone cluster 1, H2ba

DNA binding (GO:0003677)

nucleus (GO:0005634)

284119

PTRF

polymerase I and transcript release factor

nucleosome assembly (GO:0006334)
transcription initiation from RNA polymerase I promoter
(GO:0006361)

rRNA primary transcript binding (GO:0042134)

microsome (GO:0005792)

345651

ACTBL2

actin, beta-like 2

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)

376940

ZC3H6

zinc finger CCCH-type containing 6

zinc ion binding (GO:0008270)

606495

LOC606495

hypothetical protein LOC606495

47

ACLY

ATP citrate lyase

ATP catabolic process (GO:0006200)

cytochrome-b5 reductase activity (GO:0004128)
succinate-CoA ligase (ADP-forming) activity
(GO:0004775)

cytosol (GO:0005829)

71

ACTG1

actin, gamma 1

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)

81

ACTN4

actinin, alpha 4

sensory perception of sound (GO:0007605)
positive regulation of sodium:hydrogen antiporter activity
(GO:0032417)

actin filament binding (GO:0051015)

nucleus (GO:0005634)

87

ACTN1

actinin, alpha 1

regulation of apoptosis (GO:0042981)

actin binding (GO:0003779)

focal adhesion (GO:0005925)

88

ACTN2

actinin, alpha 2

microspike biogenesis (GO:0030035)

focal adhesion (GO:0005925)

143

PARP4

poly (ADP-ribose) polymerase family, member 4

protein amino acid ADP-ribosylation (GO:0006471)

FATZ 1 binding (GO:0051374)
NAD+ ADP-ribosyltransferase activity
(GO:0003950)

nucleus (GO:0005634)

213
214

integral to plasma membrane
(GO:0005887)

ALCAM

activated leukocyte cell adhesion molecule

signal transduction (GO:0007165)

receptor binding (GO:0005102)

226

ALDOA

aldolase A, fructose-bisphosphate

glycolysis (GO:0006096)

396

ARHGDIA

anti-apoptosis (GO:0006916)

515

ATP5F1

538

ATP7A

Rho GDP dissociation inhibitor (GDI) alpha
ATP synthase, H+ transporting, mitochondrial F0
complex, subunit B1
ATPase, Cu++ transporting, alpha polypeptide
(Menkes syndrome)

T-helper cell differentiation (GO:0042093)

fructose-bisphosphate aldolase activity (GO:0004332)
Rho GDP-dissociation inhibitor activity
(GO:0005094)
cytoskeleton (GO:0005856)
hydrogen ion transporting ATP synthase activity,
rotational mechanism (GO:0046933)
mitochondrial matrix (GO:0005759)
trans-Golgi network transport vesicle
copper-exporting ATPase activity (GO:0004008)
(GO:0030140)

muscle contraction (GO:0006936)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

caldesmon 1
capping protein (actin filament) muscle Z-line,
beta

ATP synthesis coupled proton transport (GO:0015986)

800

CALD1

832

CAPZB

928

CD9

CD9 molecule

fusion of sperm to egg plasma membrane (GO:0007342)

protein binding (GO:0005515)

cytoplasm (GO:0005737)
platelet alpha granule membrane
(GO:0031092)

950

SCARB2

scavenger receptor class B, member 2

cell adhesion (GO:0007155)

receptor activity (GO:0004872)

lysosomal membrane (GO:0005765)

1147

CHUK

conserved helix-loop-helix ubiquitous kinase

IkappaB kinase activity (GO:0008384)

nucleus (GO:0005634)

1173

AP2M1

adaptor-related protein complex 2, mu 1 subunit

I-kappaB phosphorylation (GO:0007252)
regulation of defense response to virus by virus
(GO:0050690)

protein binding (GO:0005515)

peroxisomal membrane (GO:0005778)
clathrin coat of trans-Golgi network
vesicle (GO:0030130)
clathrin coat of trans-Golgi network
vesicle (GO:0030130)

1212

CLTB

clathrin, light chain (Lcb)

intracellular protein transport (GO:0006886)

calcium ion binding (GO:0005509)

1213

CLTC

clathrin, heavy chain (Hc)

protein binding (GO:0005515)

1265

CNN2

calponin 2

intracellular protein transport (GO:0006886)
actomyosin structure organization and biogenesis
(GO:0031032)

1277

COL1A1

collagen, type I, alpha 1

phosphate transport (GO:0006817)

1278

COL1A2

collagen, type I, alpha 2

phosphate transport (GO:0006817)

1293

COL6A3

collagen, type VI, alpha 3

phosphate transport (GO:0006817)

1303

COL12A1

collagen, type XII, alpha 1

phosphate transport (GO:0006817)

actin binding (GO:0003779)
extracellular matrix structural constituent
(GO:0005201)
extracellular matrix structural constituent
(GO:0005201)
serine-type endopeptidase inhibitor activity
(GO:0004867)
extracellular matrix structural constituent
conferring tensile strength (GO:0030020)

1315

COPB1

coatomer protein complex, subunit beta 1

COPI coating of Golgi vesicle (GO:0048205)

protein binding (GO:0005515)

1429

CRYZ

crystallin, zeta (quinone reductase)

visual perception (GO:0007601)

NADPH:quinone reductase activity (GO:0003960)

cytoplasm (GO:0005737)

1465

CSRP1

zinc ion binding (GO:0008270)

nucleus (GO:0005634)
actin cytoskeleton (GO:0015629)
mitochondrial outer membrane
(GO:0005741)

intercellular junction (GO:0005911)
collagen type I (GO:0005584)
collagen type I (GO:0005584)
collagen type VI (GO:0005589)
collagen type XII (GO:0005595)
Golgi-associated vesicle (GO:0005798)

1495

CTNNA1

cysteine and glycine-rich protein 1
catenin (cadherin-associated protein), alpha 1,
102kDa

CYB5A

cytochrome b5 type A (microsomal)

apical junction assembly (GO:0043297)
generation of precursor metabolites and energy
(GO:0006091)

vinculin binding (GO:0017166)

1528
1639

DCTN1

dynactin 1 (p150, glued homolog, Drosophila)
dolichyl-diphosphooligosaccharide-protein
glycosyltransferase

mitosis (GO:0007067)
protein amino acid terminal N-glycosylation
(GO:0006496)

protein binding (GO:0005515)
dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)

spindle pole (GO:0000922)

microtubule-based movement (GO:0007018)
regulation of cell-cell adhesion mediated by integrin
(GO:0033632)

microtubule motor activity (GO:0003777)

microtubule (GO:0005874)

aminopeptidase activity (GO:0004177)

integral to membrane (GO:0016021)

nervous system development (GO:0007399)

dihydropyrimidinase activity (GO:0004157)

cytoplasm (GO:0005737)

GTPase activity (GO:0003924)
translation elongation factor activity
(GO:0003746)
translation elongation factor activity
(GO:0003746)

cytosol (GO:0005829)

1650

DDOST

1781

DYNC1I2

1803

DPP4

dynein, cytoplasmic 1, intermediate chain 2
dipeptidyl-peptidase 4 (CD26, adenosine
deaminase complexing protein 2)

1808

DPYSL2

dihydropyrimidinase-like 2

1915

EEF1A1

eukaryotic translation elongation factor 1 alpha 1

translational elongation (GO:0006414)

1933

EEF1B2

1936

EEF1D

eukaryotic translation elongation factor 1 beta 2
eukaryotic translation elongation factor 1 delta
(guanine nucleotide exchange protein)

translational elongation (GO:0006414)
positive regulation of I-kappaB kinase/NF-kappaB
cascade (GO:0043123)

aldo-keto reductase activity (GO:0004033)

microsome (GO:0005792)

cytosol (GO:0005829)

cytosol (GO:0005829)

214
1937

EEF1G

eukaryotic translation elongation factor 1 gamma

translational elongation (GO:0006414)

translation elongation factor activity
(GO:0003746)

cytosol (GO:0005829)
cytoplasm (GO:0005737)

1938

EEF2

eukaryotic translation elongation factor 2

translational elongation (GO:0006414)

GTPase activity (GO:0003924)

2040

STOM

stomatin

protein homooligomerization (GO:0051260)

protein binding (GO:0005515)

melanosome (GO:0042470)

2271

FH

fumarate hydratase

tricarboxylic acid cycle (GO:0006099)

fumarate hydratase activity (GO:0004333)

mitochondrial matrix (GO:0005759)

2274

FHL2

four and a half LIM domains 2

androgen receptor binding (GO:0050681)

nucleus (GO:0005634)

2314

FLII

flightless I homolog (Drosophila)

actin binding (GO:0003779)

centrosome (GO:0005813)

actin filament binding (GO:0051015)

actin cytoskeleton (GO:0015629)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

2316

FLNA

filamin A, alpha (actin binding protein 280)

androgen receptor signaling pathway (GO:0030521)
regulation of transcription, DNA-dependent
(GO:0006355)
positive regulation of transcription factor import into
nucleus (GO:0042993)

2317

FLNB

filamin B, beta (actin binding protein 278)

skeletal muscle development (GO:0007519)

2318

FLNC

filamin C, gamma (actin binding protein 280)

2495

FTH1

2547

XRCC6

ferritin, heavy polypeptide 1
X-ray repair complementing defective repair in
Chinese hamster cells 6 (Ku autoantigen, 70kDa)

cellular iron ion homeostasis (GO:0006879)
double-strand break repair via nonhomologous end
joining (GO:0006303)

ferric iron binding (GO:0008199)

plasma membrane (GO:0005886)

double-stranded DNA binding (GO:0003690)
ion transmembrane transporter activity
(GO:0015075)

nucleus (GO:0005634)
integral to plasma membrane
(GO:0005887)

2697

GJA1

gap junction protein, alpha 1, 43kDa

sensory perception of sound (GO:0007605)

2744

GLS

glutaminase

glutamine catabolic process (GO:0006543)

glutaminase activity (GO:0004359)

mitochondrial matrix (GO:0005759)

2746

GLUD1

glutamate dehydrogenase 1

glutamate catabolic process (GO:0006538)

ATP binding (GO:0005524)

mitochondrial matrix (GO:0005759)

2747

GLUD2

glutamate metabolic process (GO:0006536)
acetylcholine receptor signaling, muscarinic pathway
(GO:0007213)

mitochondrial matrix (GO:0005759)

GNB1

glutamate dehydrogenase 2
guanine nucleotide binding protein (G protein),
beta polypeptide 1

glutamate dehydrogenase activity (GO:0004352)

2782

GTPase activity (GO:0003924)

2804

GOLGB1

golgin B1, golgi integral membrane protein

Golgi organization and biogenesis (GO:0007030)

protein binding (GO:0005515)

2934

GSN

gelsolin (amyloidosis, Finnish type)

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

Golgi stack (GO:0005795)
actin cytoskeleton (GO:0015629)

2950

GSTP1

glutathione S-transferase pi

anti-apoptosis (GO:0006916)

glutathione transferase activity (GO:0004364)

cytoplasm (GO:0005737)

3007

HIST1H1D

histone cluster 1, H1d

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

3010

HIST1H1T

histone cluster 1, H1t

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

3017

HIST1H2BD

histone cluster 1, H2bd

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

3024

HIST1H1A

histone cluster 1, H1a

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

3094

HINT1

histidine triad nucleotide binding protein 1

protein kinase C binding (GO:0005080)

3106

HLA-B

major histocompatibility complex, class I, B

MHC class I receptor activity (GO:0032393)

nucleus (GO:0005634)
integral to plasma membrane
(GO:0005887)

3107

HLA-C

major histocompatibility complex, class I, C

MHC class I receptor activity (GO:0032393)

axonemal dynein complex (GO:0005858)

3146

HMGB1
HNRNPA2B
1

signal transduction (GO:0007165)
antigen processing and presentation of peptide antigen
via MHC class I (GO:0002474)
antigen processing and presentation of peptide antigen
via MHC class I (GO:0002474)
negative regulation of transcriptional preinitiation
complex assembly (GO:0017055)

3181

high-mobility group box 1

nuclear mRNA splicing, via spliceosome (GO:0000398)

DNA bending activity (GO:0008301)
single-stranded telomeric DNA binding
(GO:0043047)

3184

HNRNPD

heterogeneous nuclear ribonucleoprotein A2/B1
heterogeneous nuclear ribonucleoprotein D (AUrich element RNA binding protein 1, 37kDa)

nuclear mRNA splicing, via spliceosome (GO:0000398)

DNA binding (GO:0003677)

3185

HNRNPF

heterogeneous nuclear ribonucleoprotein F

nuclear mRNA splicing, via spliceosome (GO:0000398)

3295

HSD17B4

hydroxysteroid (17-beta) dehydrogenase 4

fatty acid metabolic process (GO:0006631)

RNA binding (GO:0003723)
3-hydroxyacyl-CoA dehydrogenase activity
(GO:0003857)

3305

HSPA1L

heat shock 70kDa protein 1-like

response to unfolded protein (GO:0006986)

ATP binding (GO:0005524)

condensed chromosome (GO:0000793)
nucleus (GO:0005634)
chromosome, telomeric region
(GO:0000781)
nucleus (GO:0005634)
peroxisomal matrix (GO:0005782)
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3306

HSPA2

heat shock 70kDa protein 2

male meiosis (GO:0007140)

ATP binding (GO:0005524)

cell surface (GO:0009986)

3308

HSPA4

heat shock 70kDa protein 4

response to unfolded protein (GO:0006986)

ATP binding (GO:0005524)

cytoplasm (GO:0005737)

3311

HSPA7

heat shock 70kDa protein 7 (HSP70B)

response to unfolded protein (GO:0006986)

ATP binding (GO:0005524)

cellular_component (GO:0005575)

3312

HSPA8

heat shock 70kDa protein 8

protein folding (GO:0006457)

ATPase activity, coupled (GO:0042623)

melanosome (GO:0042470)

3313

HSPA9

heat shock 70kDa protein 9 (mortalin)

anti-apoptosis (GO:0006916)

ATP binding (GO:0005524)

mitochondrion (GO:0005739)

3315

HSPB1

nucleus (GO:0005634)

HSP90AA1

anti-apoptosis (GO:0006916)
positive regulation of nitric oxide biosynthetic process
(GO:0045429)
positive regulation of nitric oxide biosynthetic process
(GO:0045429)

identical protein binding (GO:0042802)

3320

ATP binding (GO:0005524)

melanosome (GO:0042470)

ATP binding (GO:0005524)

melanosome (GO:0042470)
secretory granule membrane
(GO:0030667)

3326

HSP90AB1

heat shock 27kDa protein 1
heat shock protein 90kDa alpha (cytosolic), class
A member 1
heat shock protein 90kDa alpha (cytosolic), class
B member 1

3382

ICA1

islet cell autoantigen 1, 69kDa

neurotransmitter transport (GO:0006836)

3417

IDH1

isocitrate dehydrogenase 1 (NADP+), soluble

3609

ILF3

interleukin enhancer binding factor 3, 90kDa

tricarboxylic acid cycle (GO:0006099)
negative regulation of transcription, DNA-dependent
(GO:0045892)

3611

ILK

3704

ITPA

integrin-linked kinase
integrin, alpha 3 (antigen CD49C, alpha 3 subunit
of VLA-3 receptor)
integrin, alpha V (vitronectin receptor, alpha
polypeptide, antigen CD51)
inosine triphosphatase (nucleoside triphosphate
pyrophosphatase)

3799

KIF5B

kinesin family member 5B

3675

ITGA3

3685

ITGAV

protein amino acid phosphorylation (GO:0006468)

protein binding (GO:0005515)
isocitrate dehydrogenase (NADP+) activity
(GO:0004450)
double-stranded RNA binding (GO:0003725)
protein serine/threonine kinase activity
(GO:0004674)

peroxisome (GO:0005777)
nucleus (GO:0005634)
cell junction (GO:0030054)

integrin-mediated signaling pathway (GO:0007229)

calcium ion binding (GO:0005509)

integrin complex (GO:0008305)

integrin-mediated signaling pathway (GO:0007229)

calcium ion binding (GO:0005509)
nucleoside-triphosphate diphosphatase activity
(GO:0047429)

integrin complex (GO:0008305)

ATP binding (GO:0005524)

kinesin complex (GO:0005871)

Ran GTPase binding (GO:0008536)

nucleus (GO:0005634)

protein binding (GO:0005515)

nucleotide metabolic process (GO:0009117)

cytoplasm (GO:0005737)

3843

IPO5

importin 5

vesicle transport along microtubule (GO:0047496)
NLS-bearing substrate import into nucleus
(GO:0006607)

3856

KRT8

keratin 8

cytoskeleton organization and biogenesis (GO:0007010)

3895

KTN1

kinectin 1 (kinesin receptor)

microtubule-based movement (GO:0007018)

receptor activity (GO:0004872)

intermediate filament (GO:0005882)
integral to plasma membrane
(GO:0005887)

3939

LDHA

lactate dehydrogenase A

anaerobic glycolysis (GO:0019642)

L-lactate dehydrogenase activity (GO:0004459)

cytosol (GO:0005829)

3958

LGALS3

lectin, galactoside-binding, soluble, 3

IgE binding (GO:0019863)

nucleus (GO:0005634)

3998

LMAN1

lectin, mannose-binding, 1

protein folding (GO:0006457)

mannose binding (GO:0005537)

Golgi membrane (GO:0000139)

4008

LMO7

protein ubiquitination (GO:0016567)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)

4082

MARCKS

LIM domain 7
myristoylated alanine-rich protein kinase C
substrate

cell motility (GO:0006928)

actin filament binding (GO:0051015)

actin cytoskeleton (GO:0015629)

4478

MSN

moesin

cytoskeleton (GO:0005856)

MYH9

myosin, heavy chain 9, non-muscle

cell motility (GO:0006928)
membrane protein ectodomain proteolysis
(GO:0006509)

receptor binding (GO:0005102)

4627

actin-dependent ATPase activity (GO:0030898)

4629

MYH11

myosin, heavy chain 11, smooth muscle

muscle thick filament assembly (GO:0030241)

ATP binding (GO:0005524)

stress fiber (GO:0001725)
striated muscle thick filament
(GO:0005863)

4638

MYLK

myosin light chain kinase

protein amino acid phosphorylation (GO:0006468)

myosin light chain kinase activity (GO:0004687)

4691

NCL

nucleolin

angiogenesis (GO:0001525)

DNA binding (GO:0003677)

nucleus (GO:0005634)

4735

SEPT2

septin 2

cell cycle (GO:0007049)

GTP binding (GO:0005525)

nucleus (GO:0005634)

4736

RPL10A

ribosomal protein L10a

translational elongation (GO:0006414)

structural constituent of ribosome (GO:0003735)

cytosol (GO:0005829)

4841

NONO

non-POU domain containing, octamer-binding

mRNA processing (GO:0006397)

DNA binding (GO:0003677)

nucleus (GO:0005634)
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4869

NPM1

nucleophosmin (nucleolar phosphoprotein B23,
numatrin)

4914

NTRK1

neurotrophic tyrosine kinase, receptor, type 1

activation of adenylate cyclase activity (GO:0007190)

5052

PRDX1

peroxiredoxin 1

skeletal development (GO:0001501)

anti-apoptosis (GO:0006916)

transcription coactivator activity (GO:0003713)
transmembrane receptor protein tyrosine kinase
activity (GO:0004714)

centrosome (GO:0005813)
integral to plasma membrane
(GO:0005887)

peroxiredoxin activity (GO:0051920)
bisphosphoglycerate 2-phosphatase activity
(GO:0004083)

melanosome (GO:0042470)

5223

PGAM1

phosphoglycerate mutase 1 (brain)

glycolysis (GO:0006096)

5230

PGK1

phosphoglycerate kinase 1
plectin 1, intermediate filament binding protein
500kDa
procollagen-lysine 1, 2-oxoglutarate 5dioxygenase 1

glycolysis (GO:0006096)
cytoskeletal anchoring at plasma membrane
(GO:0007016)

ATP binding (GO:0005524)

cytoplasm (GO:0005737)

actin binding (GO:0003779)

hydroxylysine biosynthetic process (GO:0046947)

iron ion binding (GO:0005506)

cytoskeleton (GO:0005856)
rough endoplasmic reticulum membrane
(GO:0030867)

protein kinase cascade (GO:0007243)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)
anaphase-promoting complex-dependent proteasomal
ubiquitin-dependent protein catabolic process
(GO:0031145)

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

threonine endopeptidase activity (GO:0004298)

nucleus (GO:0005634)

ATPase activity (GO:0016887)

nucleus (GO:0005634)

protein binding (GO:0005515)

cytosol (GO:0005829)

protein binding (GO:0005515)
double-stranded telomeric DNA binding
(GO:0003691)

cytosol (GO:0005829)
nuclear chromosome, telomeric region
(GO:0000784)

5339

PLEC1

5351

PLOD1

5589

PRKCSH

protein kinase C substrate 80K-H

PSMA1

proteasome (prosome, macropain) subunit, alpha
type, 1

5686

PSMA5

proteasome (prosome, macropain) subunit, alpha
type, 5

5689

PSMB1

proteasome (prosome, macropain) subunit, beta
type, 1

5693

PSMB5

proteasome (prosome, macropain) subunit, beta
type, 5

5705

PSMC5

proteasome (prosome, macropain) 26S subunit,
ATPase, 5

5708

PSMD2

proteasome (prosome, macropain) 26S subunit,
non-ATPase, 2

5713

PSMD7

proteasome (prosome, macropain) 26S subunit,
non-ATPase, 7

5813

PURA

purine-rich element binding protein A
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6119

RPA3

replication protein A3, 14kDa

DNA unwinding during replication (GO:0006268)
regulation of transcription, DNA-dependent
(GO:0006355)
proteasomal ubiquitin-dependent protein catabolic
process (GO:0043161)
nucleotide-excision repair, DNA damage removal
(GO:0000718)
nucleotide-excision repair, DNA damage removal
(GO:0000718)

6122

RPL3

ribosomal protein L3

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6124

RPL4

ribosomal protein L4

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6125

RPL5

ribosomal protein L5

5S rRNA binding (GO:0008097)

5814

PURB

purine-rich element binding protein B

5887

RAD23B

RAD23 homolog B (S. cerevisiae)

6117

RPA1

replication protein A1, 70kDa

cytosol (GO:0005829)

single-stranded DNA binding (GO:0003697)

nucleus (GO:0005634)

single-stranded DNA binding (GO:0003697)

nucleus (GO:0005634)

single-stranded DNA binding (GO:0003697)

PML body (GO:0016605)

single-stranded DNA binding (GO:0003697)

nucleus (GO:0005634)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)

6128

RPL6

ribosomal protein L6

translational elongation (GO:0006414)
regulation of transcription, DNA-dependent
(GO:0006355)

6160

RPL31

ribosomal protein L31

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6165

RPL35A

ribosomal protein L35a

translational elongation (GO:0006414)

tRNA binding (GO:0000049)

6176

RPLP1

ribosomal protein, large, P1

translational elongation (GO:0006414)

RNA binding (GO:0003723)

DNA binding (GO:0003677)
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6188

RPS3

ribosomal protein S3

translational elongation (GO:0006414)

RNA binding (GO:0003723)

cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
integral to endoplasmic reticulum
membrane (GO:0030176)

6189

RPS3A

ribosomal protein S3A

induction of apoptosis (GO:0006917)

RNA binding (GO:0003723)

6206

RPS12

ribosomal protein S12

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6209

RPS15

ribosomal protein S15
ribosome binding protein 1 homolog 180kDa
(dog)

translational elongation (GO:0006414)
intracellular protein transport across a membrane
(GO:0065002)

structural constituent of ribosome (GO:0003735)

Ras suppressor protein 1
splicing factor proline/glutamine-rich
(polypyrimidine tract binding protein associated)

signal transduction (GO:0007165)

protein binding (GO:0005515)

mRNA processing (GO:0006397)

DNA binding (GO:0003677)

nucleus (GO:0005634)

protein binding (GO:0005515)

cytoplasm (GO:0005737)

calcium:sodium antiporter activity (GO:0005432)

melanosome (GO:0042470)

6238

RRBP1

6251

RSU1

receptor activity (GO:0004872)

6421

SFPQ

6449

SGTA

6520

SLC3A2

small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
solute carrier family 3 (activators of dibasic and
neutral amino acid transport), member 2
calcium ion transport (GO:0006816)

6708

SPTA1

spectrin, alpha, erythrocytic 1 (elliptocytosis 2)

barbed-end actin filament capping (GO:0051016)

actin filament binding (GO:0051015)

cytoskeleton (GO:0005856)

6709

SPTAN1

spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

cytosol (GO:0005829)

6711

SPTBN1

spectrin, beta, non-erythrocytic 1

barbed-end actin filament capping (GO:0051016)

actin binding (GO:0003779)

nucleolus (GO:0005730)

6810

STX4

syntaxin 4

intracellular protein transport (GO:0006886)

SNAP receptor activity (GO:0005484)

vacuole (GO:0005773)

6876

TAGLN

transgelin

muscle development (GO:0007517)

actin binding (GO:0003779)

7057

THBS1

thrombospondin 1

nervous system development (GO:0007399)

heparin binding (GO:0008201)

cytoplasm (GO:0005737)
platelet alpha granule lumen
(GO:0031093)

7086

TKT

transketolase (Wernicke-Korsakoff syndrome)

transketolase activity (GO:0004802)

cytosol (GO:0005829)

7158

TP53BP1

tumor protein p53 binding protein 1

metabolic process (GO:0008152)
positive regulation of transcription, DNA-dependent
(GO:0045893)

DNA binding (GO:0003677)

7162

TPBG

trophoblast glycoprotein

cell motility (GO:0006928)

protein binding (GO:0005515)

nucleus (GO:0005634)
integral to plasma membrane
(GO:0005887)

7169

TPM2

tropomyosin 2 (beta)

regulation of ATPase activity (GO:0043462)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

7171

TPM4

tropomyosin 4

cell motility (GO:0006928)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

7203

CCT3

chaperonin containing TCP1, subunit 3 (gamma)

protein folding (GO:0006457)

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)

7295

TXN

thioredoxin

signal transduction (GO:0007165)

protein binding (GO:0005515)

cytosol (GO:0005829)

7296

TXNRD1

thioredoxin reductase 1

signal transduction (GO:0007165)

FAD binding (GO:0050660)

nucleus (GO:0005634)

7317

UBA1

DNA replication (GO:0006260)

ATP binding (GO:0005524)

7345

UCHL1

ubiquitin-like modifier activating enzyme 1
ubiquitin carboxyl-terminal esterase L1 (ubiquitin
thiolesterase)

protein deubiquitination (GO:0016579)

ubiquitin thiolesterase activity (GO:0004221)

cytoplasm (GO:0005737)
cytoplasm (GO:0005737)

7407

VARS

valyl-tRNA synthetase

valyl-tRNA aminoacylation (GO:0006438)

valine-tRNA ligase activity (GO:0004832)

7408

VASP

vasodilator-stimulated phosphoprotein

cell motility (GO:0006928)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

7414

VCL

vinculin

lamellipodium biogenesis (GO:0030032)

actin binding (GO:0003779)

focal adhesion (GO:0005925)

7415

VCP

valosin-containing protein

caspase activation (GO:0006919)

ATPase activity (GO:0016887)

7424

VEGFC

vascular endothelial growth factor C

positive regulation of cell proliferation (GO:0008284)

growth factor activity (GO:0008083)

microsome (GO:0005792)
platelet alpha granule lumen
(GO:0031093)

7430

EZR

actin filament bundle formation (GO:0051017)
double-strand break repair via nonhomologous end
joining (GO:0006303)

cortical cytoskeleton (GO:0030863)

XRCC5

ezrin
X-ray repair complementing defective repair in
Chinese hamster cells 5 (double-strand-break

actin filament binding (GO:0051015)

7520

ATP binding (GO:0005524)

nucleus (GO:0005634)
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rejoining; Ku autoantigen, 80kDa)

YWHAZ

tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, beta
polypeptide
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, gamma
polypeptide
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, zeta
polypeptide

FXR1

fragile X mental retardation, autosomal homolog 1

8218

CLTCL1

clathrin, heavy chain-like 1

receptor-mediated endocytosis (GO:0006898)

signal transducer activity (GO:0004871)

8290

HIST3H3

histone cluster 3, H3

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

8335

HIST1H2AB

histone cluster 1, H2ab

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

8411

EEA1

early endosome antigen 1

phosphatidylinositol binding (GO:0005545)

8531

CSDA

cold shock domain protein A

vesicle fusion (GO:0006906)
negative regulation of transcription from RNA
polymerase II promoter (GO:0000122)

nucleus (GO:0005634)
early endosome membrane
(GO:0031901)

double-stranded DNA binding (GO:0003690)

nucleus (GO:0005634)

8615

USO1

USO1 homolog, vesicle docking protein (yeast)

vesicle fusion with Golgi apparatus (GO:0048280)

protein transporter activity (GO:0008565)

Golgi membrane (GO:0000139)

8661

EIF3A

eukaryotic translation initiation factor 3, subunit A

regulation of translational initiation (GO:0006446)

translation initiation factor activity (GO:0003743)

cytosol (GO:0005829)

8662

EIF3B

eukaryotic translation initiation factor 3, subunit B

translational initiation (GO:0006413)

translation initiation factor activity (GO:0003743)

cytosol (GO:0005829)

8666

EIF3G

eukaryotic translation initiation factor 3, subunit G

regulation of translational initiation (GO:0006446)

translation initiation factor activity (GO:0003743)

cytosol (GO:0005829)

8668

EIF3I

eukaryotic translation initiation factor 3, subunit I

regulation of translational initiation (GO:0006446)

translation initiation factor activity (GO:0003743)

cytosol (GO:0005829)

8971

H1FX

H1 histone family, member X

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

9093

DNAJA3

mitochondrial matrix (GO:0005759)

VAPA

protein folding (GO:0006457)
positive regulation of I-kappaB kinase/NF-kappaB
cascade (GO:0043123)

zinc ion binding (GO:0008270)

9218

DnaJ (Hsp40) homolog, subfamily A, member 3
VAMP (vesicle-associated membrane protein)associated protein A, 33kDa

protein heterodimerization activity (GO:0046982)

9219

MTA2

metastasis associated 1 family, member 2

zinc ion binding (GO:0008270)

9230

RAB11B

GTPase activity (GO:0003924)

plasma membrane (GO:0005886)

9276

COPB2

RAB11B, member RAS oncogene family
coatomer protein complex, subunit beta 2 (beta
prime)

chromatin assembly or disassembly (GO:0006333)
small GTPase mediated signal transduction
(GO:0007264)

tight junction (GO:0005923)
histone deacetylase complex
(GO:0000118)

COPI coating of Golgi vesicle (GO:0048205)

protein binding (GO:0005515)

COPI vesicle coat (GO:0030126)

9590

AKAP12

A kinase (PRKA) anchor protein (gravin) 12

protein targeting (GO:0006605)

protein kinase A binding (GO:0051018)

cytoskeleton (GO:0005856)
melanosome (GO:0042470)

7529

YWHAB

7532

YWHAG

7534
8087

activation of pro-apoptotic gene products (GO:0008633)

monooxygenase activity (GO:0004497)

melanosome (GO:0042470)

negative regulation of protein kinase activity
(GO:0006469)

protein kinase C binding (GO:0005080)

cytoplasm (GO:0005737)

anti-apoptosis (GO:0006916)

transcription factor binding (GO:0008134)

melanosome (GO:0042470)

skeletal muscle development (GO:0007519)

RNA binding (GO:0003723)

nucleolus (GO:0005730)
clathrin coat of trans-Golgi network
vesicle (GO:0030130)

9601

PDIA4

protein disulfide isomerase family A, member 4

protein secretion (GO:0009306)

protein disulfide isomerase activity (GO:0003756)

9706

ULK2

unc-51-like kinase 2 (C. elegans)

axonogenesis (GO:0007409)

protein serine/threonine kinase activity (GO:0004674)

9761

KIAA0152

KIAA0152

9782

MATR3

9871

SEC24D

matrin 3
SEC24 related gene family, member D (S.
cerevisiae)

9943

OXSR1

9961

MVP

10095

ARPC1B

integral to membrane (GO:0016021)
zinc ion binding (GO:0008270)

nuclear inner membrane (GO:0005637)

ER to Golgi vesicle-mediated transport (GO:0006888)

zinc ion binding (GO:0008270)

COPII vesicle coat (GO:0030127)

oxidative-stress responsive 1

protein amino acid phosphorylation (GO:0006468)

protein serine/threonine kinase activity (GO:0004674)

major vault protein
actin related protein 2/3 complex, subunit 1B,
41kDa

mRNA transport (GO:0051028)
cell motility (GO:0006928)

nucleus (GO:0005634)
actin binding (GO:0003779)

cytoplasm (GO:0005737)

219
10109

ARPC2

10483

SEC23B

10487

CAP1

10528
10540

actin related protein 2/3 complex, subunit 2,
34kDa

regulation of actin filament polymerization (GO:0030833)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

Sec23 homolog B (S. cerevisiae)
CAP, adenylate cyclase-associated protein 1
(yeast)

ER to Golgi vesicle-mediated transport (GO:0006888)

zinc ion binding (GO:0008270)

COPII vesicle coat (GO:0030127)

activation of adenylate cyclase activity (GO:0007190)

actin binding (GO:0003779)

plasma membrane (GO:0005886)

NOL5A

nucleolar protein 5A (56kDa with KKE/D repeat)

rRNA processing (GO:0006364)

RNA binding (GO:0003723)

nucleus (GO:0005634)

DCTN2

dynactin 2 (p50)

microtubule-based process (GO:0007017)

protein binding (GO:0005515)

centrosome (GO:0005813)

10574

CCT7

chaperonin containing TCP1, subunit 7 (eta)

protein folding (GO:0006457)

ATP binding (GO:0005524)

cytoplasm (GO:0005737)

10575

CCT4

chaperonin containing TCP1, subunit 4 (delta)

protein folding (GO:0006457)

ATP binding (GO:0005524)

melanosome (GO:0042470)

10576

CCT2

protein folding (GO:0006457)

ATP binding (GO:0005524)

cytosol (GO:0005829)

10606

PAICS

chaperonin containing TCP1, subunit 2 (beta)
phosphoribosylaminoimidazole carboxylase,
phosphoribosylaminoimidazole
succinocarboxamide synthetase

'de novo' IMP biosynthetic process (GO:0006189)

ATP binding (GO:0005524)

phosphoribosylaminoimidazole
carboxylase complex (GO:0009320)

10611

PDLIM5

PDZ and LIM domain 5

protein kinase C binding (GO:0005080)

actin cytoskeleton (GO:0015629)

GTPase activity (GO:0003924)
alkyl hydroperoxide reductase activity
(GO:0008785)

stress fiber (GO:0001725)

10801
10935

PRDX3

9-Sep

septin 9
peroxiredoxin 3

protein heterooligomerization (GO:0051291)
positive regulation of NF-kappaB transcription factor
activity (GO:0051092)

10938

EHD1

GTPase activity (GO:0003924)

10963

STIP1

EH-domain containing 1
stress-induced-phosphoprotein 1 (Hsp70/Hsp90organizing protein)

mitochondrion (GO:0005739)
early endosome membrane
(GO:0031901)

response to stress (GO:0006950)

binding (GO:0005488)

nucleus (GO:0005634)

10992

SF3B2

splicing factor 3b, subunit 2, 145kDa

nucleus (GO:0005634)

DSTN

destrin (actin depolymerizing factor)

nuclear mRNA splicing, via spliceosome (GO:0000398)
actin polymerization and/or depolymerization
(GO:0008154)

nucleic acid binding (GO:0003676)

11034

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

11316

COPE

coatomer protein complex, subunit epsilon

COPI coating of Golgi vesicle (GO:0048205)

11328

FKBP9

protein folding (GO:0006457)

protein binding (GO:0005515)
peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)

chromatin remodeling (GO:0006338)

protein domain specific binding (GO:0019904)

ER to Golgi vesicle-mediated transport (GO:0006888)

protein binding (GO:0005515)

11335

CBX3

FK506 binding protein 9, 63 kDa
chromobox homolog 3 (HP1 gamma homolog,
Drosophila)

22872

SEC31A

SEC31 homolog A (S. cerevisiae)

22995

CEP152

centrosomal protein 152kDa

23022

PALLD

palladin, cytoskeletal associated protein

cytoskeleton organization and biogenesis (GO:0007010)

23193

GANAB

glucosidase, alpha; neutral AB

carbohydrate metabolic process (GO:0005975)

COPI vesicle coat (GO:0030126)
endoplasmic reticulum (GO:0005783)
nuclear centromeric heterochromatin
(GO:0031618)
COPII vesicle coat (GO:0030127)
centrosome (GO:0005813)

muscle alpha-actinin binding (GO:0051371)
glucan 1,3-alpha-glucosidase activity
(GO:0033919)

nucleus (GO:0005634)
melanosome (GO:0042470)

23307

FKBP15

FK506 binding protein 15, 133kDa

protein folding (GO:0006457)

23345

SYNE1

spectrin repeat containing, nuclear envelope 1

nuclear organization and biogenesis (GO:0006997)

23446

SLC44A1

choline transport (GO:0015871)

actin binding (GO:0003779)
choline transmembrane transporter activity
(GO:0015220)

transport (GO:0006810)

ATPase activity (GO:0016887)

lysosomal membrane (GO:0005765)

cell cycle arrest (GO:0007050)

microtubule binding (GO:0008017)

cytoskeleton (GO:0005856)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

poly(A) binding (GO:0008143)

nucleus (GO:0005634)

23461

ABCA5

solute carrier family 44, member 1
ATP-binding cassette, sub-family A (ABC1),
member 5

23499

MACF1

microtubule-actin crosslinking factor 1

23603

CORO1C

coronin, actin binding protein, 1C

phagocytosis (GO:0006909)

26509

FER1L3

fer-1-like 3, myoferlin (C. elegans)

muscle contraction (GO:0006936)

26986

PABPC1

poly(A) binding protein, cytoplasmic 1

mRNA polyadenylation (GO:0006378)

cytoplasm (GO:0005737)
nucleus (GO:0005634)
integral to membrane (GO:0016021)

nucleus (GO:0005634)

220
27020

NPTN

neuroplastin

positive regulation of long-term neuronal synaptic
plasticity (GO:0048170)

cell adhesion molecule binding (GO:0050839)

integral to membrane (GO:0016021)

29766

TMOD3

tropomodulin 3 (ubiquitous)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

30846

EHD2

EH-domain containing 2

GTPase activity (GO:0003924)

nucleus (GO:0005634)

51087

YBX2

Y box binding protein 2

transcription from RNA polymerase II promoter
(GO:0006366)

DNA binding (GO:0003677)

nucleus (GO:0005634)

51350

KRT76

keratin 76

cytoskeleton organization and biogenesis (GO:0007010)

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

51742

ARID4B

AT rich interactive domain 4B (RBP1-like)

chromatin assembly or disassembly (GO:0006333)

DNA binding (GO:0003677)

chromatin (GO:0000785)

54997

TESC

magnesium ion binding (GO:0000287)

nucleus (GO:0005634)

viral reproduction (GO:0016032)

55075

UACA

tescalcin
uveal autoantigen with coiled-coil domains and
ankyrin repeats

55299

BXDC2

brix domain containing 2

ribosome biogenesis and assembly (GO:0042254)

protein binding (GO:0005515)

nucleus (GO:0005634)

55752

SEPT11

septin 11

protein heterooligomerization (GO:0051291)

GTP binding (GO:0005525)

stress fiber (GO:0001725)

55917

CTTNBP2NL

CTTNBP2 N-terminal like

actin cytoskeleton (GO:0015629)

56005

C19orf10

chromosome 19 open reading frame 10

extracellular region (GO:0005576)

56911

C21orf7

chromosome 21 open reading frame 7

protein binding (GO:0005515)

nucleus (GO:0005634)

56969

RPL23AP13

nucleotide binding (GO:0000166)

ribosome (GO:0005840)

57222

ERGIC1

ribosomal protein L23a pseudogene 13
endoplasmic reticulum-golgi intermediate
compartment (ERGIC) 1

ER to Golgi vesicle-mediated transport (GO:0006888)

Golgi membrane (GO:0000139)

nucleus (GO:0005634)

60681

FKBP10

FK506 binding protein 10, 65 kDa

protein folding (GO:0006457)

protein binding (GO:0005515)
peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)

63971

KIF13A

kinesin family member 13A

microtubule-based movement (GO:0007018)

ATP binding (GO:0005524)

microtubule (GO:0005874)

64098

PARVG

parvin, gamma

cell-matrix adhesion (GO:0007160)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

65992

C20orf116

chromosome 20 open reading frame 116

protein binding (GO:0005515)

extracellular region (GO:0005576)

66005

CHID1

chitinase domain containing 1

chitin catabolic process (GO:0006032)

chitinase activity (GO:0004568)

lysosome (GO:0005764)

81035

COLEC12

collectin sub-family member 12

phosphate transport (GO:0006817)

scavenger receptor activity (GO:0005044)

integral to membrane (GO:0016021)

81567

TXNDC5

thioredoxin domain containing 5

anti-apoptosis (GO:0006916)

isomerase activity (GO:0016853)

endoplasmic reticulum (GO:0005783)

84936

ZFYVE19

zinc finger, FYVE domain containing 19

113026

PLCD3

phospholipase C, delta 3

cytoplasm (GO:0005737)

127829

ARL8A

ADP-ribosylation factor-like 8A

intracellular signaling cascade (GO:0007242)
small GTPase mediated signal transduction
(GO:0007264)

zinc ion binding (GO:0008270)
phosphoinositide phospholipase C activity
(GO:0004435)
GTPase activity (GO:0003924)

lysosome (GO:0005764)

140597

TCEAL2

transcription elongation factor A (SII)-like 2

regulation of transcription, DNA-dependent (GO:0006355)

145165

FAM10A4

family with sequence similarity 10, member A4 pseudogene

153562

MARVELD2

MARVEL domain containing 2

nucleus (GO:0005634)
binding (GO:0005488)

sensory perception of sound (GO:0007605)

158358

KIAA2026

KIAA2026

255101

CCDC108

coiled-coil domain containing 108

255738

PCSK9

proprotein convertase subtilisin/kexin type 9

protein autoprocessing (GO:0016540)

283149

BCL9L

B-cell CLL/lymphoma 9-like

regulation of transcription, DNA-dependent (GO:0006355)

endoplasmic reticulum (GO:0005783)

cytoplasm (GO:0005737)
tight junction (GO:0005923)

structural molecule activity (GO:0005198)

integral to membrane (GO:0016021)

calcium ion binding (GO:0005509)

extracellular space (GO:0005615)
nucleus (GO:0005634)

221
338773

TMEM119

transmembrane protein 119

348654

GEN1

Gen homolog 1, endonuclease (Drosophila)

integral to membrane (GO:0016021)
DNA repair (GO:0006281)

endonuclease activity (GO:0004519)

nucleus (GO:0005634)

360132

FKBP9L

FK506 binding protein 9-like

protein folding (GO:0006457)

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

388474

LOC388474

similar to ribosomal protein L7a

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

ribosome (GO:0005840)

388697

HRNR

hornerin

multicellular organismal development (GO:0007275)

calcium ion binding (GO:0005509)

440686

HIST2H3PS2

histone cluster 2, H3, pseudogene 2

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

440733

LOC440733

similar to insulinoma protein (rig)

translation (GO:0006412)

structural constituent of ribosome (GO:0003735)

small ribosomal subunit (GO:0015935)

440915

FKSG30

kappa-actin

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)

441531

PGAM4

phosphoglycerate mutase family member 4

glycolysis (GO:0006096)

bisphosphoglycerate 2-phosphatase activity (GO:0004083)

554313

HIST2H4B

histone cluster 2, H4b

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

641455

P704P

prostate-specific P704P

protein binding (GO:0005515)

646821

LOC646821

similar to beta-actin

protein binding (GO:0005515)

653852

LOC653852

similar to Filamin-C (Gamma-filamin) (Filamin-2) (Protein FLNc) (Actin-binding-like protein) (ABP-L) (ABP-280-like protein)

72

ACTG2

actin, gamma 2, smooth muscle, enteric

ATP binding (GO:0005524)

213

ALB

albumin

hemolysis by symbiont of host red blood cells
(GO:0019836)

3371

TNC

tenascin C (hexabrachion)

signal transduction (GO:0007165)

11117

EMILIN1

26154

ABCA12

55239

OGFOD1

elastin microfibril interfacer 1
ATP-binding cassette, sub-family A (ABC1),
member 12
2-oxoglutarate and iron-dependent oxygenase
domain containing 1

374454

KRT77

keratin 77

copper ion binding (GO:0005507)

nucleus (GO:0005634)

cytoskeleton (GO:0005856)
platelet alpha granule lumen
(GO:0031093)
proteinaceous extracellular matrix
(GO:0005578)

phosphate transport (GO:0006817)

receptor binding (GO:0005102)
extracellular matrix structural constituent
(GO:0005201)

cytoplasm (GO:0005737)

lipid transport (GO:0006869)

ATPase activity (GO:0016887)

integral to membrane (GO:0016021)

protein metabolic process (GO:0019538)

iron ion binding (GO:0005506)
structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

222
Results acquired from proteomic analysis of acellular HDF
Proteins

Gene Symbol

Description

290

ANPEP

Biological Process_max

Molecular Function_max

Cellular Component_max

aminopeptidase activity (GO:0004177)

integral to plasma membrane
(GO:0005887)

309

ANXA6

alanyl (membrane) aminopeptidase (aminopeptidase N, proteolysis (GO:0006508)
aminopeptidase M, microsomal aminopeptidase, CD13,
p150)
annexin A6

483

ATP1B3

ATPase, Na+/K+ transporting, beta 3 polypeptide

potassium ion transport (GO:0006813)

493

ATP2B4

ATPase, Ca++ transporting, plasma membrane 4

calcium ion transport (GO:0006816)

857

CAV1

caveolin 1, caveolae protein, 22kDa

960

CD44

CD44 molecule (Indian blood group)

1072

CFL1

cofilin 1 (non-muscle)

anti-apoptosis (GO:0006916)

actin binding (GO:0003779)

integral to plasma membrane
(GO:0005887)
integral to plasma membrane
(GO:0005887)
integral to plasma membrane
(GO:0005887)
nucleus (GO:0005634)

1277

COL1A1

collagen, type I, alpha 1

phosphate transport (GO:0006817)

1291

COL6A1

collagen, type VI, alpha 1

phosphate transport (GO:0006817)

extracellular matrix structural constituent
(GO:0005201)
protein binding (GO:0005515)

collagen type VI (GO:0005589)

1292

COL6A2

collagen, type VI, alpha 2

phosphate transport (GO:0006817)

protein binding, bridging (GO:0030674)

cytoplasm (GO:0005737)

1293

COL6A3

collagen, type VI, alpha 3

phosphate transport (GO:0006817)

1915

EEF1A1

eukaryotic translation elongation factor 1 alpha 1

translational elongation (GO:0006414)

serine-type endopeptidase inhibitor activity
(GO:0004867)
GTPase activity (GO:0003924)

cytosol (GO:0005829)

1917

EEF1A2

eukaryotic translation elongation factor 1 alpha 2

translational elongation (GO:0006414)

GTPase activity (GO:0003924)

nucleus (GO:0005634)

2200

FBN1

fibrillin 1

skeletal development (GO:0001501)

2316

FLNA

filamin A, alpha (actin binding protein 280)

actin cytoskeleton (GO:0015629)

2335

FN1

fibronectin 1

2597

GAPDH

glyceraldehyde-3-phosphate dehydrogenase

positive regulation of transcription factor
import into nucleus (GO:0042993)
transmembrane receptor protein tyrosine
kinase signaling pathway (GO:0007169)
glycolysis (GO:0006096)

transmembrane receptor activity
(GO:0004888)
actin filament binding (GO:0051015)

2778

GNAS

GNAS complex locus

3105

HLA-A

major histocompatibility complex, class I, A

3136

HLA-H

calcium ion binding (GO:0005509)

melanosome (GO:0042470)
melanosome (GO:0042470)

cholesterol homeostasis (GO:0042632)

sodium:potassium-exchanging ATPase
activity (GO:0005391)
calcium-transporting ATPase activity
(GO:0005388)
cholesterol binding (GO:0015485)

cell-matrix adhesion (GO:0007160)

hyaluronic acid binding (GO:0005540)

heparin binding (GO:0008201)
glyceraldehyde-3-phosphate
dehydrogenase (phosphorylating) activity
(GO:0004365)
GTPase activity (GO:0003924)

collagen type I (GO:0005584)

collagen type VI (GO:0005589)

microfibril (GO:0001527)

ER-Golgi intermediate compartment
(GO:0005793)
cytoplasm (GO:0005737)

3309

HSPA5

G-protein signaling, adenylate cyclase
activating pathway (GO:0007189)
antigen processing and presentation of
peptide antigen via MHC class I
(GO:0002474)
major histocompatibility complex, class I, H
antigen processing and presentation of
(pseudogene)
peptide antigen via MHC class I
(GO:0002474)
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)

heterotrimeric G-protein complex
(GO:0005834)
MHC class I receptor activity (GO:0032393) integral to plasma membrane
(GO:0005887)

3339

HSPG2

heparan sulfate proteoglycan 2

cell adhesion (GO:0007155)

protein binding (GO:0005515)

basement membrane (GO:0005604)

3688

ITGB1
KRT2

integrin-mediated signaling pathway
(GO:0007229)
epidermis development (GO:0008544)

3857

KRT9

keratin 9 (epidermolytic palmoplantar keratoderma)

3858

KRT10

keratin 10 (epidermolytic hyperkeratosis; keratosis
palmaris et plantaris)

intermediate filament organization
(GO:0045109)
epidermis development (GO:0008544)

protein heterodimerization activity
(GO:0046982)
structural constituent of cytoskeleton
(GO:0005200)
structural constituent of cytoskeleton
(GO:0005200)
protein binding (GO:0005515)

melanosome (GO:0042470)

3849

integrin, beta 1 (fibronectin receptor, beta polypeptide,
antigen CD29 includes MDF2, MSK12)
keratin 2 (epidermal ichthyosis bullosa of Siemens)

MHC class I receptor activity (GO:0032393) integral to plasma membrane
(GO:0005887)
ATP binding (GO:0005524)

endoplasmic reticulum (GO:0005783)

intermediate filament (GO:0005882)
intermediate filament (GO:0005882)
intermediate filament (GO:0005882)

223
3888

KRT82

keratin 82

protein binding (GO:0005515)

4000

LMNA

lamin A/C

4627

MYH9

myosin, heavy chain 9, non-muscle

5315

PKM2

pyruvate kinase, muscle

5630

PRPH

peripherin

6184

RPN1

ribophorin I

6513

SLC2A1

7011

TEP1

solute carrier family 2 (facilitated glucose transporter),
member 1
telomerase-associated protein 1

7057

THBS1

thrombospondin 1

telomere maintenance via recombination
(GO:0000722)
nervous system development (GO:0007399)

7070

THY1

Thy-1 cell surface antigen

retinal cone cell development (GO:0046549)

membrane protein ectodomain proteolysis
(GO:0006509)
glycolysis (GO:0006096)

protein amino acid N-linked glycosylation via
asparagine (GO:0018279)
glucose transport (GO:0015758)

7277

TUBA4A

tubulin, alpha 4a

microtubule-based movement (GO:0007018)

7431

VIM

vimentin

cell motility (GO:0006928)

intermediate filament (GO:0005882)

protein binding (GO:0005515)

nucleus (GO:0005634)

actin-dependent ATPase activity
(GO:0030898)
pyruvate kinase activity (GO:0004743)

stress fiber (GO:0001725)
cytosol (GO:0005829)

structural molecule activity (GO:0005198)

intermediate filament (GO:0005882)

dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)
sugar:hydrogen symporter activity
(GO:0005351)
telomerase activity (GO:0003720)

melanosome (GO:0042470)

heparin binding (GO:0008201)
Rho GTPase activator activity
(GO:0005100)
GTPase activity (GO:0003924)

melanosome (GO:0042470)
chromosome, telomeric region
(GO:0000781)
platelet alpha granule lumen
(GO:0031093)
integral to plasma membrane
(GO:0005887)
microtubule (GO:0005874)

structural constituent of cytoskeleton
cytoskeleton (GO:0005856)
(GO:0005200)
transcription cofactor activity (GO:0003712) NuA4 histone acetyltransferase
complex (GO:0035267)
microtubule plus-end binding
kinetochore microtubule (GO:0005828)
(GO:0051010)
GTPase activity (GO:0003924)
integral to membrane (GO:0016021)

8295

TRRAP

transformation/transcription domain-associated protein

histone acetylation (GO:0016573)

23332

CLASP1

cytoplasmic linker associated protein 1

negative regulation of microtubule
depolymerization (GO:0007026)

25923

ATL3

atlastin 3

27127

SMC1B

structural maintenance of chromosomes 1B

meiosis (GO:0007126)

ATPase activity (GO:0016887)

nucleus (GO:0005634)

27253

PCDH17

protocadherin 17

homophilic cell adhesion (GO:0007156)

calcium ion binding (GO:0005509)

integral to membrane (GO:0016021)

54734

RAB39

RAB39, member RAS oncogene family

small GTPase mediated signal transduction
(GO:0007264)

GTP binding (GO:0005525)

plasma membrane (GO:0005886)

57653

KIAA1529

KIAA1529

79026

AHNAK

AHNAK nucleoprotein

nervous system development (GO:0007399)

protein binding (GO:0005515)

nucleus (GO:0005634)

219770

GJD4

gap junction protein, delta 4, 40.1kDa

cell communication (GO:0007154)

284119

PTRF

polymerase I and transcript release factor

81

ACTN4

actinin, alpha 4

rRNA primary transcript binding
(GO:0042134)
actin filament binding (GO:0051015)

nucleus (GO:0005634)

actin binding (GO:0003779)

focal adhesion (GO:0005925)

receptor binding (GO:0005102)

integral to membrane (GO:0016021)

87

ACTN1

actinin, alpha 1

transcription initiation from RNA polymerase I
promoter (GO:0006361)
positive regulation of sodium:hydrogen
antiporter activity (GO:0032417)
regulation of apoptosis (GO:0042981)

214

ALCAM

activated leukocyte cell adhesion molecule

signal transduction (GO:0007165)

integral to membrane (GO:0016021)
microsome (GO:0005792)

226

ALDOA

aldolase A, fructose-bisphosphate

glycolysis (GO:0006096)

integral to plasma membrane
(GO:0005887)
fructose-bisphosphate aldolase activity (GO:0004332)

274

BIN1

bridging integrator 1

regulation of endocytosis (GO:0030100)

protein binding (GO:0005515)

actin cytoskeleton (GO:0015629)

301

ANXA1

annexin A1

anti-apoptosis (GO:0006916)

cornified envelope (GO:0001533)

302

ANXA2

annexin A2

skeletal development (GO:0001501)

311

ANXA11

annexin A11

immune response (GO:0006955)

phospholipase A2 inhibitor activity
(GO:0019834)
phospholipase inhibitor activity
(GO:0004859)
calcium ion binding (GO:0005509)

522

ATP5J

ATP synthase, H+ transporting, mitochondrial F0
complex, subunit F6

ATP synthesis coupled proton transport
(GO:0015986)

hydrogen ion transporting ATP synthase
activity, rotational mechanism
(GO:0046933)

melanosome (GO:0042470)
melanosome (GO:0042470)
mitochondrion (GO:0005739)

224
538

ATP7A

682

BSG

ATPase, Cu++ transporting, alpha polypeptide (Menkes T-helper cell differentiation (GO:0042093)
syndrome)
basigin (Ok blood group)
cell surface receptor linked signal
transduction (GO:0007166)
calreticulin
cellular calcium ion homeostasis
(GO:0006874)
calumenin

copper-exporting ATPase activity
(GO:0004008)
mannose binding (GO:0005537)

trans-Golgi network transport vesicle
(GO:0030140)
melanosome (GO:0042470)

zinc ion binding (GO:0008270)

endoplasmic reticulum (GO:0005783)

calcium ion binding (GO:0005509)

melanosome (GO:0042470)

811

CALR

813

CALU

821

CANX

calnexin

protein folding (GO:0006457)

calcium ion binding (GO:0005509)

melanosome (GO:0042470)

829

CAPZA1

capping protein (actin filament) muscle Z-line, alpha 1

actin binding (GO:0003779)

832

CAPZB

capping protein (actin filament) muscle Z-line, beta

actin binding (GO:0003779)

F-actin capping protein complex
(GO:0008290)
cytoplasm (GO:0005737)

871

SERPINH1

950

SCARB2

serpin peptidase inhibitor, clade H (heat shock protein
47), member 1, (collagen binding protein 1)
scavenger receptor class B, member 2

barbed-end actin filament capping
(GO:0051016)
barbed-end actin filament capping
(GO:0051016)
response to unfolded protein (GO:0006986)

serine-type endopeptidase inhibitor activity
(GO:0004867)
receptor activity (GO:0004872)

lysosomal membrane (GO:0005765)

966

CD59

CD59 molecule, complement regulatory protein

1192

CLIC1

chloride intracellular channel 1

cell adhesion (GO:0007155)
cell surface receptor linked signal
transduction (GO:0007166)
chloride transport (GO:0006821)

protein binding (GO:0005515)

anchored to membrane (GO:0031225)

voltage-gated chloride channel activity
(GO:0005247)
calcium ion binding (GO:0005509)

nucleus (GO:0005634)

1212

CLTB

clathrin, light chain (Lcb)

intracellular protein transport (GO:0006886)

1278

COL1A2

collagen, type I, alpha 2

phosphate transport (GO:0006817)

extracellular matrix structural constituent
(GO:0005201)
zinc ion binding (GO:0008270)
aldo-keto reductase activity (GO:0004033)

1465

CSRP1

cysteine and glycine-rich protein 1

1528

CYB5A

cytochrome b5 type A (microsomal)

1727

CYB5R3

cytochrome b5 reductase 3

generation of precursor metabolites and
energy (GO:0006091)
iron ion transport (GO:0006826)

1803

DPP4

1808

DPYSL2

dipeptidyl-peptidase 4 (CD26, adenosine deaminase
complexing protein 2)
dihydropyrimidinase-like 2

regulation of cell-cell adhesion mediated by
integrin (GO:0033632)
nervous system development (GO:0007399)

1809

DPYSL3

dihydropyrimidinase-like 3

nervous system development (GO:0007399)

1936

EEF1D

2023

ENO1

eukaryotic translation elongation factor 1 delta (guanine positive regulation of I-kappaB kinase/NFnucleotide exchange protein)
kappaB cascade (GO:0043123)
enolase 1, (alpha)
glycolysis (GO:0006096)

2027

ENO3

enolase 3 (beta, muscle)

glycolysis (GO:0006096)

2271

FH

fumarate hydratase

tricarboxylic acid cycle (GO:0006099)

2274

FHL2

four and a half LIM domains 2

2317

FLNB

filamin B, beta (actin binding protein 278)

androgen receptor signaling pathway
(GO:0030521)
skeletal muscle development (GO:0007519)

2318

FLNC

filamin C, gamma (actin binding protein 280)

2734

GLG1

golgi apparatus protein 1

2923

PDIA3

protein disulfide isomerase family A, member 3

protein import into nucleus (GO:0006606)

2934

GSN

gelsolin (amyloidosis, Finnish type)

2950

GSTP1

glutathione S-transferase pi

barbed-end actin filament capping
(GO:0051016)
anti-apoptosis (GO:0006916)

3012

HIST1H2AE

histone cluster 1, H2ae

endoplasmic reticulum (GO:0005783)

clathrin coat of trans-Golgi network
vesicle (GO:0030130)
collagen type I (GO:0005584)
nucleus (GO:0005634)

cytochrome-b5 reductase activity
(GO:0004128)
aminopeptidase activity (GO:0004177)

mitochondrial outer membrane
(GO:0005741)
mitochondrial outer membrane
(GO:0005741)
integral to membrane (GO:0016021)

dihydropyrimidinase activity (GO:0004157)

cytoplasm (GO:0005737)

dihydropyrimidinase activity (GO:0004157)

cytoplasm (GO:0005737)

translation elongation factor activity
(GO:0003746)
transcription corepressor activity
(GO:0003714)
phosphopyruvate hydratase activity
(GO:0004634)
fumarate hydratase activity (GO:0004333)

cytosol (GO:0005829)

phosphopyruvate hydratase complex
(GO:0000015)
mitochondrial matrix (GO:0005759)

androgen receptor binding (GO:0050681)

nucleus (GO:0005634)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

fibroblast growth factor binding
(GO:0017134)
phospholipase C activity (GO:0004629)

Golgi membrane (GO:0000139)
melanosome (GO:0042470)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

glutathione transferase activity
(GO:0004364)

cytoplasm (GO:0005737)

nucleus (GO:0005634)
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3017

HIST1H2BD

histone cluster 1, H2bd

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

3106

HLA-B

major histocompatibility complex, class I, B

MHC class I receptor activity (GO:0032393) integral to plasma membrane
(GO:0005887)

3107

HLA-C

major histocompatibility complex, class I, C

3181

HNRNPA2B1

heterogeneous nuclear ribonucleoprotein A2/B1

3184

HNRNPD

3187

HNRNPH1

heterogeneous nuclear ribonucleoprotein D (AU-rich
element RNA binding protein 1, 37kDa)
heterogeneous nuclear ribonucleoprotein H1 (H)

3190

HNRNPK

heterogeneous nuclear ribonucleoprotein K

3191

HNRNPL

heterogeneous nuclear ribonucleoprotein L

3305

HSPA1L

heat shock 70kDa protein 1-like

antigen processing and presentation of
peptide antigen via MHC class I
(GO:0002474)
antigen processing and presentation of
peptide antigen via MHC class I
(GO:0002474)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
response to unfolded protein (GO:0006986)

ATP binding (GO:0005524)

3306

HSPA2

heat shock 70kDa protein 2

male meiosis (GO:0007140)

ATP binding (GO:0005524)

cell surface (GO:0009986)

3311

HSPA7

heat shock 70kDa protein 7 (HSP70B)

response to unfolded protein (GO:0006986)

ATP binding (GO:0005524)

cellular_component (GO:0005575)

3312

HSPA8

heat shock 70kDa protein 8

protein folding (GO:0006457)

ATPase activity, coupled (GO:0042623)

melanosome (GO:0042470)

3313

HSPA9

heat shock 70kDa protein 9 (mortalin)

anti-apoptosis (GO:0006916)

ATP binding (GO:0005524)

mitochondrion (GO:0005739)

3315

HSPB1

heat shock 27kDa protein 1

anti-apoptosis (GO:0006916)

identical protein binding (GO:0042802)

nucleus (GO:0005634)

3320

HSP90AA1

ATP binding (GO:0005524)

melanosome (GO:0042470)

3326

HSP90AB1

ATP binding (GO:0005524)

melanosome (GO:0042470)

3329

HSPD1

heat shock protein 90kDa alpha (cytosolic), class A
member 1
heat shock protein 90kDa alpha (cytosolic), class B
member 1
heat shock 60kDa protein 1 (chaperonin)

3371

TNC

tenascin C (hexabrachion)

positive regulation of nitric oxide biosynthetic
process (GO:0045429)
positive regulation of nitric oxide biosynthetic
process (GO:0045429)
protein import into mitochondrial matrix
(GO:0030150)
signal transduction (GO:0007165)

3848

KRT1

keratin 1 (epidermolytic hyperkeratosis)

fibrinolysis (GO:0042730)

3856

KRT8

keratin 8

cytoskeleton organization and biogenesis
(GO:0007010)
translational elongation (GO:0006414)

nucleus (GO:0005634)

MHC class I receptor activity (GO:0032393) axonemal dynein complex
(GO:0005858)
single-stranded telomeric DNA binding
(GO:0043047)
DNA binding (GO:0003677)

nucleus (GO:0005634)

poly(U) binding (GO:0008266)

chromosome, telomeric region
(GO:0000781)
nucleus (GO:0005634)

DNA binding (GO:0003677)

nucleus (GO:0005634)

RNA binding (GO:0003723)

nucleus (GO:0005634)

ATP binding (GO:0005524)

mitochondrial matrix (GO:0005759)

receptor binding (GO:0005102)
receptor activity (GO:0004872)

proteinaceous extracellular matrix
(GO:0005578)
cytoskeleton (GO:0005856)

protein binding (GO:0005515)

intermediate filament (GO:0005882)

structural constituent of ribosome
(GO:0003735)
IgE binding (GO:0019863)

cytosolic small ribosomal subunit
(GO:0022627)
nucleus (GO:0005634)

actin filament binding (GO:0051015)

actin cytoskeleton (GO:0015629)

3921

RPSA

ribosomal protein SA

3958

LGALS3

lectin, galactoside-binding, soluble, 3

4082

MARCKS

myristoylated alanine-rich protein kinase C substrate

4267

CD99

CD99 molecule

cell adhesion (GO:0007155)

protein binding (GO:0005515)

4637

MYL6

muscle filament sliding (GO:0030049)

4676

NAP1L4

myosin, light chain 6, alkali, smooth muscle and nonmuscle
nucleosome assembly protein 1-like 4

actin-dependent ATPase activity
(GO:0030898)
unfolded protein binding (GO:0051082)

integral to plasma membrane
(GO:0005887)
unconventional myosin complex
(GO:0016461)
nucleus (GO:0005634)

4691

NCL

nucleolin

angiogenesis (GO:0001525)

DNA binding (GO:0003677)

nucleus (GO:0005634)

4830

NME1

non-metastatic cells 1, protein (NM23A) expressed in

GTP biosynthetic process (GO:0006183)

ATP binding (GO:0005524)

nucleus (GO:0005634)

4841

NONO

non-POU domain containing, octamer-binding

mRNA processing (GO:0006397)

DNA binding (GO:0003677)

nucleus (GO:0005634)

4914

NTRK1

neurotrophic tyrosine kinase, receptor, type 1

activation of adenylate cyclase activity
(GO:0007190)

4924

NUCB1

nucleobindin 1

transmembrane receptor protein tyrosine
kinase activity (GO:0004714)
calcium ion binding (GO:0005509)

integral to plasma membrane
(GO:0005887)
ER-Golgi intermediate compartment
(GO:0005793)

cell motility (GO:0006928)

nucleosome assembly (GO:0006334)
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4925

NUCB2

nucleobindin 2

5034

P4HB

peptidyl-proline hydroxylation to 4-hydroxy-Lproline (GO:0018401)
skeletal development (GO:0001501)

procollagen-proline 4-dioxygenase activity
(GO:0004656)
peroxiredoxin activity (GO:0051920)

glycolysis (GO:0006096)

5052

PRDX1

procollagen-proline, 2-oxoglutarate 4-dioxygenase
(proline 4-hydroxylase), beta polypeptide
peroxiredoxin 1

5223

PGAM1

phosphoglycerate mutase 1 (brain)

calcium ion binding (GO:0005509)

ER-Golgi intermediate compartment
(GO:0005793)
melanosome (GO:0042470)
melanosome (GO:0042470)

5230

PGK1

phosphoglycerate kinase 1

glycolysis (GO:0006096)

bisphosphoglycerate 2-phosphatase activity cytosol (GO:0005829)
(GO:0004083)
ATP binding (GO:0005524)
cytoplasm (GO:0005737)

5232

PGK2

phosphoglycerate kinase 2

glycolysis (GO:0006096)

ATP binding (GO:0005524)

cytosol (GO:0005829)

5339

PLEC1

plectin 1, intermediate filament binding protein 500kDa

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

5478

PPIA

peptidylprolyl isomerase A (cyclophilin A)

cytoskeletal anchoring at plasma membrane
(GO:0007016)
provirus integration (GO:0019047)

PPIB

peptidylprolyl isomerase B (cyclophilin B)

protein folding (GO:0006457)

5589

PRKCSH

protein kinase C substrate 80K-H

protein kinase cascade (GO:0007243)

peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)
peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)
calcium ion binding (GO:0005509)

nucleus (GO:0005634)

5479

5686

PSMA5

5713

PSMD7

5725

PTBP1

6125

RPL5

proteasome (prosome, macropain) subunit, alpha type, anaphase-promoting complex-dependent
5
proteasomal ubiquitin-dependent protein
catabolic process (GO:0031145)
proteasome (prosome, macropain) 26S subunit, nonanaphase-promoting complex-dependent
ATPase, 7
proteasomal ubiquitin-dependent protein
catabolic process (GO:0031145)
polypyrimidine tract binding protein 1
nuclear mRNA splicing, via spliceosome
(GO:0000398)
ribosomal protein L5
translational elongation (GO:0006414)

6128

RPL6

ribosomal protein L6

6147

RPL23A

ribosomal protein L23a

regulation of transcription, DNA-dependent
(GO:0006355)
translational elongation (GO:0006414)

6176

RPLP1

ribosomal protein, large, P1

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6206

RPS12

ribosomal protein S12

translational elongation (GO:0006414)

RNA binding (GO:0003723)

melanosome (GO:0042470)
endoplasmic reticulum (GO:0005783)

threonine endopeptidase activity
(GO:0004298)

nucleus (GO:0005634)

protein binding (GO:0005515)

cytosol (GO:0005829)

poly-pyrimidine tract binding (GO:0008187) nucleus (GO:0005634)
5S rRNA binding (GO:0008097)
DNA binding (GO:0003677)
rRNA binding (GO:0019843)

cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic small ribosomal subunit
(GO:0022627)
ribosome (GO:0005840)

6233

RPS27A

ribosomal protein S27a

protein modification process (GO:0006464)

zinc ion binding (GO:0008270)

6238

RRBP1

ribosome binding protein 1 homolog 180kDa (dog)

receptor activity (GO:0004872)

6281

S100A10

S100 calcium binding protein A10

intracellular protein transport across a
membrane (GO:0065002)
signal transduction (GO:0007165)

6421

SFPQ

mRNA processing (GO:0006397)

DNA binding (GO:0003677)

nucleus (GO:0005634)

response to superoxide (GO:0000303)

manganese ion binding (GO:0030145)

mitochondrial matrix (GO:0005759)

actin binding (GO:0003779)

cytosol (GO:0005829)

actin binding (GO:0003779)

nucleolus (GO:0005730)

6648

SOD2

splicing factor proline/glutamine-rich (polypyrimidine
tract binding protein associated)
superoxide dismutase 2, mitochondrial

6709

SPTAN1

spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)

6711

SPTBN1

spectrin, beta, non-erythrocytic 1

integral to endoplasmic reticulum
membrane (GO:0030176)

calcium ion binding (GO:0005509)

6876

TAGLN

transgelin

barbed-end actin filament capping
(GO:0051016)
barbed-end actin filament capping
(GO:0051016)
muscle development (GO:0007517)

actin binding (GO:0003779)

cytoplasm (GO:0005737)

7086

TKT

transketolase (Wernicke-Korsakoff syndrome)

metabolic process (GO:0008152)

transketolase activity (GO:0004802)

cytosol (GO:0005829)

7170

TPM3

tropomyosin 3

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

7171

TPM4

tropomyosin 4

regulation of muscle contraction
(GO:0006937)
cell motility (GO:0006928)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

7184

HSP90B1

heat shock protein 90kDa beta (Grp94), member 1

anti-apoptosis (GO:0006916)

ATP binding (GO:0005524)

melanosome (GO:0042470)
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7273

TTN

titin

7381

UQCRB

ubiquinol-cytochrome c reductase binding protein

regulation of Rho protein signal transduction
(GO:0035023)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
aerobic respiration (GO:0009060)

7307

U2AF1

U2 small nuclear RNA auxiliary factor 1

7415

VCP

valosin-containing protein

caspase activation (GO:0006919)

7416

VDAC1

voltage-dependent anion channel 1

apoptotic program (GO:0008632)

7417

VDAC2

voltage-dependent anion channel 2

anion transport (GO:0006820)

7520

XRCC5

double-strand break repair via
nonhomologous end joining (GO:0006303)

7529

YWHAB

protein serine/threonine kinase activity
(GO:0004674)
zinc ion binding (GO:0008270)

condensed nuclear chromosome
(GO:0000794)
Cajal body (GO:0015030)

ubiquinol-cytochrome-c reductase activity
(GO:0008121)
ATPase activity (GO:0016887)

mitochondrion (GO:0005739)

voltage-gated anion channel activity
(GO:0008308)
voltage-gated anion channel activity
(GO:0008308)
ATP binding (GO:0005524)

mitochondrial outer membrane
(GO:0005741)
mitochondrial outer membrane
(GO:0005741)
nucleus (GO:0005634)

monooxygenase activity (GO:0004497)

melanosome (GO:0042470)

microsome (GO:0005792)

7532

YWHAG

7534

YWHAZ

8335

HIST1H2AB

X-ray repair complementing defective repair in Chinese
hamster cells 5 (double-strand-break rejoining; Ku
autoantigen, 80kDa)
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, beta polypeptide
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, gamma polypeptide
tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, zeta polypeptide
histone cluster 1, H2ab

8339

HIST1H2BG

histone cluster 1, H2bg

8343

HIST1H2BF

histone cluster 1, H2bf

8344

HIST1H2BE

histone cluster 1, H2be

8346

HIST1H2BI

histone cluster 1, H2bi

8347

HIST1H2BC

histone cluster 1, H2bc

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

8348

HIST1H2BO

histone cluster 1, H2bo

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

8411

EEA1

early endosome antigen 1

vesicle fusion (GO:0006906)

phosphatidylinositol binding (GO:0005545)

early endosome membrane
(GO:0031901)
Golgi apparatus (GO:0005794)

activation of pro-apoptotic gene products
(GO:0008633)
negative regulation of protein kinase activity
(GO:0006469)
anti-apoptosis (GO:0006916)

protein kinase C binding (GO:0005080)

cytoplasm (GO:0005737)

transcription factor binding (GO:0008134)

melanosome (GO:0042470)

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

nucleus (GO:0005634)

8546

AP3B1

adaptor-related protein complex 3, beta 1 subunit

endocytosis (GO:0006897)

protein binding (GO:0005515)

8570

KHSRP

KH-type splicing regulatory protein

mRNA processing (GO:0006397)

8826

IQGAP1

IQ motif containing GTPase activating protein 1

8880

FUBP1

far upstream element (FUSE) binding protein 1

9217

VAPB

9218

VAPA

9991

ROD1

VAMP (vesicle-associated membrane protein)associated protein B and C
VAMP (vesicle-associated membrane protein)associated protein A, 33kDa
ROD1 regulator of differentiation 1 (S. pombe)

regulation of small GTPase mediated signal
transduction (GO:0051056)
transcription from RNA polymerase II
promoter (GO:0006366)
endoplasmic reticulum unfolded protein
response (GO:0030968)
positive regulation of I-kappaB kinase/NFkappaB cascade (GO:0043123)
mRNA processing (GO:0006397)

RNA splicing factor activity,
nucleus (GO:0005634)
transesterification mechanism
(GO:0031202)
Ras GTPase activator activity
actin filament (GO:0005884)
(GO:0005099)
single-stranded DNA binding (GO:0003697) nucleus (GO:0005634)

10092

ARPC5

actin related protein 2/3 complex, subunit 5, 16kDa

10146

G3BP1

beta-tubulin binding (GO:0048487)

endoplasmic reticulum (GO:0005783)

protein heterodimerization activity
(GO:0046982)
RNA binding (GO:0003723)

tight junction (GO:0005923)

actin cytoskeleton organization and
actin binding (GO:0003779)
biogenesis (GO:0030036)
Ras protein signal transduction (GO:0007265) ATP binding (GO:0005524)

10151

HNRNPA3P1

GTPase activating protein (SH3 domain) binding
protein 1
heterogeneous nuclear ribonucleoprotein A3 pseudogene 1

10236

HNRNPR

heterogeneous nuclear ribonucleoprotein R

10250

SRRM1

serine/arginine repetitive matrix 1

nuclear mRNA splicing, via spliceosome
(GO:0000398)
nuclear mRNA splicing, via spliceosome
(GO:0000398)

nucleus (GO:0005634)
cytoplasm (GO:0005737)
nucleus (GO:0005634)

RNA binding (GO:0003723)

nucleus (GO:0005634)

RNA splicing factor activity,
transesterification mechanism
(GO:0031202)

nuclear speck (GO:0016607)
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10382

TUBB4

tubulin, beta 4

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

cytoskeleton (GO:0005856)

steroid hormone receptor activity
(GO:0003707)
actin binding (GO:0003779)

integral to membrane (GO:0016021)

zinc ion binding (GO:0008270)

synaptic vesicle (GO:0008021)

10424

PGRMC2

progesterone receptor membrane component 2

10487

CAP1

CAP, adenylate cyclase-associated protein 1 (yeast)

10493

VAT1

10540

DCTN2

vesicle amine transport protein 1 homolog (T.
californica)
dynactin 2 (p50)

microtubule-based process (GO:0007017)

protein binding (GO:0005515)

centrosome (GO:0005813)

10549

PRDX4

peroxiredoxin 4

I-kappaB phosphorylation (GO:0007252)

10581

IFITM2

interferon induced transmembrane protein 2 (1-8D)

immune response (GO:0006955)

thioredoxin peroxidase activity
(GO:0008379)
protein binding (GO:0005515)

integral to membrane (GO:0016021)

10726

NUDC

nuclear distribution gene C homolog (A. nidulans)

mitosis (GO:0007067)

protein binding (GO:0005515)

nucleus (GO:0005634)

10857

PGRMC1

progesterone receptor membrane component 1

10935

PRDX3

peroxiredoxin 3

10959

TMED2

transmembrane emp24 domain trafficking protein 2

10963

STIP1

response to stress (GO:0006950)

binding (GO:0005488)

10970

CKAP4

stress-induced-phosphoprotein 1 (Hsp70/Hsp90organizing protein)
cytoskeleton-associated protein 4

10971

YWHAQ

11034

DSTN

tyrosine 3-monooxygenase/tryptophan 5monooxygenase activation protein, theta polypeptide
destrin (actin depolymerizing factor)

protein kinase C inhibitor activity
(GO:0008426)
actin binding (GO:0003779)

11052

CPSF6

cleavage and polyadenylation specific factor 6, 68kDa

negative regulation of transcription, DNAdependent (GO:0045892)
actin polymerization and/or depolymerization
(GO:0008154)
mRNA processing (GO:0006397)

RNA binding (GO:0003723)

paraspeckles (GO:0042382)

11171

STRAP

serine/threonine kinase receptor associated protein

mRNA processing (GO:0006397)

protein binding (GO:0005515)

nucleus (GO:0005634)

11328

FKBP9

FK506 binding protein 9, 63 kDa

protein folding (GO:0006457)

endoplasmic reticulum (GO:0005783)

11335

CBX3

chromatin remodeling (GO:0006338)
protein folding (GO:0006457)

peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)
protein domain specific binding
(GO:0019904)
ATP binding (GO:0005524)

nuclear centromeric heterochromatin
(GO:0031618)
cytoplasm (GO:0005737)

carbohydrate metabolic process
(GO:0005975)
cholesterol efflux (GO:0033344)

glucan 1,3-alpha-glucosidase activity
(GO:0033919)
SNAP receptor activity (GO:0005484)

phagocytic vesicle (GO:0045335)

22948

CCT5

chromobox homolog 3 (HP1 gamma homolog,
Drosophila)
chaperonin containing TCP1, subunit 5 (epsilon)

23193

GANAB

glucosidase, alpha; neutral AB

23673

STX12

syntaxin 12

activation of adenylate cyclase activity
(GO:0007190)
cell growth (GO:0016049)

transition metal ion binding (GO:0046914)
positive regulation of NF-kappaB transcription alkyl hydroperoxide reductase activity
factor activity (GO:0051092)
(GO:0008785)
protein transport (GO:0015031)
protein binding (GO:0005515)

plasma membrane (GO:0005886)

cytoplasm (GO:0005737)

microsome (GO:0005792)
mitochondrion (GO:0005739)
zymogen granule membrane
(GO:0042589)
nucleus (GO:0005634)
integral to membrane (GO:0016021)
cytoplasm (GO:0005737)
actin cytoskeleton (GO:0015629)

melanosome (GO:0042470)

26237
26355

FAM162A

family with sequence similarity 162, member A

26509

FER1L3

fer-1-like 3, myoferlin (C. elegans)

integral to membrane (GO:0016021)
muscle contraction (GO:0006936)

nucleus (GO:0005634)

29978

UBQLN2

ubiquilin 2

protein modification process (GO:0006464)

binding (GO:0005488)

nucleus (GO:0005634)

29979

UBQLN1

ubiquilin 1

protein modification process (GO:0006464)

kinase binding (GO:0019900)

nucleus (GO:0005634)

50809

HP1BP3

heterochromatin protein 1, binding protein 3

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

51060

TXNDC12

cell redox homeostasis (GO:0045454)

YBX2

protein-disulfide reductase (glutathione)
activity (GO:0019153)
DNA binding (GO:0003677)

endoplasmic reticulum (GO:0005783)

51087

thioredoxin domain containing 12 (endoplasmic
reticulum)
Y box binding protein 2

51132

RNF12

ring finger protein 12

54344

DPM3

dolichyl-phosphate mannosyltransferase polypeptide 3

transcription corepressor activity
(GO:0003714)
dolichyl-phosphate beta-Dmannosyltransferase activity (GO:0004582)

transcriptional repressor complex
(GO:0017053)
integral to endoplasmic reticulum
membrane (GO:0030176)

transcription from RNA polymerase II
promoter (GO:0006366)
regulation of transcription, DNA-dependent
(GO:0006355)
protein amino acid C-linked glycosylation via
2'-alpha-mannosyl-L-tryptophan

nucleus (GO:0005634)

229
(GO:0018406)
55752

11-Sep

septin 11

protein heterooligomerization (GO:0051291)

GTP binding (GO:0005525)

stress fiber (GO:0001725)

55970

GNG12
RNF20

G-protein coupled receptor protein signaling
pathway (GO:0007186)
chromatin modification (GO:0016568)

signal transducer activity (GO:0004871)

56254

guanine nucleotide binding protein (G protein), gamma
12
ring finger protein 20

56969

RPL23AP13

ribosomal protein L23a pseudogene 13

57142

RTN4

reticulon 4

57153

SLC44A2

solute carrier family 44, member 2

65992

C20orf116

chromosome 20 open reading frame 116

80184

CEP290

centrosomal protein 290kDa

81567

TXNDC5

thioredoxin domain containing 5

81873

ARPC5L

actin related protein 2/3 complex, subunit 5-like

90462

ZNF605

zinc finger protein 605

92689

FAM114A1

family with sequence similarity 114, member A1

negative regulation of axon extension
(GO:0030517)
positive regulation of I-kappaB kinase/NFkappaB cascade (GO:0043123)

zinc ion binding (GO:0008270)

heterotrimeric G-protein complex
(GO:0005834)
nucleus (GO:0005634)

nucleotide binding (GO:0000166)

ribosome (GO:0005840)

protein binding (GO:0005515)

integral to endoplasmic reticulum
membrane (GO:0030176)
integral to membrane (GO:0016021)

choline transmembrane transporter activity
(GO:0015220)
protein binding (GO:0005515)

extracellular region (GO:0005576)

eye photoreceptor cell development
(GO:0042462)
anti-apoptosis (GO:0006916)

microtubule minus-end binding
(GO:0051011)
isomerase activity (GO:0016853)

centrosome (GO:0005813)
endoplasmic reticulum (GO:0005783)

regulation of actin filament polymerization
(GO:0030833)
regulation of transcription, DNA-dependent
(GO:0006355)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)
cytoplasm (GO:0005737)

113146

AHNAK2

AHNAK nucleoprotein 2

keratinization (GO:0031424)

protein binding (GO:0005515)

nucleus (GO:0005634)

114799

ESCO1

establishment of cohesion 1 homolog 1 (S. cerevisiae)

DNA repair (GO:0006281)

zinc ion binding (GO:0008270)

nucleus (GO:0005634)

protein binding (GO:0005515)

integral to membrane (GO:0016021)

calcium ion binding (GO:0005509)

muscle myosin complex (GO:0005859)

114990

VASN

vasorin

126961

HIST2H3C

histone cluster 2, H3c

140465

MYL6B

140576

S100A16

myosin, light chain 6B, alkali, smooth muscle and nonmuscle
S100 calcium binding protein A16

158358

KIAA2026

KIAA2026

167227

DCP2

DCP2 decapping enzyme homolog (S. cerevisiae)

222068

TMED4

transmembrane emp24 protein transport domain
containing 4

287023

muscle filament sliding (GO:0030049)

calcium ion binding (GO:0005509)

nuclear-transcribed mRNA catabolic process, manganese ion binding (GO:0030145)
nucleus (GO:0005634)
nonsense-mediated decay (GO:0000184)
positive regulation of I-kappaB kinase/NFsignal transducer activity (GO:0004871)
integral to membrane (GO:0016021)
kappaB cascade (GO:0043123)
mRNA processing (GO:0006397)
single-stranded DNA binding (GO:0003697) nucleus (GO:0005634)

343069

HNRNPCL1

heterogeneous nuclear ribonucleoprotein C-like 1

RNA binding (GO:0003723)

nucleus (GO:0005634)

345651

ACTBL2

actin, beta-like 2

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)

347701

LOC347701

calgizzarin-like

360132

FKBP9L

FK506 binding protein 9-like

protein folding (GO:0006457)

calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

375775

PNPLA7

patatin-like phospholipase domain containing 7

lipid metabolic process (GO:0006629)

hydrolase activity (GO:0016787)

integral to membrane (GO:0016021)

440686

HIST2H3PS2

histone cluster 2, H3, pseudogene 2

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

440915

FKSG30

kappa-actin

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)

441531

PGAM4

phosphoglycerate mutase family member 4

641455

P704P

prostate-specific P704P

440055

glycolysis (GO:0006096)

bisphosphoglycerate 2-phosphatase activity (GO:0004083)
protein binding (GO:0005515)

230
642461

LOC642461

similar to Isoleucyl-tRNA synthetase, mitochondrial precursor (Isoleucine--tRNA ligase) (IleRS)

646821

LOC646821

similar to beta-actin

653852

LOC653852

similar to Filamin-C (Gamma-filamin) (Filamin-2) (Protein FLNc) (Actin-binding-like protein) (ABP-L) (ABP-280-like protein)

850981

SMD2

30

ACAA1

protein binding (GO:0005515)

38

ACAT1

47

ACLY

Core Sm protein Sm D2; part of heteroheptameric
complex (with Smb1p, Smd1p, Smd3p, Sme1p, Smx3p,
and Smx2p) that is part of the spliceosomal U1, U2, U4,
and U5 snRNPs; homolog of human Sm D2
acetyl-Coenzyme A acyltransferase 1 (peroxisomal 3oxoacyl-Coenzyme A thiolase)
acetyl-Coenzyme A acetyltransferase 1 (acetoacetyl
Coenzyme A thiolase)
ATP citrate lyase

59

ACTA2

actin, alpha 2, smooth muscle, aorta

60

ACTB

actin, beta

sensory perception of sound (GO:0007605)

ATP binding (GO:0005524)

sensory perception of sound (GO:0007605)

ATP binding (GO:0005524)

71

ACTG1

actin, gamma 1

72

ACTG2

actin, gamma 2, smooth muscle, enteric

160

AP2A1

adaptor-related protein complex 2, alpha 1 subunit

nuclear mRNA splicing, via spliceosome
(GO:0000398)

RNA splicing factor activity,
transesterification mechanism
(GO:0031202)

nucleus (GO:0005634)

fatty acid metabolic process (GO:0006631)

acetyl-CoA C-acyltransferase activity
(GO:0003988)
acetyl-CoA C-acetyltransferase activity
(GO:0003985)
succinate-CoA ligase (ADP-forming) activity
(GO:0004775)
ATP binding (GO:0005524)

peroxisome (GO:0005777)

metabolic process (GO:0008152)
ATP catabolic process (GO:0006200)

regulation of defense response to virus by
virus (GO:0050690)
regulation of defense response to virus by
virus (GO:0050690)
nucleobase, nucleoside, nucleotide and
nucleic acid metabolic process (GO:0006139)
protein amino acid N-linked glycosylation
(GO:0006487)
apoptosis (GO:0006915)

cytoskeleton (GO:0005856)

protein binding (GO:0005515)
ATP binding (GO:0005524)

mitochondrial matrix (GO:0005759)

transmembrane receptor protein tyrosine
kinase activity (GO:0004714)
ATP:ADP antiporter activity (GO:0005471)

integral to plasma membrane
(GO:0005887)
mitochondrion (GO:0005739)

phospholipase inhibitor activity
(GO:0004859)
protein binding (GO:0005515)

cytoplasm (GO:0005737)

AP2B1

adaptor-related protein complex 2, beta 1 subunit
adenylate kinase 3-like 1

238

ALK

anaplastic lymphoma receptor tyrosine kinase

293

SLC25A6

308

ANXA5

solute carrier family 25 (mitochondrial carrier; adenine
nucleotide translocator), member 6
annexin A5

372

ARCN1

archain 1

COPI coating of Golgi vesicle (GO:0048205)

498

ATP5A1

ATP synthase, H+ transporting, mitochondrial F1
complex, alpha subunit 1, cardiac muscle

ATP synthesis coupled proton transport
(GO:0015986)

509

ATP5C1

ATP synthase, H+ transporting, mitochondrial F1
complex, gamma polypeptide 1

ATP synthesis coupled proton transport
(GO:0015986)

633

BGN

biglycan

800

CALD1

caldesmon 1

muscle contraction (GO:0006936)

hydrogen ion transporting ATP synthase
activity, rotational mechanism
(GO:0046933)
hydrogen ion transporting ATP synthase
activity, rotational mechanism
(GO:0046933)
extracellular matrix structural constituent
(GO:0005201)
actin binding (GO:0003779)

976

CD97

CD97 molecule

G-protein coupled receptor activity
(GO:0004930)
protein binding (GO:0005515)
extracellular matrix structural constituent
(GO:0005201)
heparin binding (GO:0008201)

CLTC

clathrin, heavy chain (Hc)

1282

COL4A1

collagen, type IV, alpha 1

phosphate transport (GO:0006817)

NuA4 histone acetyltransferase
complex (GO:0035267)
cytoskeleton (GO:0005856)

clathrin coat of trans-Golgi network
vesicle (GO:0030130)
cytosol (GO:0005829)

AK3L1

1213

cytoskeleton (GO:0005856)

protein binding (GO:0005515)

205

neuropeptide signaling pathway
(GO:0007218)
intracellular protein transport (GO:0006886)

cytosol (GO:0005829)

ATP binding (GO:0005524)

163

anti-apoptosis (GO:0006916)

mitochondrial matrix (GO:0005759)

1289

COL5A1

collagen, type V, alpha 1

phosphate transport (GO:0006817)

1303

COL12A1

collagen, type XII, alpha 1

phosphate transport (GO:0006817)

1314

COPA

coatomer protein complex, subunit alpha

COPI coating of Golgi vesicle (GO:0048205)

1329

COX5B

cytochrome c oxidase subunit Vb

respiratory gaseous exchange (GO:0007585) zinc ion binding (GO:0008270)

extracellular matrix structural constituent
conferring tensile strength (GO:0030020)
hormone activity (GO:0005179)

COPI vesicle coat (GO:0030126)
mitochondrial matrix (GO:0005759)

mitochondrial matrix (GO:0005759)

transport vesicle (GO:0030133)
cytoskeleton (GO:0005856)
integral to plasma membrane
(GO:0005887)
clathrin coat of trans-Golgi network
vesicle (GO:0030130)
cytoplasm (GO:0005737)
collagen type V (GO:0005588)
collagen type XII (GO:0005595)
microsome (GO:0005792)
mitochondrial inner membrane
(GO:0005743)

231
1495

CTNNA1

catenin (cadherin-associated protein), alpha 1, 102kDa apical junction assembly (GO:0043297)

vinculin binding (GO:0017166)

actin cytoskeleton (GO:0015629)

1508
1778

CTSB

cathepsin B

proteolysis (GO:0006508)

dynein, cytoplasmic 1, heavy chain 1

1832

DSP

desmoplakin

mitotic spindle organization and biogenesis
(GO:0007052)
peptide cross-linking (GO:0018149)

cysteine-type endopeptidase activity
(GO:0004197)
ATPase activity, coupled (GO:0042623)

lysosome (GO:0005764)

DYNC1H1

1937

EEF1G

eukaryotic translation elongation factor 1 gamma

translational elongation (GO:0006414)

1938

EEF2

eukaryotic translation elongation factor 2

translational elongation (GO:0006414)

translation elongation factor activity
(GO:0003746)
GTPase activity (GO:0003924)

1973

EIF4A1

eukaryotic translation initiation factor 4A, isoform 1

translation (GO:0006412)

ATP binding (GO:0005524)

glycolysis (GO:0006096)

2025

ENO1P

enolase 1, (alpha) pseudogene

2058

EPRS

glutamyl-prolyl-tRNA synthetase

2194

FASN

fatty acid synthase

2199

FBLN2

fibulin 2

2539

G6PD

glucose-6-phosphate dehydrogenase

2617

GARS

glycyl-tRNA synthetase

glycyl-tRNA aminoacylation (GO:0006426)

2673

GFPT1

glutamine-fructose-6-phosphate transaminase 1

fructose 6-phosphate metabolic process
(GO:0006002)

2876

GPX1

glutathione peroxidase 1

3008

HIST1H1E

histone cluster 1, H1e

3009

HIST1H1B

3030

HADHA

3032

HADHB

3151

protein binding, bridging (GO:0030674)

phosphopyruvate hydratase activity
(GO:0004634)
glutamyl-tRNA aminoacylation (GO:0006424) glutamate-tRNA ligase activity
(GO:0004818)
fatty acid biosynthetic process (GO:0006633) oleoyl-(acyl-carrier-protein) hydrolase
activity (GO:0004320)
calcium ion binding (GO:0005509)
glucose 6-phosphate utilization (GO:0006010) glucose-6-phosphate dehydrogenase
activity (GO:0004345)
glycine-tRNA ligase activity (GO:0004820)

cytoplasmic dynein complex
(GO:0005868)
cell-cell adherens junction
(GO:0005913)
cytosol (GO:0005829)
cytoplasm (GO:0005737)
cytosol (GO:0005829)
phosphopyruvate hydratase complex
(GO:0000015)
soluble fraction (GO:0005625)
melanosome (GO:0042470)
proteinaceous extracellular matrix
(GO:0005578)
cytosol (GO:0005829)
soluble fraction (GO:0005625)
cytoplasm (GO:0005737)

anti-apoptosis (GO:0006916)

glutamine-fructose-6-phosphate
transaminase (isomerizing) activity
(GO:0004360)
SH3 domain binding (GO:0017124)

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

histone cluster 1, H1b

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

fatty acid beta-oxidation (GO:0006635)

acetyl-CoA C-acetyltransferase activity
(GO:0003985)

mitochondrion (GO:0005739)

fatty acid beta-oxidation (GO:0006635)

acetyl-CoA C-acyltransferase activity
(GO:0003988)

mitochondrial matrix (GO:0005759)

HMGN2

hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacylCoenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), alpha subunit
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacylCoenzyme A thiolase/enoyl-Coenzyme A hydratase
(trifunctional protein), beta subunit
high-mobility group nucleosomal binding domain 2

DNA binding (GO:0003677)

chromatin (GO:0000785)

3159

HMGA1

high mobility group AT-hook 1

establishment and/or maintenance of
chromatin architecture (GO:0006325)
nucleosome disassembly (GO:0006337)

chromatin (GO:0000785)

3182

HNRNPAB

heterogeneous nuclear ribonucleoprotein A/B

3418

IDH2

isocitrate dehydrogenase 2 (NADP+), mitochondrial

positive regulation of gene-specific
transcription (GO:0043193)
tricarboxylic acid cycle (GO:0006099)

ligand-dependent nuclear receptor
transcription coactivator activity
(GO:0030374)
transcription factor activity (GO:0003700)

3615

IMPDH2

IMP (inosine monophosphate) dehydrogenase 2

GMP biosynthetic process (GO:0006177)

3799

KIF5B

kinesin family member 5B

3895

KTN1

kinectin 1 (kinesin receptor)

vesicle transport along microtubule
(GO:0047496)
microtubule-based movement (GO:0007018)

3915

LAMC1

laminin, gamma 1 (formerly LAMB2)

3939

LDHA

lactate dehydrogenase A

positive regulation of epithelial cell
proliferation (GO:0050679)
anaerobic glycolysis (GO:0019642)

4017

LOXL2

lysyl oxidase-like 2

protein modification process (GO:0006464)

mitochondrion (GO:0005739)

nucleus (GO:0005634)

isocitrate dehydrogenase (NADP+) activity mitochondrion (GO:0005739)
(GO:0004450)
IMP dehydrogenase activity (GO:0003938) cytosol (GO:0005829)
ATP binding (GO:0005524)

kinesin complex (GO:0005871)

receptor activity (GO:0004872)

integral to plasma membrane
(GO:0005887)
laminin-1 complex (GO:0005606)

extracellular matrix structural constituent
(GO:0005201)
L-lactate dehydrogenase activity
(GO:0004459)
protein-lysine 6-oxidase activity
(GO:0004720)

cytosol (GO:0005829)
extracellular space (GO:0005615)

232
4191

MDH2

malate dehydrogenase 2, NAD (mitochondrial)

4430

MYO1B

myosin IB

4628

MYH10

myosin, heavy chain 10, non-muscle

4629

MYH11

myosin, heavy chain 11, smooth muscle

4632

MYL1

4701

NDUFA7

4735

2-Sep

glycolysis (GO:0006096)

actin-dependent ATPase activity
(GO:0030898)
muscle thick filament assembly (GO:0030241) ATP binding (GO:0005524)

myosin, light chain 1, alkali; skeletal, fast

muscle filament sliding (GO:0030049)

calcium ion binding (GO:0005509)

striated muscle thick filament
(GO:0005863)
muscle myosin complex (GO:0005859)

NADH dehydrogenase (ubiquinone) 1 alpha
subcomplex, 7, 14.5kDa
septin 2

mitochondrial electron transport, NADH to
ubiquinone (GO:0006120)
cell cycle (GO:0007049)

NADH dehydrogenase (ubiquinone) activity mitochondrion (GO:0005739)
(GO:0008137)
GTP binding (GO:0005525)
nucleus (GO:0005634)

nuclear mRNA splicing, via spliceosome
(GO:0000398)
nucleotide catabolic process (GO:0009166)

double-stranded DNA binding
(GO:0003690)
5'-nucleotidase activity (GO:0008253)

nucleus (GO:0005634)

protein metabolic process (GO:0019538)

procollagen-proline 4-dioxygenase activity
(GO:0004656)
phosphoenolpyruvate carboxykinase (GTP)
activity (GO:0004613)
phosphoglucomutase activity
(GO:0004614)
phosphate carrier activity (GO:0015320)

endoplasmic reticulum (GO:0005783)

YBX1

Y box binding protein 1

NT5E

5'-nucleotidase, ecto (CD73)

5033

P4HA1

gluconeogenesis (GO:0006094)

5106

PCK2

procollagen-proline, 2-oxoglutarate 4-dioxygenase
(proline 4-hydroxylase), alpha polypeptide I
phosphoenolpyruvate carboxykinase 2 (mitochondrial)

5236

PGM1

phosphoglucomutase 1

glucose metabolic process (GO:0006006)

5250

SLC25A3

solute carrier family 25 (mitochondrial carrier;
phosphate carrier), member 3
serpin peptidase inhibitor, clade E (nexin, plasminogen
activator inhibitor type 1), member 2
protein kinase, DNA-activated, catalytic polypeptide

generation of precursor metabolites and
energy (GO:0006091)
regulation of proteolysis (GO:0030162)

SERPINE2
PRKDC

myosin complex (GO:0016459)
stress fiber (GO:0001725)

4907

5591

mitochondrial matrix (GO:0005759)

regulation of cell shape (GO:0008360)

4904

5270

L-malate dehydrogenase activity
(GO:0030060)
ATP binding (GO:0005524)

double-strand break repair via
nonhomologous end joining (GO:0006303)
protein amino acid phosphorylation
(GO:0006468)

serine-type endopeptidase inhibitor activity
(GO:0004867)
DNA-dependent protein kinase activity
(GO:0004677)
MAP kinase activity (GO:0004707)

anchored to membrane (GO:0031225)

mitochondrion (GO:0005739)
cytosol (GO:0005829)
mitochondrial inner membrane
(GO:0005743)
extracellular region (GO:0005576)
nucleus (GO:0005634)

5596

MAPK4

mitogen-activated protein kinase 4

5866

RAB3IL1

RAB3A interacting protein (rabin3)-like 1

5954

RCN1

reticulocalbin 1, EF-hand calcium binding domain

5965

RECQL

RecQ protein-like (DNA helicase Q1-like)

DNA repair (GO:0006281)

ATP binding (GO:0005524)

nucleus (GO:0005634)

6124

RPL4

ribosomal protein L4

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6133

RPL9

ribosomal protein L9

translational elongation (GO:0006414)

RNA binding (GO:0003723)

cytosolic large ribosomal subunit
(GO:0022625)
cytosol (GO:0005829)

6134

RPL10

ribosomal protein L10

translational elongation (GO:0006414)

6135

RPL11

ribosomal protein L11

translational elongation (GO:0006414)

structural constituent of ribosome
(GO:0003735)
rRNA binding (GO:0019843)

guanyl-nucleotide exchange factor activity (GO:0005085)
calcium ion binding (GO:0005509)

endoplasmic reticulum (GO:0005783)

6138

RPL15

ribosomal protein L15

translational elongation (GO:0006414)

RNA binding (GO:0003723)

cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosol (GO:0005829)

6139

RPL17

ribosomal protein L17

RNA binding (GO:0003723)

cytosol (GO:0005829)

6141

RPL18

ribosomal protein L18

positive regulation of I-kappaB kinase/NFkappaB cascade (GO:0043123)
translational elongation (GO:0006414)

RNA binding (GO:0003723)

6146

RPL22

ribosomal protein L22

translational elongation (GO:0006414)

heparin binding (GO:0008201)

6156

RPL30

ribosomal protein L30

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6157

RPL27A

ribosomal protein L27a

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6159

RPL29

ribosomal protein L29

translational elongation (GO:0006414)

heparin binding (GO:0008201)

6175

RPLP0

ribosomal protein, large, P0

translational elongation (GO:0006414)

RNA binding (GO:0003723)

cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)
cytosolic large ribosomal subunit
(GO:0022625)

233
6181

RPLP2

ribosomal protein, large, P2

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6185

RPN2

ribophorin II

dolichyl-diphosphooligosaccharide-protein
glycotransferase activity (GO:0004579)
RNA binding (GO:0003723)
rRNA binding (GO:0019843)

6187

RPS2

ribosomal protein S2

protein amino acid N-linked glycosylation via
asparagine (GO:0018279)
translational elongation (GO:0006414)

6191

RPS4X

ribosomal protein S4, X-linked

translational elongation (GO:0006414)

6201

RPS7

ribosomal protein S7

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6207

RPS13

ribosomal protein S13

translational elongation (GO:0006414)

RNA binding (GO:0003723)

6209

RPS15

ribosomal protein S15

translational elongation (GO:0006414)
nuclear mRNA splicing, via spliceosome
(GO:0000398)
calcium ion transport (GO:0006816)

7045

TGFBI

solute carrier family 3 (activators of dibasic and neutral
amino acid transport), member 2
transforming growth factor, beta-induced, 68kDa

visual perception (GO:0007601)

structural constituent of ribosome
(GO:0003735)
transcription corepressor activity
(GO:0003714)
calcium:sodium antiporter activity
(GO:0005432)
integrin binding (GO:0005178)

7058

THBS2

thrombospondin 2

cell adhesion (GO:0007155)

heparin binding (GO:0008201)

7094

TLN1

talin 1

cytoskeletal anchoring at plasma membrane
(GO:0007016)

actin binding (GO:0003779)

6427

SFRS2

splicing factor, arginine/serine-rich 2

6520

SLC3A2

cytosolic large ribosomal subunit
(GO:0022625)
endoplasmic reticulum (GO:0005783)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
cytosolic small ribosomal subunit
(GO:0022627)
PML body (GO:0016605)
melanosome (GO:0042470)
proteinaceous extracellular matrix
(GO:0005578)
platelet alpha granule lumen
(GO:0031093)
focal adhesion (GO:0005925)

7120

TMSL6

thymosin-like 6 (pseudogene)

7168

TPM1

tropomyosin 1 (alpha)

sarcomere (GO:0030017)

TPM2

tropomyosin 2 (beta)

regulation of muscle contraction
(GO:0006937)
regulation of ATPase activity (GO:0043462)

actin binding (GO:0003779)

7169

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

7203

CCT3

chaperonin containing TCP1, subunit 3 (gamma)

protein folding (GO:0006457)

ATP binding (GO:0005524)

cytoskeleton (GO:0005856)
microtubule (GO:0005874)

7278

TUBA3C

tubulin, alpha 3c

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

7284

TUFM

Tu translation elongation factor, mitochondrial

translational elongation (GO:0006414)

GTPase activity (GO:0003924)

mitochondrion (GO:0005739)

7385

UQCRC2

ubiquinol-cytochrome c reductase core protein II

proteolysis (GO:0006508)

mitochondrion (GO:0005739)

7408

VASP

vasodilator-stimulated phosphoprotein

cell motility (GO:0006928)

metalloendopeptidase activity
(GO:0004222)
actin binding (GO:0003779)

7414

VCL

vinculin

lamellipodium biogenesis (GO:0030032)

actin binding (GO:0003779)

focal adhesion (GO:0005925)

7791

ZYX

zyxin

signal transduction (GO:0007165)

zinc ion binding (GO:0008270)

focal adhesion (GO:0005925)

8294

HIST1H4I

histone cluster 1, H4i

8301

PICALM

phosphatidylinositol binding clathrin assembly protein

receptor-mediated endocytosis (GO:0006898) phosphatidylinositol binding (GO:0005545)

8407

TAGLN2

transgelin 2

muscle development (GO:0007517)

protein binding (GO:0005515)

8802

SUCLG1

succinate-CoA ligase, alpha subunit

tricarboxylic acid cycle (GO:0006099)

actin cytoskeleton (GO:0015629)

Golgi apparatus (GO:0005794)

8815

BANF1

barrier to autointegration factor 1

provirus integration (GO:0019047)

succinate-CoA ligase (ADP-forming) activity mitochondrial matrix (GO:0005759)
(GO:0004775)
DNA binding (GO:0003677)
nucleus (GO:0005634)

8968

HIST1H3F

histone cluster 1, H3f

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

8974

P4HA2

procollagen-proline, 2-oxoglutarate 4-dioxygenase
(proline 4-hydroxylase), alpha polypeptide II
PDZ and LIM domain 7 (enigma)

protein metabolic process (GO:0019538)

procollagen-proline 4-dioxygenase activity
(GO:0004656)
receptor-mediated endocytosis (GO:0006898) zinc ion binding (GO:0008270)

cytoskeleton (GO:0005856)

ATP synthase, H+ transporting, mitochondrial F0
complex, subunit F2
protein disulfide isomerase family A, member 4

ATP biosynthetic process (GO:0006754)

mitochondrion (GO:0005739)

9260

PDLIM7

9551

ATP5J2

9601

PDIA4

protein secretion (GO:0009306)

hydrogen ion transmembrane transporter
activity (GO:0015078)
protein disulfide isomerase activity
(GO:0003756)

nucleus (GO:0005634)
endoplasmic reticulum (GO:0005783)

melanosome (GO:0042470)
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9689

BZW1

basic leucine zipper and W2 domains 1

9948

WDR1

WD repeat domain 1

regulation of transcription, DNA-dependent
(GO:0006355)
sensory perception of sound (GO:0007605)

10095

ARPC1B

actin related protein 2/3 complex, subunit 1B, 41kDa

cell motility (GO:0006928)

binding (GO:0005488)

cytoplasm (GO:0005737)

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

actin binding (GO:0003779)

cytoplasm (GO:0005737)

10097

ACTR2

ARP2 actin-related protein 2 homolog (yeast)

cell motility (GO:0006928)

ATP binding (GO:0005524)

cytoplasm (GO:0005737)

10105

PPIF

peptidylprolyl isomerase F (cyclophilin F)

protein folding (GO:0006457)

10109

ARPC2

actin related protein 2/3 complex, subunit 2, 34kDa

cytoskeleton (GO:0005856)

10130

PDIA6

protein disulfide isomerase family A, member 6

regulation of actin filament polymerization
(GO:0030833)
protein folding (GO:0006457)

peptidyl-prolyl cis-trans isomerase activity
(GO:0003755)
actin binding (GO:0003779)

10226

M6PRBP1

mannose-6-phosphate receptor binding protein 1

vesicle-mediated transport (GO:0016192)

10376

TUBA1B

tubulin, alpha 1b

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

10383

TUBB2C

tubulin, beta 2C

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

cytoskeleton (GO:0005856)

10399

GNB2L1

guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1

receptor binding (GO:0005102)

cytoplasm (GO:0005737)

10409

BASP1

brain abundant, membrane attached signal protein 1

10492

SYNCRIP

10514

MYBBP1A

synaptotagmin binding, cytoplasmic RNA interacting
protein
MYB binding protein (P160) 1a

10525

HYOU1

10575

CCT4

10594

10631

protein disulfide isomerase activity
(GO:0003756)

mitochondrial matrix (GO:0005759)

melanosome (GO:0042470)
endosome (GO:0005768)

cytoskeleton (GO:0005856)
mRNA processing (GO:0006397)

RNA binding (GO:0003723)

microsome (GO:0005792)

DNA-directed DNA polymerase activity
(GO:0003887)
ATP binding (GO:0005524)

nucleus (GO:0005634)

hypoxia up-regulated 1

regulation of transcription, DNA-dependent
(GO:0006355)
response to stress (GO:0006950)

chaperonin containing TCP1, subunit 4 (delta)

protein folding (GO:0006457)

ATP binding (GO:0005524)

melanosome (GO:0042470)

PRPF8

PRP8 pre-mRNA processing factor 8 homolog (S.
cerevisiae)

nuclear mRNA splicing, via spliceosome
(GO:0000398)

nuclear speck (GO:0016607)

POSTN

periostin, osteoblast specific factor

skeletal development (GO:0001501)

RNA splicing factor activity,
transesterification mechanism
(GO:0031202)
heparin binding (GO:0008201)

10694

CCT8

chaperonin containing TCP1, subunit 8 (theta)

protein folding (GO:0006457)

ATPase activity, coupled (GO:0042623)

10787

NCKAP1

NCK-associated protein 1

apoptosis (GO:0006915)

protein binding (GO:0005515)

integral to membrane (GO:0016021)

10979

FERMT2

fermitin family homolog 2 (Drosophila)

regulation of cell shape (GO:0008360)

protein binding (GO:0005515)

stress fiber (GO:0001725)

10985

GCN1L1

translation factor activity, nucleic acid
binding (GO:0008135)
protein binding (GO:0005515)

cytoplasm (GO:0005737)

IMMT

GCN1 general control of amino-acid synthesis 1-like 1
(yeast)
inner membrane protein, mitochondrial (mitofilin)

regulation of translation (GO:0006417)

10989
11098

PRSS23

protease, serine, 23

proteolysis (GO:0006508)

11117

EMILIN1

elastin microfibril interfacer 1

phosphate transport (GO:0006817)
COPI coating of Golgi vesicle (GO:0048205)

11316

COPE

coatomer protein complex, subunit epsilon

22872

SEC31A

SEC31 homolog A (S. cerevisiae)

22874

PLEKHA6

ER to Golgi vesicle-mediated transport
(GO:0006888)
pleckstrin homology domain containing, family A member 6

22995

CEP152

centrosomal protein 152kDa

23451

SF3B1

splicing factor 3b, subunit 1, 155kDa

23474

ETHE1

ethylmalonic encephalopathy 1

endoplasmic reticulum (GO:0005783)

proteinaceous extracellular matrix
(GO:0005578)
cytoplasm (GO:0005737)

mitochondrial inner membrane
(GO:0005743)
nucleus (GO:0005634)

serine-type endopeptidase activity
(GO:0004252)
extracellular matrix structural constituent
(GO:0005201)
protein binding (GO:0005515)

COPI vesicle coat (GO:0030126)

protein binding (GO:0005515)

COPII vesicle coat (GO:0030127)

RNA splicing factor activity,
transesterification mechanism
(GO:0031202)
zinc ion binding (GO:0008270)

nuclear speck (GO:0016607)

cytoplasm (GO:0005737)

centrosome (GO:0005813)
nuclear mRNA splicing, via spliceosome
(GO:0000398)

mitochondrial matrix (GO:0005759)
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23603

CORO1C

coronin, actin binding protein, 1C

phagocytosis (GO:0006909)

actin binding (GO:0003779)

actin cytoskeleton (GO:0015629)

25796

PGLS

6-phosphogluconolactonase

pentose-phosphate shunt (GO:0006098)

6-phosphogluconolactonase activity (GO:0017057)

28298

Rpl32

ribosomal protein L32

translation (GO:0006412)

structural constituent of ribosome
(GO:0003735)

28972

SPCS1

29956

LASS2

signal peptidase complex subunit 1 homolog (S.
cerevisiae)
LAG1 homolog, ceramide synthase 2

29995

LMCD1

30846

EHD2

30968
55226

transcription factor activity (GO:0003700)

cytosolic large ribosomal subunit
(GO:0022625)
integral to endoplasmic reticulum
membrane (GO:0030176)
nucleus (GO:0005634)

LIM and cysteine-rich domains 1

zinc ion binding (GO:0008270)

cellular_component (GO:0005575)

EH-domain containing 2

GTPase activity (GO:0003924)

nucleus (GO:0005634)

STOML2

stomatin (EPB72)-like 2

receptor binding (GO:0005102)

cytoskeleton (GO:0005856)

NAT10

N-acetyltransferase 10

N-acetyltransferase activity (GO:0008080)

nucleus (GO:0005634)

55324

ABCF3

ATP-binding cassette, sub-family F (GCN20), member 3

55379

LRRC59

leucine rich repeat containing 59

57455

REXO1

REX1, RNA exonuclease 1 homolog (S. cerevisiae)

58477

SRPRB

signal recognition particle receptor, B subunit

63905

MANBAL

mannosidase, beta A, lysosomal-like

proteolysis (GO:0006508)
regulation of transcription, DNA-dependent
(GO:0006355)

metabolic process (GO:0008152)

ATPase activity (GO:0016887)

regulation of transcription, DNA-dependent
(GO:0006355)

protein binding (GO:0005515)

microsome (GO:0005792)

exonuclease activity (GO:0004527)

chromatin (GO:0000785)

GTP binding (GO:0005525)

endoplasmic reticulum (GO:0005783)
integral to membrane (GO:0016021)

64098

PARVG

parvin, gamma

cell-matrix adhesion (GO:0007160)

64307

Rpl24

ribosomal protein L24

translation (GO:0006412)

79068

FTO

fat mass and obesity associated

79664

NARG2

NMDA receptor regulated 2

79709

GLT25D1

glycosyltransferase 25 domain containing 1

81876

RAB1B

RAB1B, member RAS oncogene family

84617

TUBB6

tubulin, beta 6

84790

TUBA1C

85443

DCLK3

92755

LOC92755

hypothetical gene LOC92755

actin binding (GO:0003779)

cytoskeleton (GO:0005856)

structural constituent of ribosome
(GO:0003735)
determination of left/right symmetry (GO:0007368)

ribosome (GO:0005840)

lipopolysaccharide biosynthetic process
(GO:0009103)
regulation of transcription, DNA-dependent
(GO:0006355)
microtubule-based movement (GO:0007018)

transferase activity, transferring glycosyl
groups (GO:0016757)
ATP binding (GO:0005524)

endoplasmic reticulum (GO:0005783)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

tubulin, alpha 1c

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

doublecortin-like kinase 3

protein amino acid phosphorylation
(GO:0006468)

protein serine/threonine kinase activity
(GO:0004674)

nucleus (GO:0005634)

nucleus (GO:0005634)

Golgi apparatus (GO:0005794)

94081

SFXN1

sideroflexin 1

iron ion transport (GO:0006826)

iron ion binding (GO:0005506)

mitochondrion (GO:0005739)

94239

H2AFV

H2A histone family, member V

nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

nucleus (GO:0005634)

112464

PRKCDBP

protein kinase C, delta binding protein

negative regulation of cell cycle (GO:0045786)

167681

PRSS35

protease, serine, 35

proteolysis (GO:0006508)

extracellular region (GO:0005576)

203068

TUBB

tubulin, beta

microtubule-based movement (GO:0007018)

serine-type endopeptidase activity
(GO:0004252)
GTPase activity (GO:0003924)

cytoskeleton (GO:0005856)

347733

TUBB2B

tubulin, beta 2B

microtubule-based movement (GO:0007018)

GTPase activity (GO:0003924)

microtubule (GO:0005874)

388474

LOC388474

similar to ribosomal protein L7a

translation (GO:0006412)

ribosome (GO:0005840)

392447

hCG_1644323

hCG1644323

translation (GO:0006412)

structural constituent of ribosome
(GO:0003735)
structural constituent of ribosome
(GO:0003735)

ribosome (GO:0005840)
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402221

LOC402221

actin pseudogene

554313

HIST2H4B

histone cluster 2, H4b

562774
641293

LOC641293

ribosomal protein L21 pseudogene

protein binding (GO:0005515)
nucleosome assembly (GO:0006334)

DNA binding (GO:0003677)

collagen catabolic process (GO:0030574)

oxidoreductase activity, acting on single donors with incorporation of molecular
oxygen, incorporation of two atoms of oxygen (GO:0016702)
structural constituent of ribosome
ribosome (GO:0005840)
(GO:0003735)

translation (GO:0006412)

nucleus (GO:0005634)
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Appendix C
Protocols used for background subtraction from fluorescence inages acquired using CoolSnap EZ camera (Photometrics,

Tucson, AZ) mounted on a Nikon Eclipse TE 2000-S inverted microscope (Nikon, Melville, NY)
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Acquiring images
• Start ¬ Program ¬NIS Elements F¬ nis_f.exe
• Be sure that the ‘Live’ button is clicked in the Camera section within the left hand side panel
• Focus the microscope on your sample ¬ Click on ‘Autoexposure’ ¬ Note the autoexposure value ¬ Click on
“Capture”
• Save the image (top panel - ‘save as’) as a TIFF file.
• Now acquire an image of your control at the same autoexposure value as your sample image…..NOTE this step
is important to be able to compare the two images and subtract your background.

Photoshop steps
File ¬ Open¬ open both your sample and the control image.
NOTE: if you want to overlay DAPI along with your stain, you will have to open 4 images:
a) Stain_sample
b) Stain_control
c) DAPI_sample…same precise spot,
d) DAPI_control…not necessarily the same spot as your stain_control image (just a reference)
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Things to note:
The images should be at a 100% …the title bar of the image will
read xxxyyy.tif@100%(Gray) All the images should be the same size.
Right Click on the title bar ¬ Image size, Note image size.
Prefered - Width - 696 pixels , Height - 520 pixels
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Open a new image--- File ¬ New
Within the ‘New’ Window, make sure that the Width and Height match with your image size and in Mode RGB color must be selected
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Background subtraction
Click on your control image
Go to image on the menu-bar and click on histogram. Note the value of the mean intensity, click OK. In older versions of
photoshop the way to get the histogram is by Windows ¬ Histogram

Click on your sample image
Go to Image¬ Adjustments¬ Levels
In the ‘Levels’ window, within the Input levels boxes, enter the mean noted in the control image.
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There will be a reduction in the background of the sample image.
Now copy the content of the background subtracted image (Select the image by Ctrl+A followed by copy Ctrl+C)
Click on the window of the new image, click on the appropriate channel and paste the image in image window. For eg select
channel Green for FITC. Your image will not show up green, it will when you select RGB

Similarly subtract background for DAPI and copy the image and select the blue channel of the new image and paste the blue
image
Unselect the RGB as well the RED channel so as to view the colours of the stains

243
Before saving your final image do not forget to delete the red (unused channel)
Select the red channel
Go to Image¬ Adjustments¬ Levels
Set output values as 0 to 0
Save.
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Appendix D

A) Preliminary results for microwell studies
B) Representative image for quantification of positive expression of pluripotent markers SSEA3 and SSEA4 using cytospin
C) Representative images of hPSCs cultured on lyophilized acellular substrates
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A) Preliminary results for microwell studies

Figure 1: Schematic of the microwell slide fabrication [72]

A

B

C

Figure 2: Representative images of hPSCs grown in the microwell with regular media changes (A), cells collected from the
media on Day 40 were plated on MEF formed colonies (B) and stained positive for alkaline phosphatase (C), Scale bar =
100μm.
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A

B

Figure 3: Representative images of hPSCs grown in the microwell, collected on Day 40 and plated on MEFs formed colonies
that stained positive for SSEA4 (A) and OCT$ (B), Scale bar = 100μm

A

B

Figure 4: Live dead assay was performed on cells in 100 and 300 μm microwell slide, Scale bar = 100μm
Green dye stains for live cells,,Red dye stains for dead cells
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B) Representative image for quantification of positive expression of pluripotent markers SSEA3 and SSEA4 using
cytospin

Figure 1: Representative images of hPSCs, BG01v (A,B) and WA09 (C,D) stained for pluripotent markers SSEA3 (A, C) and
SSEA4 (B,D) for quantification of marker expression. Scale bar = 100μm
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C) Representative images of hPSCs cultured on lyophilized acellular substrates

Figure 1: Representative images of hPSCs, BG01v (A,C) and WA09 (B,D) stained for pluripotent markers alkaline
phosphatase (C,D). Scale bar = 100μm
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